<SEC-DOCUMENT>0001493152-23-012135.txt : 20230413
<SEC-HEADER>0001493152-23-012135.hdr.sgml : 20230413
<ACCEPTANCE-DATETIME>20230413161516
ACCESSION NUMBER:		0001493152-23-012135
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230413
FILED AS OF DATE:		20230413
DATE AS OF CHANGE:		20230413

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		23818517

	BUSINESS ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103
		BUSINESS PHONE:		646-813-4701

	MAIL ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Rule
14a-101)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
REQUIRED IN PROXY STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Amendment
No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &thinsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&#9744;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>ABEONA
    THERAPEUTICS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Registrant as Specified in its Charter)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Person(s) Filing Proxy Statement, if Other Than the Registrant)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6555
Carnegie Ave., 4th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleveland,
OH 44103</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>646-813-4701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
13, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
Our Stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Abeona Therapeutics Inc. (the
&ldquo;Company&rdquo;) to be held virtually on Wednesday, May 17, 2023 at 9:00 a.m., Eastern Time. Our Annual Meeting will be held in
a virtual format only. You will be able to attend the Annual Meeting, vote and submit your questions during the Annual Meeting via a
live webcast through the link www.virtualshareholdermeeting.com/ABEO2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice of Annual Meeting and the proxy statement that follow describe the business to be considered and acted upon by stockholders of
the Company at the Annual Meeting. Please carefully review the information contained in the proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IT
IS VERY IMPORTANT THAT YOU MARK, SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD IN THE ENVELOPE PROVIDED AS SOON AS POSSIBLE. YOU MAY
VIRTUALLY ATTEND THE ANNUAL MEETING BY VISITING WWW.VIRTUALSHAREHOLDERMEETING.COM/ABEO2023 ON THE MEETING DATE. IF YOU VIRTUALLY ATTEND
THE ANNUAL MEETING AND WISH TO VOTE AT THE ANNUAL MEETING, YOU MAY REVOKE YOUR PROXY AT THAT TIME BY REQUESTING THE RIGHT TO VOTE DURING
THE ANNUAL MEETING. YOU MAY ALSO REVOKE YOUR PROXY AT ANY TIME BEFORE IT IS EXERCISED BY VOTING, BY SUBMITTING ANOTHER PROXY BEARING
A LATER DATE, OR BY GIVING NOTICE IN WRITING TO OUR SECRETARY NOT LATER THAN THE DAY PRIOR TO THE ANNUAL MEETING.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Vishwas Seshadri</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas
    Seshadri </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6555
Carnegie Ave., 4th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleveland,
OH 44103</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>646-813-4701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_1"></A>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
be held on Wednesday, May 17, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLEASE
TAKE NOTICE that the 2023 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Abeona Therapeutics Inc. (the &ldquo;Company&rdquo;)
will be held virtually over the Internet on Wednesday, May 17, 2023, at 9:00 a.m., Eastern Time, for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To elect Michael Amoroso
    and Christine Silverstein as Class 1 directors to hold office for a term of three years and until their successors are elected and
    qualified;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To approve the Abeona Therapeutics
    Inc. 2023 Equity Incentive Plan;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To approve, on an advisory basis, the compensation
    of the Company&rsquo;s named executive officers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To ratify the appointment
    of Whitley Penn LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the foregoing, the Annual Meeting will include the transaction of such other business as may properly come before the Annual
Meeting, or any adjournment(s), continuation(s), rescheduling(s) or postponement(s) thereof. The Board of Directors has fixed the close
of business on Tuesday, March 29, 2023 (the &ldquo;Record Date&rdquo;), as the record date for the determination of stockholders entitled
to receive notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. Only stockholders of record at
the close of business on the Record Date are entitled to notice of and to vote at the Annual Meeting. A complete list of stockholders
entitled to vote at the Annual Meeting will be available for inspection by stockholders at our offices during normal business hours,
during the 10 days prior to the Annual Meeting as well as during the Annual Meeting at www.virtualshareholdermeeting.com/ABEO2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
relating to the proposals described above is set forth in the accompanying proxy statement. Please carefully review the proxy statement,
which is accompanied by our annual report for the fiscal year ended December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are invited to attend the Annual Meeting to be held virtually over the Internet on Wednesday, May 17, 2023 at 9:00 a.m., Eastern Time.
YOUR VOTE IS IMPORTANT. If you do not expect to virtually attend the Annual Meeting, or if you do plan to virtually attend but wish to
vote by proxy, please complete, date, sign and mail the enclosed proxy card in the return envelope provided addressed to Vote Processing,
c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. Proxies will also be accepted as follows: (1) via the Internet by accessing www.proxyvote.com
and following the on-screen instructions or scanning the QR code on the proxy card with your smartphone; (2) by calling toll-free at
1-800-690-6903 from any touch-tone telephone and following the instructions; (3) by signing, dating and returning your proxy card in
the prepaid enclosed envelope and (4) by attending the virtual Annual Meeting at www.virtualshareholdermeeting.com/ABEO2023. You should
have your proxy card available in front of you when you log onto the Internet or call. You can vote online or by phone until 11:59 p.m.
Eastern Time the day before the Annual Meeting.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Vishwas Seshadri</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas
    Seshadri </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    &amp; Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleveland,
OH</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
13, 2023</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ANNUAL
MEETING OF STOCKHOLDERS TO BE HELD ON MAY 17, 2023</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Notice of Meeting, proxy statement, proxy card and annual report on</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
10-K for the year ended December 31, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>are
available at www.proxyvote.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors (the &ldquo;Board&rdquo;) of Abeona Therapeutics Inc. (&ldquo;Abeona&rdquo; or the &ldquo;Company&rdquo;) is providing
this Proxy Statement in connection with Abeona&rsquo;s 2023 Annual Meeting of Stockholders to be held virtually over the Internet at
www.virtualshareholdermeeting.com/ABEO2023 on Wednesday, May 17, 2023, at 9:00 a.m. Eastern Time, and any adjournment or postponement
thereof (the &ldquo;Annual Meeting&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
materials or a Notice of Internet Availability of Proxy Materials (the &ldquo;Notice&rdquo;) are being first released or mailed to stockholders
on or about April 13, 2023. In accordance with rules and regulations adopted by the Securities and Exchange Commission (the &ldquo;SEC&rdquo;),
Abeona may furnish proxy materials, including the Proxy Statement, proxy card and annual report on Form 10-K for the year ended December
31, 2022, by providing Internet access to those documents, instead of mailing a printed copy of its proxy materials to each stockholder
of record. This Proxy Statement and our Annual Report are available at www.proxyvote.com.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap"><B>Page <BR>
    Number</B></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#S_1"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice of Annual Meeting of Stockholders</U></FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Statement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance Matters</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Report</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation of Directors</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pay Versus Performance</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Proposals
    to Be Voted Upon</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 1 &ndash; Election of Directors</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap">17</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 2 &ndash; Approval of the Abeona Therapeutics Inc. 2023 Equity Incentive Plan</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 3 &ndash; Advisory Vote on the Compensation of the Company&rsquo;s Named Executive Officers</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal 4 &ndash; Ratification of Appointment of Whitley Penn LLP as the Company&rsquo;s Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Matters</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap">35</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#S_2">Appendix A &ndash; Abeona Therapeutics Inc. 2023 Equity Incentive Plan</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; white-space: nowrap">A-1</TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>PROXY
STATEMENT SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights information contained elsewhere in this proxy statement. This summary does not contain all information that you should
consider, and you should review all of the information contained in the proxy statement before voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
Meeting of Stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Time:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9:00
    a.m. Eastern Time</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Location:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Online
    only at <U>www.virtualshareholdermeeting.com/ABEO2023</U>. Stockholders will not be able to attend the Annual Meeting in person.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Record
    Date:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    29, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
    as of the Record Date are entitled to vote. Each share of common stock is entitled to one vote.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposals
and Voting Recommendations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in"><B><I>Proposal
    No.</I></B></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Proposal</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
    Recommendation</I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">1</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect Michael Amoroso and Christine Silverstein as Class 1 Directors to hold office for a term of three years and until their successors
    are elected and qualified</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
    EACH NOMINEE</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">2</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve the Abeona Therapeutics Inc. 2023 Equity Incentive Plan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">3</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, on an advisory basis, the compensation of the Company&rsquo;s named executive officers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">4</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of Whitley Penn LLP as our independent registered public accounting firm for the fiscal year ending December
    31, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Methods</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can vote in one of four ways:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Visit www.proxyvote.com to vote VIA THE INTERNET</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Call
    toll-free at 1-800-690-6903 and follow the instructions to vote VIA TELEPHONE</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sign, date and return your proxy card in the prepaid
    enclosed envelope to vote BY MAIL</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attend the meeting to vote VIA THE INTERNET</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6555
Carnegie Ave., 4th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleveland,
OH 44103</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(646)
813-4701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNUAL
MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
Be Held on Wednesday, May 17, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement is furnished by Abeona Therapeutics Inc., a Delaware corporation (&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;Abeona&rdquo;
or the &ldquo;Company&rdquo;), to holders of its common stock, par value $0.01 per share (&ldquo;Common Stock&rdquo;), in connection
with the solicitation of proxies by our Board of Directors (the &ldquo;Board&rdquo;) for use at our Annual Meeting of Stockholders (the
&ldquo;Annual Meeting&rdquo;), and at any and all adjournments or postponements thereof. This proxy statement and the accompanying form
of proxy is first being sent to holders of Common Stock on or about April 13, 2023. Our mailing address and the location of our
principal executive offices is 6555 Carnegie Ave., 4th Floor, Cleveland, OH 44103. Our telephone number is (646) 813-4701. The purposes
of the Annual Meeting are set forth in the Notice of Annual Meeting of Stockholders (the &ldquo;Notice of Annual Meeting&rdquo;), which
accompanies this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a virtual format for our Annual Meeting to provide a consistent experience to all stockholders regardless of location. We
have designed the virtual Annual Meeting to provide substantially the same opportunities to participate as you would have at an in-person
meeting, including the ability to vote. Detailed instructions on how to vote and submit your questions at the Annual Meeting may be found
online at <U>www.virtualshareholdermeeting.com/ABEO2023</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
shares of Common Stock represented by properly executed proxies or voting instruction forms will be voted at the Annual Meeting in accordance
with the directions marked on the proxies or voting instruction forms, unless such proxies or voting instruction forms have previously
been revoked. If no directions are indicated on such proxies or voting instruction forms, they will be voted FOR THE NOMINEE in Proposal
1 &ndash; the election of the nominee named under Election of Directors; FOR Proposal 2 &ndash; to approve the Abeona Therapeutics Inc.
2023 Equity Incentive Plan; FOR Proposal 3 &ndash; to approve, on an advisory basis, the compensation of the Company&rsquo;s named executive
officers; and FOR Proposal 4 &ndash; the ratification of the appointment of Whitley Penn LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any other matters are properly presented at the Annual Meeting for action, the proxy holders will vote the proxies (which confer discretionary
authority upon such holders to vote on such matters) in accordance with their best judgment, subject to compliance with Rule 14a-4(c)
of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Each proxy executed and returned by a stockholder
may be revoked at any time before it is voted by timely submission of a written notice of revocation or by submission of a duly executed
proxy bearing a later date (in either case directed to the Secretary of the Company not later than the day prior to the Annual Meeting),
or, if a stockholder is virtually present at the Annual Meeting, he or she may elect to revoke his or her proxy and request the right
to vote his or her shares personally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares of Common Stock are registered directly in your name with our transfer agent, American Stock Transfer &amp; Trust Company,
you are considered a &ldquo;stockholder of record&rdquo; or a &ldquo;registered stockholder&rdquo; of those shares. You should follow
the instructions on the Notice of Annual Meeting to ensure that your vote is counted. Alternatively, you may virtually attend and vote
at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in an account at a bank, brokerage firm, or other similar organization (which we refer to as a &ldquo;broker&rdquo;),
then you are a beneficial owner of shares held in &ldquo;street name.&rdquo; In that case, you will have received these proxy materials
from the bank, brokerage firm, or other similar organization holding your account. As a beneficial owner, you will have to direct your
broker on how to vote the shares held in your account in accordance with your broker&rsquo;s requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the close of business on March 29, 2023, the record date for the Annual Meeting (the &ldquo;Record Date&rdquo;), the number of issued
and outstanding shares of our Common Stock entitled to vote was 17,831,018. Each share of Common Stock entitles its holder to one vote
with respect to all matters submitted to stockholders for a vote at the Annual Meeting. Consistent with the Company&rsquo;s amended and
restated bylaws (the &ldquo;Bylaws&rdquo;), uncontested director elections proceed by majority voting. In an uncontested election, a
nominee for director will be elected to the Board if the votes cast &ldquo;for&rdquo; such nominee&rsquo;s election exceed the votes
cast &ldquo;against&rdquo; such nominee&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
complete list of Company stockholders entitled to vote at the Annual Meeting will be available at our principal executive offices during
normal business hours, at least 10 days prior to the Annual Meeting and during the Annual Meeting at www.virtualshareholdermeeting.com/ABEO2023.
According to our Bylaws, the presence, through virtual attendance or by proxy, of the holders of one-third of the shares of Common Stock
outstanding and entitled to vote constitutes a quorum for the conduct of business at the Annual Meeting. Abstentions and broker non-votes
are counted as present for purposes of determining whether a quorum is present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
broker non-vote occurs when brokers, who hold their clients&rsquo; shares in street name, sign and submit proxies for such shares and
vote such shares on some matters but not others. This would occur when brokers have not received any instructions from their clients,
in which case the brokers, as the holders of record, are permitted to vote on &ldquo;routine&rdquo; matters, which include the ratification
of the appointment of an independent registered public accounting firm, but not on &ldquo;non-routine&rdquo; matters, such as the election
of directors and the adoption of the Abeona Therapeutics Inc. 2023 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal 1, the directors will be elected upon the affirmative vote of a majority of the votes cast. For Proposal 1, stockholders may
vote &ldquo;FOR,&rdquo; &ldquo;AGAINST,&rdquo; or &ldquo;ABSTAIN.&rdquo; Abstentions will have the effect of an &ldquo;AGAINST&rdquo;
such proposal. Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for Proposal 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals
2 and 3 each will be approved upon the affirmative vote of a majority of the outstanding shares of Common Stock present through virtual
attendance or by proxy at the Annual Meeting and entitled to vote on the respective Proposal. Stockholders may vote &ldquo;FOR&rdquo;
or &ldquo;AGAINST,&rdquo; or &ldquo;ABSTAIN&rdquo; from voting. Abstentions will have the effect of a vote &ldquo;AGAINST&rdquo; each
of Proposals 2 and 3, respectively. Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the votes
for Proposals 2 and 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
4, the ratification of Whitley Penn LLP as our independent public accountant, will be approved upon the affirmative vote of a majority
of the outstanding shares of Common Stock voting present through virtual attendance or by proxy at the Annual Meeting. Abstentions will
have the effect of a vote &ldquo;AGAINST&rdquo; such proposal. Brokers may vote on Proposal 4 absent instructions from the beneficial
owner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is not aware of any matters that will be brought before the Annual Meeting other than those matters specifically set forth in the
Notice of Annual Meeting. However, if any other matter properly comes before the Annual Meeting, it is intended that the persons named
in the enclosed form of proxy, or their substitutes acting thereunder, will vote on such matter in accordance with the recommendations
of the Board, or, if no such recommendations are made, in accordance with their best judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
expenses in connection with solicitation of proxies will be borne by us. We will also request brokers, dealers, banks and voting trustees,
and their nominees, to make available the Notice of Annual Meeting, this proxy statement, the accompanying form of proxy and our annual
report on Form 10-K for the fiscal year ended December 31, 2022 (the &ldquo;Annual Report&rdquo;) to beneficial owners and will reimburse
them for their expenses in forwarding these materials. We expect to solicit proxies primarily by mail, but our directors, officers and
employees may also solicit in person, by telephone or email, on behalf of the Board without additional compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of record as of the Record Date can attend the Annual Meeting online by logging onto our virtual forum at <U>www.virtualshareholdermeeting.com/ABEO2023
</U>and following the instructions provided on their proxy card, vote instruction card or &ldquo;Important Notice Regarding the Availability
of Proxy Materials.&rdquo; To participate in the Annual Meeting, you will need the 16-digit control number included on your proxy card,
voter instruction card or &ldquo;Important Notice Regarding the Availability of Proxy Materials.&rdquo; If you do not have this control
number at the time of the Annual Meeting, you will still be able to attend virtually, but you will not be able to vote or ask questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
virtual Annual Meeting platform is fully supported across browsers (Microsoft Edge, Firefox, Chrome, and Safari) and devices (desktops,
laptops, tablets, and cell phones) running the most updated version of applicable software and plugins. Attendees should ensure that
they have a strong Wi-Fi connection wherever they intend to participate in the virtual Annual Meeting. Attendees should also give themselves
plenty of time to log in and ensure that they can hear streaming audio prior to the start of the virtual Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement should be read together with our annual report for the fiscal year ended December 31, 2022, including the financial statements
and management&rsquo;s discussion and analysis of financial condition and results of operations contained therein.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_002"></A>Corporate
Governance Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Delaware General Corporation Law and our Bylaws, our business, property and affairs are managed by or under the direction of our
Board. Members of the Board are kept informed of our business through discussions with our senior management, including our Chief Executive
Officer, by reviewing materials provided to them and by participating in meetings of the Board and its committees. The Board is currently
comprised of nine directors. The Board meets during our fiscal year to review significant developments affecting us and to act on matters
requiring Board approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted a number of corporate governance documents, including charters for its Audit Committee, Compensation Committee and
Nominating and Corporate Governance Committee; corporate governance guidelines; a code of business conduct and ethics for employees,
executive officers and directors (including its principal executive officer and principal financial officer) and a whistleblower policy
regarding the treatment of complaints on accounting, internal accounting controls and auditing matters. All of these documents are available
on our website at www.abeonatherapeutics.com under the heading &ldquo;Investors &amp; Media&mdash;Corporate Governance&mdash;Governance
Documents,&rdquo; and a copy of any such document may be obtained, without charge, upon written request to the Company, c/o Investor
Relations, 6555 Carnegie Ave., 4<SUP>th</SUP> Floor, Cleveland, OH 44103.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
Communications with the Board</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has established a process for stockholders to send communications to it. Stockholders may send written communications to the Board
or individual directors to Abeona Therapeutics Inc., Board of Directors, c/o Corporate Secretary, 6555 Carnegie Ave., 4<SUP>th</SUP>
Floor, Cleveland, OH 44103. Stockholders also may send communications via email to IR@abeonatherapeutics.com with the notation &ldquo;Attention:
Corporate Secretary&rdquo; in the subject field. All communications will be reviewed by the Corporate Secretary of the Company, who will
determine whether such communications are relevant and for a proper purpose and appropriate for Board review and, if applicable, will
submit such communications to the Board on a periodic basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) and are subject to the Nasdaq rules and regulations governing director
independence. The Board has determined that each of Leila Alland, M.D., Mark J. Alvino, Faith L. Charles, Paul Mann, Todd Wider, M.D.
and Donald A. Wuchterl are independent under applicable Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Leadership Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has no set policy with respect to the separation of the roles of Chairman of the Board and principal executive officer. Michael
Amoroso currently serves as our Chairman of the Board and Vishwas Seshadri as Chief Executive Officer (principal executive officer).
Our Board currently does not have a lead independent director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board leadership structure is commonly utilized by other public companies in the United States, and we believe that it is effective for
us. We believe this leadership structure is appropriate for us given the size and scope of our business, the experience and active involvement
of our independent directors and our corporate governance practices, which include regular communication with and interaction between
and among the Chief Executive Officer, Chief Financial Officer and General Counsel and the independent directors. Of the current members
of our Board, six are independent from management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Diversity Matrix as of March 29, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 58%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Female</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Male</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Binary</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Did
                                            Not </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclose
    </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gender</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    number of directors: 9</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
    I: Gender Identity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
    II: Demographic Background</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">African
    American or Black</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alaskan
    Native or Native American</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asian</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hispanic
    or Latinx</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Native
    Hawaiian or Pacific Islander</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
    or more Races or Ethnicities</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did
    not disclose demographic background</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
of Directors&rsquo; Role in Risk Oversight</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is responsible for overseeing our management and operations, including overseeing our risk assessment and risk management functions.
We believe that our directors provide effective oversight of risk management functions. We perform a risk review on a regular basis wherein
the management team evaluates the risks we expect to face in the upcoming year and over a longer-term horizon. From this risk assessment,
plans are developed to deal with the risks identified. The results of this risk assessment are provided to the Board for its consideration
and review. In addition, members of our management periodically present to the Board the strategies, issues and plans for the areas of
our business for which they are responsible. While the Board oversees risk management, our management is responsible for day-to-day risk
management processes. Additionally, the Board requires that management raise exceptional issues to the Board. We believe this division
of responsibilities is the most effective approach for addressing the risks we face and that the Board leadership structure supports
this approach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Business Conduct and Ethics (the &ldquo;Code&rdquo;) that applies to all of our employees (including executive
officers) and directors. The Code is available on our website at www.abeonatherapeutics.com under the heading &ldquo;Investors &amp;
Media&mdash;Corporate Governance&mdash;Governance Documents.&rdquo; We intend to satisfy any disclosure requirements under applicable
SEC or Nasdaq rules regarding any waiver of a provision of the Code applicable to any executive officer or director, by posting such
information on such website. We shall provide to any person without charge, upon request, a copy of the Code. Any such request must be
made in writing to Abeona Therapeutics Inc., c/o Investor Relations, 6555 Carnegie Ave., 4<SUP>th</SUP> Floor, Cleveland, OH 44103.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our insider trading policy, directors, executive officers and employees generally may not engage in short-term, speculative trading in
Company stock, such as entering into short sales, buying, selling or writing puts or calls, or engaging in hedging or other derivative
transactions; hold Company stock in a margin account; or pledge Company stock as collateral for a loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officers
and Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current directors and executive officers are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
    of Office</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Amoroso</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director since March 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leila
    Alland, M.D. </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since April 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    J. Alvino</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since March 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faith
    L. Charles</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since March 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Mann</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since June 2020</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Silverstein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since March 2020</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todd
    Wider, M.D. </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since May 2015</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    A. Wuchterl</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since April 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas
    Seshadri, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer, Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since October 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Vazzano</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since March 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brendan
    O&rsquo;Malley, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since September 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws presently provide that our Board shall consist of three to 15 members, divided into three staggered
classes as nearly equal in number as possible. The Board is currently comprised of nine directors. Our directors serve for a term of
three years and until the respective election and qualification of their successors. Pursuant to our Bylaws, the Board selects our Chairman
of the Board and our executive officers. Each of our executive officers is selected by the Board for a term of one year or until the
executive officer&rsquo;s successor is duly elected and qualified or until such executive officer&rsquo;s resignation or removal. There
is no family relationship among any of our directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board established an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each of the committees
of the Board acts pursuant to a separate written charter adopted by the Board, each of which is available on our website at www.abeonatherapeutics.com
under &ldquo;Investors &amp; Media&mdash;Corporate Governance&mdash;Governance Documents.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee is currently comprised of Paul Mann (Chair), Mark J. Alvino and Faith L. Charles. The Board has determined that each
of Messrs. Mann and Alvino qualify as an &ldquo;audit committee financial expert,&rdquo; under applicable SEC rules and regulations.
The Audit Committee&rsquo;s responsibilities and duties are, among other things, to engage the independent auditors, review the audit
fees, supervise matters relating to audit functions and review and set internal policies and procedure regarding audits, accounting and
other financial controls. The Board has determined that Messrs. Mann and Alvino and Ms. Charles are independent under applicable SEC
and Nasdaq rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee is currently comprised of Mark J. Alvino (Chair), Leila Alland, M.D. and Todd Wider, M.D. All committee members
are non-employee directors under applicable SEC rules and are &ldquo;outside&rdquo; directors under Internal Revenue Code Section 162(m).
All Compensation Committee members also are independent under applicable SEC and Nasdaq rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee is currently comprised of Faith L. Charles (Chair), Leila Alland, M.D. and Donald A. Wuchterl.
The Nominating and Corporate Governance Committee is responsible for, among other things, considering potential Board members, making
recommendations to the full Board as to nominees for election to the Board, assessing the effectiveness of the Board and implementing
our corporate governance guidelines. All Nominating and Corporate Governance Committee members also are independent under applicable
SEC and Nasdaq rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings
Attendance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board held 14 meetings during the 2022 fiscal year. Each director attended 75% or more of the Board meetings and meetings of committees
of which he or she was a member that were held during the period of his or her service as a director in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee held four meetings during the 2022 fiscal year. The Compensation Committee did not hold any meetings during the 2022
fiscal year, but met on January 17, 2023, to discuss and take action on compensation matters for year-end 2022 (e.g., executive bonus
payouts); other matters before the Compensation Committee in 2022 were handled via unanimous written consent. The Nominating and Corporate
Governance Committee held two meetings during the 2022 fiscal year, and all members were present. All of the directors then currently
serving as director attended the 2022 annual meeting of stockholders. Although we currently do not require directors to attend annual
stockholder meetings, we do encourage directors to do so and welcome their attendance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delinquent
Section 16(a) Reports</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the 2022 fiscal year, one Form 4 for Dr. Seshadri was not timely filed with respect to one transaction identified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
and Executive Compensation Governance Principles</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted certain governance principles related to director and executive compensation as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual equity awards made
    to non-employee directors shall be granted on a different date than annual equity awards to executive officers. Final deliberations
    or voting on the compensation of non-employee directors (including any changes to the annual compensation package) shall be made
    at a different Board (or committee) meeting than any deliberations or voting on the compensation of executive officers (including
    any changes to the annual compensation package).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an annual basis, the
    Compensation Committee selects and retains an independent consultant to compare the Company&rsquo;s executive compensation levels,
    policies, practices and procedures to a set of peer companies selected by the Compensation Committee with input from the independent
    consultant. The independent consultant prepares and submits to the Compensation Committee a report summarizing this comparative study
    and its recommendations relating to executive compensation. The Company&rsquo;s executive officers play no substantive role in the
    selection or dismissal of the independent consultant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an annual basis, qualified
    experts in the field present recent developments and best practices concerning executive compensation to the Compensation Committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an annual basis, the
    proposed package for the non-employee director compensation must be recommended by the Compensation Committee to the Board following
    the receipt of a report from an independent consultant analyzing the non-employee director compensation package of the Company&rsquo;s
    peer companies.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outside
Compensation Consultants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
2022, the Compensation Committee engaged Radford Inc. (&ldquo;Radford&rdquo;) as an independent compensation consultant to provide certain
services related to executive and non-employee director compensation. Radford assisted with the Compensation Committee&rsquo;s review
of the Company&rsquo;s annual salary, bonus and equity compensation plans for executive officers and annual cash and equity compensation
for non-employee directors. Radford does not provide any other services to the Company unless approved by the Compensation Committee,
and no such services were provided in 2022. After considering the relevant factors, the Company determined that no conflicts of interest
have been raised in connection with the services Radford performed for the Compensation Committee in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>AUDIT
COMMITTEE REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
fulfilling its oversight responsibility, the Audit Committee reviewed and discussed our audited 2022 year-end financial statements with
management and with Whitley Penn LLP, our independent registered public accounting firm. The Audit Committee discussed with the independent
registered public accounting firm the matters required to be discussed by the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;)
Auditing Standard No. 61, <I>Communications with Audit Committees</I>. In addition, the Audit Committee received from the independent
registered public accounting firm written disclosures and the letter required by the applicable standards of the PCAOB. The Audit Committee
also discussed with the independent registered public accounting firm the auditors&rsquo; independence from management and the Company,
including a review of audit and non-audit fees and the matters covered by the written disclosures and letter provided by the independent
registered public accounting firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee discussed with Whitley Penn LLP the overall scope and plans for the audit. The Audit Committee met with Whitley Penn
LLP to discuss the results of its audit and reviews, its evaluations of the Company and its personnel, our internal controls and the
overall quality of our financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the reviews and discussions referred to above, the Audit Committee reviewed and recommended to the Board that our audited 2022 year-end
financial statements be included in our Annual Report, for filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Audit Committee Report shall not be deemed to be &ldquo;soliciting material&rdquo; or &ldquo;filed&rdquo; or incorporated by
reference in future filings with the SEC, or subject to the liabilities of Section 18 of the Exchange Act, except to the extent the Company
specifically incorporates it by reference into such future filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Mann, Chairman</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    J. Alvino</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faith
    L. Charles</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_004"></A>Compensation
of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>On
July 1, 2022, the Company effected a 25-for-1 reverse stock split of its issued and outstanding shares of Common Stock. As a result of
the reverse split, each 25 pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock. Share
amounts and prices disclosed in this proxy statement have been restated, as required, to reflect the reverse stock split as if it had
occurred on January 1, 2021.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
for Board Service in 2022.</I> Each director who is not also an Abeona employee is entitled to receive an annual board fee and an annual
committee fee for their service on each Board committee. These fees are paid in cash quarterly. In addition, we reimburse each director,
whether an employee or not, for the expense of attending Board and committee meetings. There were no additional fees paid for service
as a chairperson of a Board committee, with the exception of the Chairman of the Board who receives an additional $30,000 per year for
serving as Chairman. During 2022, the annual board fee was $50,000 and the annual committee fee was $7,500 per committee served.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, incumbent non-employee directors were each granted equity awards valued at $37,386 for service on the Board in 2022 consisting
of restricted stock. All equity awards were granted on a different date than any equity awards to executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation Table &ndash; 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Fees</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Earned or</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Paid</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Stock</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">in Cash</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left; padding-bottom: 1.5pt">Leila Alland, M.D.</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; width: 14%; text-align: right">65,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; width: 14%; text-align: right">37,386</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; width: 14%; text-align: right">102,386</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Mark J. Alvino</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">65,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">102,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Michael Amoroso</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">80,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">117,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Faith L. Charles</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">65,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">102,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Paul Mann</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">57,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">94,886</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas Seshadri <SUP>(2)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Christine Silverstein</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">50,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">87,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Todd Wider, M.D.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">57,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">94,886</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Donald A. Wuchterl</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">57,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">37,386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">94,886</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below represents the compensation paid to our directors during the year ended December 31, 2022:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the fair value
    of 13,400 shares of restricted stock granted on September 26, 2022. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Seshadri did not receive compensation for his services
    as a director.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Relationships and Related Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
occasion we may engage in certain related party transactions. Pursuant to our Audit Committee charter, our policy is that all related
party transactions are reviewed and approved by the Audit Committee. There were no related party transactions in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, as of December 31, 2022, information about shares of Common Stock outstanding and available for issuance
under our existing equity compensation plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Plan Category</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of securities to </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>be issued upon exercise </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of outstanding options, </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>warrants and rights</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted-average </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercise price of </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>outstanding options, </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>warrants and rights</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of securities </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>remaining available </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for future issuance </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>under equity </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>compensation plans </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(excluding securities </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>reflected in column (a))</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(a)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(b)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(c)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Equity compensation plans approved by security holders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; text-align: left">2015 Equity Incentive Plan</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">237,570</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">37.11</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">109,544</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2005 Equity Incentive Plan<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">32.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Equity compensation plans not approved by security holders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">240,770</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">37.04</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No further grants may be made under the 2005 Equity
    Incentive Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_005"></A>Security
Ownership of Certain Beneficial Owners and Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined beneficial ownership of our Common Stock as of March 29, 2023, in accordance with the rules of the SEC. These
rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with
respect to those securities. In addition, these rules require that the Company include shares of Common Stock issuable pursuant to the
vesting of restricted stock units and the exercise of stock options and warrants that are either immediately exercisable or exercisable
within 60 days of March 29, 2023. These shares are deemed to be outstanding and beneficially owned by the person holding those options
or warrants for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose
of computing the percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table
have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community
property laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Amount and Nature of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Beneficial Ownership</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">of Common</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Percent of</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-left: 0pt; font-weight: bold">Name and Address of Beneficial Owner</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; text-align: justify; padding-bottom: 1.5pt">Directors, Director Nominees, and Named Executive Officers:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leila Alland, M.D. <SUP>(3)</SUP></FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">20,414</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark J. Alvino <SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Amoroso <SUP>(5)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,018</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faith L. Charles <SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Mann <SUP>(6)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,907</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine Silverstein <SUP>(7)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,524</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todd Wider, M.D. <SUP>(6)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,907</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald A. Wuchterl <SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas Seshadri <SUP>(8)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brendan O&rsquo;Malley <SUP>(9)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,059</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Vazzano <SUB>(10)</SUB></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,458</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">All Directors, Director Nominees, and Named Executive Officers as a group (consisting of 11 persons)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">595,677</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; text-align: justify; padding-bottom: 1.5pt">5% Beneficial Owners:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adage Capital Partners, L.P. <SUP>(11)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,331,160</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nantahala Capital Management, L.P. <SUP>(12)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,359,687</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.6</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Point72 Asset Management, L.P. <SUP>(13)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,150,648</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice Capital, LLC <SUP>(14)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,106,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deerfield Mgmt, L.P. <SUP>(15)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,739,130</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EcoR1 Capital, LLC <SUP>(16)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,785,663</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes outstanding shares
    of Common Stock held plus all shares of Common Stock issuable upon exercise of options, warrants and other rights exercisable within
    60 days after March 29, 2023.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon 17,831,018 shares of Common Stock issued
    and outstanding as of March 29, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Alland, Ms. Charles
    and Mr. Wuchterl are each known to beneficially own an aggregate of 16,488 shares of our Common Stock and presently exercisable options
    for the purchase of 3,926 shares pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Alvino is known to
    beneficially own an aggregate of 14,488 shares of our Common Stock and presently exercisable options for the purchase of 3,926 shares
    pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Amoroso is known to
    beneficially own an aggregate of 39,936 shares of our Common Stock and presently exercisable options for the purchase of 29,082 shares
    of our Common Stock pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Mann and Dr. Wider
    are each known to beneficially own an aggregate of 14,944 shares of our Common Stock and presently exercisable options for the purchase
    of 1,963 shares pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms. Silverstein is known
    to beneficially own an aggregate of 18,144 shares of our Common Stock and presently exercisable options for the purchase of 18,380
    shares of our Common Stock pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Seshadri is known to
    beneficially own an aggregate of 165,732 shares of our Common Stock and presently exercisable options for the purchase of 12,416
    shares of our Common Stock pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. O&rsquo;Malley is known
    to beneficially own an aggregate of 93,623 shares of our Common Stock and presently exercisable options for the purchase of 8,397
    shares of our Common Stock pursuant to the 2015 Equity Incentive Plan.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Vazzano is known to beneficially own an aggregate
    of 94,458 shares of our Common Stock.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on information set
    forth in a Schedule 13G/A filed with the SEC on February 9, 2023 by Adage Capital Partners, L.P. and related entities. Adage Capital
    Partners L.P.&rsquo;s address is 200 Clarendon Street, 52<SUP>nd</SUP> Floor, Boston, MA 02116.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on information set forth in a Schedule 13G filed with the SEC on February 14, 2023 by Nantahala Capital Management, LLC and related
    entities. Point72 Asset Management, L.P.&rsquo;s address is 72 Cummings Point Road, Stamford, CT 06902.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on information set forth in a Schedule 13G/A filed with the SEC on February 14, 2023 by Point72 Asset Management, L.P. and related
    entities. The address of the principal business office of Point72 Associates, Point72 Asset Management, Point72 Capital Advisors,
    Inc. and Mr. Cohen is c/o Point 72 Asset Management, L.P. 72 Cummings Point Road, Stamford, CT 06902.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on information set
    forth in a Schedule 13G filed with the SEC on February 14, 2023 by Armistice Capital, LLC and related entities. Armistice Capital,
    LLC&rsquo;s address is 510 Madison Avenue, 7<SUP>th</SUP> Floor, New York, New York 10022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on information set
    forth in a Schedule 13G/A filed with the SEC on February 10, 2023 by Deerfield Mgmt, L.P. and related entities. Deerfield Mgmt, L.P.&rsquo;s
    address is 345 Park Avenue South, 12<SUP>th</SUP> Floor, New York, NY 10010.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on information set
    forth in a Schedule 13G filed with the SEC on November 14, 2022 by EcoR1 Capital, LLC and related entities. EcoR1 Capital, LLC&rsquo;s
    address is 357 Tehama Street #3, San Francisco, CA 94103.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, except as noted above, no person or entity is the beneficial owner of more than 5% of the voting power of the Company&rsquo;s
Common Stock.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_006"></A>Executive
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>On
July 1, 2022, the Company effected a 25-for-1 reverse stock split of its issued and outstanding shares of Common Stock. As a result of
the reverse split, each 25 pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock. Share
amounts and prices disclosed in this proxy statement have been restated, as required, to reflect the reverse stock split as if it had
occurred on January 1, 2021.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the aggregate compensation paid to: (i) our principal executive officer at the end of fiscal year 2022, Vishwas
Seshadri; (ii) an additional principal executive officer who was no longer serving in that capacity at the end of fiscal year 2021, Michael
Amoroso; (iii) an additional principal financial officer who was no longer serving in that capacity at the end of fiscal year 2022, Edward
Carr; and (iv) our only other executive officers other than our principal executive officer who were serving as an executive officer
at the end of fiscal year 2022, Joseph Vazzano and Brendan O&rsquo;Malley.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Summary
Compensation Table</U></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Non-Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">All</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Option</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Stock</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Incentive Plan</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Other</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">Name and</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Salary</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Bonus</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Compensation</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Compensation</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)(1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)(3)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)(4)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vishwas Seshadri <SUP>(5)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">2022</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">505,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">125,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">478,016</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">378,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">12,800</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 5%; text-align: right">1,499,816</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1.5pt">President and Chief Executive Officer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">254,552</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">744,570</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">558,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">8,853</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">1,566,475</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Joseph Vazzano <SUP>(6)</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Chief Financial Officer</I></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">307,769</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">341,270</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">197,333</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">12,200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">918,572</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brendan O&rsquo;Malley <SUP>(7)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">390,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">65,100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">224,070</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">231,235</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">12,200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">923,205</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1.5pt">General Counsel</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">335,484</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 11pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 11pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 11pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">430,284</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">281,560</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">120,281</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">11,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">1,179,209</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward Carr <SUP>(8)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2022</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">117,312</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">10,541</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">127,853</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1.5pt">Former Chief Accounting Officer and Chief Financial Officer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">360,985</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">634,210</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">416,880</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">146,204</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">11,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">1,569,879</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 1.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Michael Amoroso <SUP>(9)</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Former President and Chief Executive Officer</I></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2021</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">450,477</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">1,589,910</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">1,013,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">11,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right">3,064,987</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects cash
    retention bonuses. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects aggregate
    grant date fair value for the fiscal years presented, computed in accordance with ASC 718, in respect of option awards and restricted
    stock awards, as applicable. Our assumptions in determining fair value are described in Note 11 of Notes to Consolidated Financial
    Statements in Part II, Item 8 of the Annual Report. Amounts shown do not reflect the compensation actually received by the named
    executive officers. Stock and option awards for Mr. Carr were forfeited upon departure.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts shown
    reflect target-based cash incentive bonuses earned with respect to the fiscal years presented. For Dr. Seshadri, he declined to accept
    a cash incentive for performance for 2021. Amounts are based on his increased salary post-promotion. For Mr. Vazzano, amounts are
    based on his annualized base salary and prorated for time worked.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    employer matching contributions to the Company&rsquo;s 401(k) Defined Contribution Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Seshadri
    was promoted to President and Chief Executive Officer on October 15, 2021. Dr. Seshadri joined the Company on June 1, 2021, and served
    as SVP, Head of Research and Clinical Development prior to his appointment to President and Chief Executive Officer.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Vazzano
    was appointed as our Chief Financial Officer on March 14, 2022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. O&rsquo;Malley
    was promoted to General Counsel on September 20, 2021. Dr. O&rsquo;Malley joined Abeona in May 2019 as Chief IP Counsel and served
    as Head of Legal &amp; IP from April 2020 until his promotion to General Counsel.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Carr was promoted to
    Chief Financial Officer on August 10, 2021. Mr. Carr joined Abeona in November 2018 as Controller and served as Chief Accounting
    Officer from January 2019 until his promotion to Chief Financial Officer. Mr. Carr resigned effective March 31, 2022. </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Amoroso was promoted
    to President and Chief Executive Officer on March 19, 2021, and resigned on October 15, 2021. Mr. Amoroso joined the Company on July
    9, 2020, and served as Chief Commercial Officer until October 31, 2020, when he was promoted to Chief Operating Officer, becoming
    the Company&rsquo;s principal executive officer.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Outstanding
Equity Awards at Fiscal Year-End</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the aggregate number of option and stock awards held by our named executive officers (&ldquo;NEOs&rdquo;)
as of December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Market Value</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Securities</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Securities</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Shares or</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">of Shares or</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Underlying</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Underlying</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Units</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Units of</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Unexercised</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Unexercised</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Option</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">of Stock</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Stock</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Options</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Options</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Exercise</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Option</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">That Have</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">That Have</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Grant</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(#)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(#)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Price</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Expiration</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Not Vested</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Not Vested</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unexercisable</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(#)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($) <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/28/2022</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 6%; text-align: right">-</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 10%; text-align: right">155,200</TD>
    <TD STYLE="width: 1%"><SUP>(3)</SUP></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 11%; text-align: right">478,016</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Vishwas Seshadri</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/15/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">7,750</TD>
    <TD><SUP>(2)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">22.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/15/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,500</TD>
    <TD><SUP>(3)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,620</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/1/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,000</TD>
    <TD><SUP>(2)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">42.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/1/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,000</TD>
    <TD><SUP>(3)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,480</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/28/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,750</TD>
    <TD><SUP>(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,070</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Joseph Vazzano</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/21/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,000</TD>
    <TD><SUP>(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,960</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/14/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,000</TD>
    <TD><SUP>(4)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,480</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/28/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,750</TD>
    <TD><SUP>(6)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,070</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/20/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,080</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">6,800</TD>
    <TD><SUP>(5)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">30.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/20/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,080</TD>
    <TD><SUP>(6)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">12,566</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2,000</TD>
    <TD><SUP>(5)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">58.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,000</TD>
    <TD><SUP>(6)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3,080</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Brendan O&rsquo;Malley</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/20/2020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">542</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">181</TD>
    <TD><SUP>(5)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">28.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/16/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">500</TD>
    <TD><SUP>(6)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,540</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/16/2020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">958</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">319</TD>
    <TD><SUP>(5)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">28.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/16/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2019</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,062</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138</TD>
    <TD><SUP>(5)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">28.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2029</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/26/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,400</TD>
    <TD><SUP>(8)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">41,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/19/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10,000</TD>
    <TD><SUP>(7)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">54.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/19/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5,000</TD>
    <TD><SUP>(8)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">15,400</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Michael Amoroso</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">8,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">8,000</TD>
    <TD><SUP>(7)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">58.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2031</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,000</TD>
    <TD><SUP>(8)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">12,320</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/2/2020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,667</TD>
    <TD><SUP>(7)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">26.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/2/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/9/2020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,333</TD>
    <TD><SUP>(7)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">28.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/9/2030</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    based on our closing share price on December 31, 2022 of $3.08.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Seshadri&rsquo;s options
    to purchase shares of Common Stock will vest in the following periods: 12,000 options at $22.75 per share granted on October 15,
    2021 will be fully vested in October 2025 and 16,000 options granted on June 1, 2021 at $42.75 per share will be fully vested in
    June 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Seshadri&rsquo;s restricted
    stock will vest in the following periods: 2,000 shares granted on October 15, 2021 will be fully vested in October 2025; 8,000 shares
    granted on June 1, 2021 will be fully vested in June 2025; and 155,200 shares of granted on September 28, 2022 will be fully vested
    in September 2026.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Vazzano&rsquo;s restricted
    stock will vest in the following periods: 8,000 shares granted on March 14, 2022 will be fully vested in March 2026; 12,000 shares
    granted on July 21, 2022 will be fully vested in July 2026; and 72,750 shares granted on September 28, 2022 will be fully vested
    in September 2026.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. O&rsquo;Malley&rsquo;s
    options to purchase shares of Common Stock will vest in the following periods: 10,880 options granted on September 20, 2021 at $30.25
    per share will be fully vested in September 2025; 4,000 options granted on March 1, 2021 at $58.50 per share will be fully vested
    in March 2025; 723 options granted on May 20, 2020 at $28.75 per share will be fully vested in March 2024; 1,277 options granted
    on March 16, 2020 at $28.75 per share will be fully vested in March 2024; and 2,200 options granted on May 31, 2019 at $28.75 per
    share will be fully vested in May 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. O&rsquo;Malley&rsquo;s
    restricted stock will vest in the following periods: 72,750 shares granted on September 28, 2022 will be fully vested in September
    2026. 5,440 shares granted on September 20, 2021 will be fully vested in September 2025; 2,000 shares granted on March 1, 2021 will
    be fully vested in March 2025; and 750 shares granted on May 20, 2020 will be fully vested in March 2024.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Amoroso&rsquo;s options
    to purchase shares of Common Stock will vest in the following periods: 20,000 options granted on March 19, 2021 at $54.50 per share
    will be fully vested in March 2025; 16,000 options granted on March 1, 2021 at $58.50 per share will be fully vested in March 2025;
    2,916 options granted on November 2, 2020 at $26.75 per share will be fully vested in November 2024; and 6,458 options granted on
    July 9, 2020 at $28.75 per share will be fully vested in July 2024.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Amoroso&rsquo;s restricted
    stock will vest in the following periods: 10,000 shares granted on March 19, 2021 will be fully vested in March 2025; 8,000 shares
    granted on March 1, 2021 will be fully vested in March 2025; and 13,400 shares granted on September 26, 2022 will be fully vested
    in September 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Pursuant to Agreements and Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>President
and Chief Executive Officer</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Seshadri entered into an employment agreement with the Company when he joined as SVP, Head of Research &amp; Clinical Development on
June 1, 2021. In his role as SVP, Head of Research &amp; Clinical Development, Dr. Seshadri received an annual base salary of $400,000
and was eligible for an annual discretionary bonus with a target of 40% of his annual base salary. On June 1, 2021, Dr. Seshadri was
granted stock options to purchase 16,000 shares of the Company&rsquo;s Common Stock pursuant to the Company&rsquo;s 2015 Equity Incentive
Plan, with 25% vesting on June 1, 2022 and the remaining 75% vesting in 36 equal monthly installments thereafter. On June 1, 2021, Dr.
Seshadri was granted 12,000 restricted shares of Common Stock pursuant to the Company&rsquo;s 2015 Equity Incentive Plan, with 6,000
shares vesting on June 1, 2022 and the remaining 6,000 shares vesting in three installments of 2,000 shares annually thereafter starting
on June 1, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2021, Dr. Seshadri was appointed President, Chief Executive Officer, and Director. In his new role as President and Chief
Executive Officer, Dr. Seshadri receives an annual base salary of $500,000 and will be eligible for an annual discretionary bonus with
a target of 50% of his annual base salary. In connection with his appointment to President and Chief Executive Officer, Dr. Seshadri
was granted 2,000 shares of restricted stock and options to purchase 12,000 shares of common stock of the Company. The options vest 25%
on the one-year anniversary of the grant date and the remaining 75% vest in 36 equal monthly installments thereafter. The restricted
stock will vest 25% on the one-year anniversary of the grant date and the remaining 75% vest in equal annual installments over the following
36 months. Dr. Seshadri is eligible to participate in all employee benefit plans that the Company may establish for similarly situated
employees, if and to the extent he is eligible pursuant to the terms of such plans and Company policies, which may be modified by the
Company at its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of his employment agreement dated October 6, 2021, Dr. Seshadri and the Company may each terminate Dr. Seshadri&rsquo;s employment
for any reason upon written notice to the other party. If Dr. Seshadri&rsquo;s employment is terminated by the Company other than for
Cause, or by Dr. Seshadri for Good Reason (as each term is defined in his employment agreement), Dr. Seshadri will be entitled to (i)
a payment equal to the sum of his base salary plus his target annual bonus opportunity, (ii) payment equal to the cost of the premium
for his health coverage under the Company&rsquo;s health plan for him and his dependents for the twelve-month period following his termination
date, (iii) a pro-rata bonus for the year of termination and (iv) accelerated vesting equivalent to 12 months of continued employment
from the Termination Date (disregarding such termination for such purpose) with respect to all unvested equity and any other long-term
incentive awards granted to Dr. Seshadri and then outstanding on the Termination Date. The Company&rsquo;s obligations in the preceding
sentence are conditioned upon, among other things, Dr. Seshadri&rsquo;s execution and nonrevocation of a release of claims in favor of
the Company and its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Dr. Seshadri remains continuously employed through the date of a Change in Control (as that term is defined in his employment agreement),
all outstanding equity compensation awards will become fully vested and exercisable immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Chief
Financial Officer</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board appointed Mr. Vazzano as Chief Financial Officer effective March 14, 2022. He was entitled to an annual base salary of $360,000,
and a target annual bonus opportunity equal to 40% of his base salary. On March 14, 2022, Mr. Vazzano was granted 8,000 restricted shares
of Common Stock pursuant to the Company&rsquo;s 2015 Equity Incentive Plan, with 25% vesting on each of March 14, 2023, March 14, 2024,
March 14, 2025 and March 14, 2026. Mr. Vazzano is eligible to participate in all employee benefit plans that the Company may establish
for similarly situated employees, if and to the extent he is eligible pursuant to the terms of such plans and Company policies, which
may be modified by the Company at its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to his employment agreement dated February 28, 2022, upon achievement of certain corporate actions effective July 2, 2022, Mr. Vazzano&rsquo;s
annual base salary was increased to $400,000, and he was granted 12,000 restricted shares of Common Stock pursuant to the Company&rsquo;s
2015 Equity Incentive Plan, with 25% vesting on each of July 21, 2023, July 21, 2024, July 21, 2025 and July 21, 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of his employment agreement, Mr. Vazzano and the Company may each terminate Mr. Vazzano&rsquo;s employment for any reason upon
written notice to the other party. If Mr. Vazzano&rsquo;s employment is terminated by the Company other than for Cause, or by Mr. Vazzano
for Good Reason (as each term is defined in his employment agreement), Mr. Vazzano will be entitled to (i) a payment equal to the sum
of twelve months of his annual base salary plus twelve months of his annual target annual bonus opportunity and (ii) payment equal to
the cost of the premium for his health coverage under the Company&rsquo;s health plan for him and his dependents for the twelve-month
period following his termination date. If Mr. Vazzano&rsquo;s employment is terminated by the Company other than for Cause, or by Mr.
Vazzano for Good Reason (as each term is defined in his employment agreement) within twelve months following a Change of Control, Mr.
Vazzano will be entitled to (i) a payment equal to the sum of twelve months of his annual base salary plus twelve months of his annual
target annual bonus opportunity and (ii) payment equal to the cost of the premium for his health coverage under the Company&rsquo;s health
plan for him and his dependents for the twelve-month period following his termination date. The Company&rsquo;s obligations in the preceding
sentence are conditioned upon, among other things, Mr. Vazzano&rsquo;s execution and nonrevocation of a release of claims in favor of
the Company and its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr. Vazzano remains continuously employed through the date of a Change in Control (as that term is defined in his employment agreement),
all outstanding equity compensation awards will become fully vested and exercisable immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General
Counsel</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
O&rsquo;Malley joined Abeona in 2019 as Chief IP Counsel. He was entitled to an annual base salary of $321,000, effective January 1,
2021 and a target annual bonus opportunity equal to 35% of his base salary. The amount of the annual bonus actually paid depended on
the extent to which the performance goals are achieved or exceeded as determined by the Board. Dr. O&rsquo;Malley is eligible to participate
in all employee benefit plans that the Company may establish for similarly situated employees, if and to the extent he is eligible pursuant
to the terms of such plans and Company policies, which may be modified by the Company at its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2021, Dr. O&rsquo;Malley was appointed SVP, General Counsel. In his new role, Dr. O&rsquo;Malley receives an annual base
salary of $372,000 and is eligible for an annual discretionary bonus with a target of 40% of his annual base salary. In connection with
his appointment as SVP, General Counsel, Dr. O&rsquo;Malley was granted 5,440 shares of restricted stock and options to purchase 10,880
shares of common stock of the Company. The options vest 25% on the one-year anniversary of the grant date and the remaining 75% vest
in 36 equal monthly installments thereafter. The restricted stock will vest 25% on the one-year anniversary of the grant date and the
remaining 75% vest in equal annual installments over the following 36 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of his employment agreement dated September 16, 2021, Dr. O&rsquo;Malley and the Company may each terminate Dr. O&rsquo;Malley&rsquo;s
employment for any reason upon written notice to the other party. If Dr. O&rsquo;Malley&rsquo;s employment is terminated by the Company
other than for Cause, or by Dr. O&rsquo;Malley for Good Reason (as each term is defined in his employment agreement), Dr. O&rsquo;Malley
will be entitled to (i) a payment equal to the sum of twelve months of his annual base salary plus twelve months of his annual target
annual bonus opportunity and (ii) payment equal to the cost of the premium for his health coverage under the Company&rsquo;s health plan
for him and his dependents for the twelve-month period following his termination date. If Dr. O&rsquo;Malley&rsquo;s employment is terminated
by the Company other than for Cause, or by Dr. O&rsquo;Malley for Good Reason (as each term is defined in his employment agreement) within
twelve months following a Change of Control, Dr. O&rsquo;Malley will be entitled to (i) a payment equal to the sum of twelve months of
his annual base salary plus twelve months of his annual target annual bonus opportunity and (ii) payment equal to the cost of the premium
for his health coverage under the Company&rsquo;s health plan for him and his dependents for the twelve-month period following his termination
date. The Company&rsquo;s obligations in the preceding sentence are conditioned upon, among other things, Dr. O&rsquo;Malley&rsquo;s
execution and nonrevocation of a release of claims in favor of the Company and its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Dr. O&rsquo;Malley remains continuously employed through the date of a Change in Control (as that term is defined in his employment agreement),
all outstanding equity compensation awards will become fully vested and exercisable immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Former
President and Chief Executive Officer</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Amoroso had entered into a letter agreement with the Company dated March 19, 2021 in connection with his appointment to President and
Chief Executive Officer. Pursuant to such agreement, Mr. Amoroso received an annual base salary of $550,000 and will be eligible for
an annual discretionary bonus with a target of 50% of his annual base salary. In connection with his appointment to President and Chief
Executive Officer, Mr. Amoroso was granted 10,000 shares of restricted stock and options to purchase 25,000 shares of Common Stock of
the Company. The options vest 25% on the one-year anniversary of the grant date and the remaining 75% vest in 36 equal monthly installments
thereafter. The restricted stock will vest 25% on the one-year anniversary of the grant date and the remaining 75% vest in equal quarterly
installments over the following 36 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Mr. Amoroso&rsquo;s agreement, Mr. Amoroso and the Company may each terminate Mr. Amoroso&rsquo;s employment for any reason
upon written notice to the other party. If Mr. Amoroso&rsquo;s employment was terminated by the Company other than for Cause, or by Mr.
Amoroso for Good Reason (as each term is defined in his employment agreement), Mr. Amoroso would have been entitled to (i) a payment
equal to the sum of his base salary plus his target annual bonus opportunity, (ii) payment equal to the cost of the premium for his health
coverage under the Company&rsquo;s health plan for him and his dependents for the twelve-month period following his termination date,
and (iii) accelerated vesting equivalent to 12 months of continued employment from the Termination Date (disregarding such termination
for such purpose) with respect to all unvested equity and any other long-term incentive awards granted to him and then outstanding on
the Termination Date. The Company&rsquo;s obligations in the preceding sentence were conditioned upon, among other things, Mr. Amoroso&rsquo;s
execution and nonrevocation of a release of claims in favor of the Company and its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr. Amoroso had remained continuously employed through the date of a Change in Control (as that term is defined in the employment agreement),
all outstanding equity compensation awards would become fully vested and exercisable immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Retirement
Benefits</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s executives are provided usual and customary retirement benefits available to all employees, including the NEOs. These
include thrift savings (401(k)), life insurance, accidental death and dismemberment insurance, medical/dental insurance, vision insurance,
long-term disability insurance and a Company-sponsored pension plan. We provide matching contributions under our 401(k) to all employees,
including the NEOs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee Discussion on Executive Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee operates under a written charter adopted by the Board and is responsible for making all compensation decisions
for the Company&rsquo;s directors and named executives including determining base salary and annual incentive compensation amounts and
recommending stock option grants and other stock-based compensation under our equity incentive plans. The Compensation Committee charter
can be found on our website at <U>www.abeonatherapeutics.com</U> under &ldquo;Investors &amp; Media&mdash;Corporate Governance&mdash;Governance
Documents.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_007"></A>Pay
Versus Performance </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing
the following disclosure, as it applies to smaller reporting companies, regarding executive &ldquo;Compensation Actually Paid&rdquo;
(&ldquo;CAP&rdquo;), as calculated under applicable SEC rules, for our principal executive officer(s) (&ldquo;PEO(s)&rdquo;) and our
other named executive officers (&ldquo;non-PEO NEOs&rdquo;) and certain financial performance measures for the fiscal years ended December
31, 2022 and 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the CAP to our PEO(s) and the CAP to our non-PEO NEOs, we are required to make various adjustments to the total compensation
amounts that have been reported in the Summary Compensation Table (&ldquo;SCT&rdquo;), as the SEC&rsquo;s valuation methods for this
section differ from those required in the SCT. Information regarding the methodology for calculating CAP to our PEO(s) and the CAP to
our non-PEO NEOs, including details regarding the amounts that were deducted from, and added to, the SCT totals to arrive at the values
presented for CAP, are provided in the footnotes to the table. A narrative discussion of the relationship between CAP and the financial
performance measures is also presented below. Note that for non-PEO NEOs, compensation is reported as an average.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pay
Versus Performance Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Summary Compensation Table Total for Dr. Seshadri (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Summary Compensation Table Total for Mr. Amoroso (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Compensation Actually Paid to Dr. Seshadri (1)(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Compensation Actually Paid to Mr. Amoroso (1)(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average Summary Compensation Table Total for Non-PEO NEOs</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average Compensation Actually Paid to Non-PEO NEOs</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Value of Initial Fixed $100 Investment Based on Total Shareholder Return</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Income (Loss) (in thousands)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; font-weight: bold; text-align: center; padding-bottom: 1.5pt">2022</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">1,499,816</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">1,304,561</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">656,543</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">513,329</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">7.85</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">(39,696</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,566,475</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,064,987</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">570,644</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">541,560</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,374,544</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">620,407</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(84,936</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
During 2021, Mr. Amoroso served as our PEO from January 1, 2021 to October 14, 2021. Dr. Seshadri has served as our PEO since
October 15, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Deductions from, and additions to, total compensation as reported in the SCT by year to calculate CAP include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Subtract</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Value of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Add</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards that</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Add</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Change in</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Change in</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Failed to</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Summary</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Year-End</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Value of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Value of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Meet</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Compensation</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Compensation</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Subtract Stock</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Prior Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Vested Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Vesting</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Actually</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Table Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Value</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Awards</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Conditions</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Paid</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Executive(s)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; width: 5%; font-weight: bold; text-align: center">2022</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: left; padding-bottom: 1.5pt">Dr. Seshadri</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 5%; text-align: right">1,499,816</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 5%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(478,016</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 7%; text-align: right">478,016</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(128,280</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(66,975</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 5%; text-align: right">1,304,561</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other NEO&rsquo;s</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,969,630</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(565,340</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">509,740</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(82,571</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,546</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(259,927</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,539,986</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>2021</B></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Dr. Seshadri</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,566,475</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(1,303,070</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">307,239</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">570,644</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Mr. Amoroso</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3,064,987</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(2,602,910</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">370,580</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(237,664</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(53,434</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">541,560</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other NEO&rsquo;s</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,749,088</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,762,934</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413,824</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(156,701</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,462</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,240,814</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>PROPOSAL
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws presently provide that our Board shall consist of between three to 15 members, shall be divided
into three classes as nearly equal in number as possible, and that each director shall serve for a term of three years and until his/her
successor is elected and qualified or until his/her earlier resignation, death or removal. By resolution, the Board has set the number
of its directors at nine directors. The term of office of one class of directors expires each year in rotation so that one class is elected
at each annual meeting of stockholders for a three-year term. The Board presently consists of nine members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 23, 2023, the Board approved a decrease in the size of the Board by two directors, from nine to seven, effective at the conclusion
of the Company&rsquo;s 2023 Annual Shareholder Meeting, in accordance with Article III.1 of the Bylaws. Also, on April 6, 2023,
Michael Amoroso, Chairman of the Board, relinquished his seat as a Class 2 director and was immediately appointed as a Class 1 director
by the Board to stand for reelection at the Annual Meeting. Mr. Amoroso&rsquo;s transition from Class 2 to Class 1 was effected solely
to maintain compliance with Article VII.B of the Company&rsquo;s Certificate of Incorporation and Article III.1 of the Bylaws, both of
which require that the three director classes of the Board be divided &ldquo;as nearly equal in number as possible,&rdquo; and Mr. Amoroso&rsquo;s
service on the Board is deemed to have continued without any break in service. The Company is not entering into any new plan, contract,
or compensatory arrangement in connection with Mr. Amoroso&rsquo;s transition of director classes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Amoroso, Mr. Mann, Ms. Silverstein and Dr. Wider are Class 1 directors with their terms set to expire at the Annual Meeting. Mr. Amoroso
and Ms. Silverstein will stand for reelection as Class 1 directors at the Annual Meeting, at which time Mr. Mann and Dr. Wider&rsquo;s
respective terms as directors will expire. The Company thanks Mr. Mann and Dr. Wider for their service to the Company over the past several
years. The Company also thanks Dr. Wider for his willingness to advise Abeona as a member of the scientific advisory board in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Alland</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> and Dr. Seshadri are Class 2 directors with
their terms set to expire at the annual meeting of stockholders in 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Alvino, Dr. Wuchterl and Ms. Charles are Class 3 directors with their terms set to expire at the annual meeting of stockholders in 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominees
for Term Expiring at the Annual Meeting (Class 1 Directors)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Amoroso and Ms. Silverstein are Class 1 directors standing for election to the Board for a three-year term expiring at the 2026 annual
meeting of stockholders. Mr. Amoroso and Ms. Silverstein have served as directors since 2021 and 2020, respectively. Mr. Amoroso&rsquo;s
and Ms. Silverstein&rsquo;s terms will expire at the Annual Meeting. If elected at the Annual Meeting, they will serve for a term of
three years expiring on the date of the annual meeting of stockholders in 2026. Mr. Amoroso and Ms. Silverstein exemplify how our Board
values professional experience in business and the pharmaceutical industry, as well as strong moral character. It is this strong and
unique background and sets of skills that our Board believes provide it, as a whole, with a strong foundation of technical expertise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no family relationship among any of the directors or officers. The nominees have each consented to serve as a director and the Board
has no reason to believe that they will be unavailable for such service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
and Experience of the Nominee for Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Michael
Amoroso</I>, 45, has been Chairman of the Board since October 15, 2021 and has been a director since March 19, 2021. Mr. Amoroso served
as our President and Chief Executive Officer from March 19, 2021 to October 15, 2021. Mr. Amoroso joined Abeona on July 9, 2020 as Chief
Commercial Officer and was promoted to Chief Operating Officer on November 1, 2020. Since October 15, 2021, Mr. Amoroso has served as
President and Chief Executive Officer of Precision BioSciences, Inc., a clinical stage biotechnology company dedicated to improving life
with its novel and proprietary ARCUS genome editing platform. From August 2018 to January 2020, he served as Senior Vice President and
Head of Worldwide Commercial Operations for Cell Therapy at Kite (a Gilead company), where he led all operations and functions charged
with bringing the first wide-spread chimeric antigen receptor T-cell (&ldquo;CAR T-cell&rdquo;) therapy, YESCARTA&reg;, to major world
markets while also preparing the organization for its future cell therapy pipeline. Prior to his time at Kite, Mr. Amoroso served in
senior level executive positions at Eisai Inc. from October 2017 to August 2018, Celgene Corporation (now a subsidiary of Bristol-Myers
Squibb) from January 2011 to October 2017 and Aventis (now Sanofi) from 2001 to 2011. Mr. Amoroso has worked with companies in the small
molecules, biologics, and cell and gene therapies space across large, medium, and small capitalization companies with his deepest areas
of expertise in rare, oncological diseases. Mr. Amoroso earned his Executive M.B.A. in Management from the Stern School of Business,
New York University, and his B.A. in Biological Sciences, summa cum laude, from Rider University. Mr. Amoroso&rsquo;s qualifications
to serve on our Board include his extensive experience in leading teams, both directly and indirectly, across clinical development, regulatory
and medical affairs, corporate affairs, and commercial affairs, both in the U.S. and globally, with direct operational experience
in various pharmaceutical companies.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Christine
Silverstein</I>, 40, became a director in March 2020. Since May 2021, Ms. Silverstein has served as Chief Financial Officer of Excision
Biotherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases.
From July 2020 to January 2021, Ms. Silverstein served as Chief Financial Officer of Emendo Biotherapeutics, a next generation gene-editing
company that was acquired in December 2020 by AnGes, Inc., a biopharmaceutical company focused on gene-based medicines. Ms. Silverstein
previously operated in various senior executive corporate finance roles within Abeona, including Chief Financial Officer from January
2019 to March 2020, Senior Vice President, Finance &amp; Strategy from May 2018 to December 2018 and Vice President, Finance &amp; Investor
Relations from April 2016 to May 2018. Prior to joining Abeona in 2016, from 2014 to 2016, she served as Head of Investor Relations at
Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system. Ms. Silverstein previously
served in senior executive roles within a biotechnology venture fund and various capital markets advisory firms. Ms. Silverstein began
her career in the financial services as an investment advisor at Royal Alliance Associates before moving to the biotechnology industry.
Ms. Silverstein also serves on the Board of Directors of Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated
to the development of innovative therapeutics to treat seizure disorders. A member of CHIEF, Deloitte&rsquo;s Chief Financial Officer
Program, Women in Bio and the National Investor Relations Institute, Ms. Silverstein holds a B.S. from the Peter Tobin College of Business
at St. John&rsquo;s University and earned various accreditations from FINRA. Ms. Silverstein&rsquo;s qualifications to serve on our Board
include her extensive corporate strategic planning, capital markets and capital raising expertise, business development, compliance and
crisis management experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nomination
and Election of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
seeking candidates for director, the Nominating and Corporate Governance Committee may solicit suggestions from incumbent directors,
management or others. After conducting an initial evaluation of a candidate, the committee will interview that candidate if it believes
the candidate might be suitable to serve as a director. The committee may also ask the candidate to meet with Company management. If
the committee believes a candidate would be a valuable addition to the Board and there is either a vacancy on the Board or the committee
believes it is in the best interests of the Company and our stockholders to increase the number of Board members to elect that candidate,
it will recommend to the full Board that candidate&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
nominating a sitting director for reelection at an annual stockholder meeting, the committee will consider the director&rsquo;s performance
on the Board and whether the director&rsquo;s reelection would be in the best interests of the Company&rsquo;s stockholders and consistent
with the Company&rsquo;s corporate governance guidelines and continued compliance with applicable law, rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that it should be comprised of directors with diverse and complementary backgrounds, and that directors should have expertise
that, at a minimum, may be useful to the Company and may contribute to the success of the Company&rsquo;s business. Directors also should
possess the highest personal and professional ethics and should be willing and able to devote an amount of time sufficient to effectively
carry out their duties and contribute to the success of the Company&rsquo;s business. When considering candidates for director, the committee
takes into account a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independence from management;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age, gender and ethnic background;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relevant business experience;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgment, skill and integrity;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing commitments to other businesses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential conflicts of interest;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate governance background;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial and accounting background;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive compensation background; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Size and composition of the existing Board.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee will consider additional candidates for director suggested by stockholders by considering
the foregoing criteria and the additional information referred to below. There are no differences in the manner in which the committee
evaluates nominees for director based on whether the nominee is recommended by a stockholder or by the Nominating and Corporate Governance
Committee. Stockholders wishing to suggest a candidate for director should write to the Company, c/o Investor Relations, 6555 Carnegie
Ave., 4<SUP>th</SUP> Floor, Cleveland, OH 44103. When submitting candidates for nomination to be elected at the Company&rsquo;s annual
meeting of stockholders, stockholders must follow the notice procedures, which are described under the heading &ldquo;Submission of Nominations
and Proposals for the 2024 Annual Meeting&rdquo; and include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The name and address of
    the stockholder and a statement that he, she or it is a stockholder of the Company and is proposing a candidate for consideration
    by the committee;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of
    Company capital stock owned by the stockholder as of the record date for the applicable annual stockholder meeting (if such date
    has been announced) and as of the date of the notice, and length of time such stockholder has held such shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The name, age and address of the candidate;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A description of the candidate&rsquo;s business and
    educational experience;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The class and number of
    shares of Company capital stock, if any, owned by the candidate, and length of time such candidate has held such shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information regarding each
    of the foregoing criteria the Board generally considers, other than the factor regarding Board size and composition, sufficient to
    enable the committee to evaluate the candidate;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A description of any relationship
    between the candidate and any customer, supplier or competitor of the Company or any actual or potential conflict of interest;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A description of any relationship or understanding
    between the stockholder and the candidate;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A statement that the candidate
    is willing to be considered and willing to serve as a director if nominated and elected;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A statement as to whether the director is independent
    under applicable SEC and Nasdaq rules; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such other information
    regarding each nominee that would be required to be included in a proxy statement filed pursuant to the proxy rules of the SEC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, pursuant to a Director Designation Agreement dated as of November 15, 2007, for as long as SCO Capital Partners LLC (&ldquo;SCO
Capital&rdquo;), and its affiliates hold at least 20% of the Company&rsquo;s Common Stock issued upon conversion of the shares of Series
A Stock issued in connection with the Company&rsquo;s 2007 note exchange, (a) SCO Capital shall have the right, from time to time, to
designate two individuals, in the sole discretion of SCO Capital, to serve as directors of the Company (the &ldquo;SCO Director Designees&rdquo;),
(b) the Company shall use its best efforts at all times to cause the number of directors to be fixed at a sufficient number such that
at least two positions shall be available for the SCO Director Designees (the &ldquo;SCO Board Seats&rdquo;), (c) the Company shall use
its best efforts to cause the SCO Director Designees to be nominated and elected for service as directors of the Company at each meeting
of the Company&rsquo;s stockholders held for the purpose of electing directors and (d) if at any time, or from time to time, one or more
of the SCO Board Seats is or becomes vacant for any reason prior to the next annual meeting of stockholders, the Company shall use its
best efforts to cause such vacancy to be filled with an SCO Director Designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal 1, the nominee will be elected upon the affirmative vote of a majority of the outstanding shares of Common Stock present through
virtual attendance or by proxy at the Annual Meeting and entitled to vote on the Proposal. For Proposal 1, stockholders may vote &ldquo;FOR,&rdquo;
&ldquo;AGAINST,&rdquo; or &ldquo;ABSTAIN.&rdquo; Abstentions will have the effect of an &ldquo;AGAINST&rdquo; such proposal. Broker non-votes,
if any, will be disregarded and will have no effect on the outcome of the vote for Proposal 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Board recommends that the stockholders vote &ldquo;FOR&rdquo; each of the nominees.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
with Respect to Other Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors
Whose Terms Expire at the Annual Meeting in 2024 (Class 2 Directors)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Leila
Alland, M.D.</I>, 60, became a director on April 14, 2021 and currently serves as a member of the Nominating and Corporate Governance
Committee and of the Compensation Committee. Dr. Alland, a pediatric hematologist-oncologist and accomplished physician-scientist, has
been working in the biopharmaceutical industry since 2001 to bring novel therapies to patients. Since December 2019, Dr. Alland has served
as Chief Medical Officer of PMV Pharmaceuticals, Inc., a Nasdaq-listed precision oncology company pioneering the discovery and development
of small molecule, tumor-agnostic therapies targeting p53 mutants. From March 2018 to November 2019, Dr. Alland served as Chief Medical
Officer of Affimed, a clinical-stage immuno-oncology company, and, from January 2016 to March 2018, Dr. Alland served as Chief Medical
Officer of Tarveda Therapeutics, a clinical stage precision oncology company. Dr. Alland also held leadership positions at AstraZeneca,
Bristol-Myers Squibb, Novartis, and Schering-Plough, where she worked on a broad range of oncology products from early to late stage
development and contributed to multiple successful drug approvals. Dr. Alland obtained her medical degree from New York University School
of Medicine and her B.A. in Biology from the University of Pennsylvania. She completed her residency in Pediatrics at The Children&rsquo;s
Hospital of Philadelphia, and her fellowship in Pediatric Hematology/Oncology at The New York Hospital and Memorial Sloan-Kettering Cancer
Center. From 1994 to 2000, Dr. Alland served as Assistant Professor of Pediatrics at Albert Einstein College of Medicine where she was
awarded the James S. McDonnell Foundation Scholar Award and pursued basic cancer research while also caring for children with cancer
and blood disorders. Since 2020, Dr. Alland has served as Director on the Board of Cytovia Therapeutics, an immune-oncology company developing
engineered cellular and antibody therapies to treat cancer. Dr. Alland is a member of the Scientific Advisory Council of Columbia University&rsquo;s
Center for Radiological Research, and serves as a scientific reviewer for the Cancer Prevention and Research Institute of Texas. Dr.
Alland&rsquo;s qualifications to serve on our Board include her leadership skills and her vast medical and scientific experience serving
companies in the biotech and pharmaceutical field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vishwas
Seshadri</I>, 47, was appointed our President, Chief Executive Officer and a director on October 15, 2021. Dr. Seshadri joined Abeona
on June 1, 2021 as SVP, Head of Research and Clinical Development. Prior to joining Abeona, from October 2010 to May 2021, Dr. Seshadri
served in roles of increasing responsibility at Celgene (now part of Bristol-Myers Squibb) focused on research &amp; development and
commercialization for novel therapies in hematology and oncology, most recently as Executive Director &amp; Worldwide Brand Leader for
Breyanzi&reg; (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory
large B-cell lymphoma. While at Celgene, he led franchise-level marketing and the project management office for CAR T-cell commercialization
and led teams supporting the successful global launch of Breyanzi. He also led development project teams for clinical development and
regulatory submissions for REVLIMID (lenalidomide) in lymphoma, strategic go/no-go decisions for Avadomide and IMFINZI (durvalumab) while
implementing program-wide efficiency measures, and managed post-marketing commitments for ISTODAX (romidepsin). In addition, Dr. Seshadri
had held U.S. and global marketing lead roles for Abraxane in non-small cell lung cancer and pancreatic cancer. Previously, he was Head
of Early-Stage Upstream Process Development for Biologics at Dr. Reddy&rsquo;s Laboratories, where he led cell-line development, cGMP
cell banking, characterization, and cell culture optimization for biosimilars. Dr. Seshadri completed his Ph.D. in Microbiology, Immunology
&amp; Molecular Biology and his post-doc in epigenetics at University of Arizona, and earned his M.B.A. in Finance and Healthcare from
the Wharton School of the University of Pennsylvania. Dr. Seshadri&rsquo;s qualifications to serve on our Board include his extensive
experience across clinical development, regulatory and medical, corporate and commercial affairs, with direct operational experience
in various pharmaceutical companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors
Whose Terms Expire at the Annual Meeting in 2025 (Class 3 Directors)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mark
J. Alvino</I>, 55, became a director on March 26, 2021 and currently serves as Chair of the Compensation Committee and as a member on
the Audit Committee. Mr. Alvino had previously served as a member of our Board from March 2006 through April 15, 2020. Since October
2014, Mr. Alvino has served as President of Hudson Square Capital LLC. From 2013 to October 2014, Mr. Alvino was leading the Life Sciences
efforts of Bradley Woods &amp; Co. Ltd. Mr. Alvino was Managing Director for Griffin Securities from 2007 to 2013. He previously worked
at Feinstein Kean Healthcare (an Ogilvy Public Relations Worldwide Company,) where he was Senior Vice President, responsible for managing
both investor and corporate communications programs for many private and public companies and acted as senior counsel throughout the
agency&rsquo;s network of offices. Prior to working at Feinstein Kean Healthcare, Mr. Alvino served as Vice President of Investor Relations
and managed the New York Office of Allen &amp; Caron, Inc., an investor relations agency. His base of clients included medical devices,
biotechnology, and e-healthcare companies. Mr. Alvino also spent several years working with Wall Street brokerages including Ladenburg,
Thallman &amp; Co. and Martin Simpson &amp; Co. Mr. Alvino&rsquo;s qualifications to serve on our Board include his leadership skills
and his experience in the areas of financial management and business strategy in the biopharmaceutical field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Faith
L. Charles</I>, 61, became a director on March 26, 2021 and currently serves as Chair of the Nominating and Corporate Governance Committee
and as a member of the Audit Committee. Ms. Charles has been a corporate transactions and securities partner at the law firm of Thompson
Hine, LLP, since 2010. She leads Thompson Hine&rsquo;s Life Sciences practice and co-heads the securities practice, advising public and
emerging biotech and pharmaceutical companies in the U.S. and internationally. Ms. Charles negotiates complex private and public financing
transactions, mergers and acquisitions, licensing transactions and strategic collaborations. She serves as outside counsel to a myriad
of life sciences companies and is known in the industry as an astute business advisor, providing valuable insights into capital markets,
corporate governance and strategic development. From 2018 until October 2021, Ms. Charles served on the board of directors and as a member
of the audit committee and chair of the compensation committee of Entera Bio, a publicly-traded biotechnology company. She also serves
on the Board of Directors of several private life science companies. Ms. Charles founded the Women in Bio Metro New York chapter and
chaired the chapter for five years. She currently serves on the national board of Women in Bio. Ms. Charles is also a member of the board
of Red Door Community (formerly Gilda&rsquo;s Club New York City.) She has been recognized as a Life Sciences Star by Euromoney&rsquo;s
LMG Life Sciences, has been named a BTI Client Service All-Star, and was named by Crain&rsquo;s New York Business to the list of 2020
Notable Women in the Law. Ms. Charles holds a JD degree from The George Washington University Law School and a B.A. in Psychology from
Barnard College, Columbia University. Ms. Charles is a graduate of Women in Bio&rsquo;s Boardroom Ready Program, an Executive Education
Program taught by The George Washington University School of Business. Ms. Charles&rsquo; qualifications to serve on our Board include
her leadership skills and her vast legal experience representing companies in the biotech and pharmaceutical field.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Donald
A. Wuchterl</I>, 53, became a director on April 14, 2021 and currently serves as member of the Nominating and Corporate Governance Committee.
Since April 2021, Mr. Wuchterl has served as Senior Vice President and Chief Manufacturing Officer at T-knife Therapeutics, a next-generation
T-cell receptor company developing innovative therapeutics for the benefit of solid tumor patients where he is responsible for all Chemistry,
Manufacturing and Controls (&ldquo;CMC&rdquo;) functions. From 2016 to 2021, Mr. Wuchterl served as Senior Vice President, Technical
Operations and Quality at Audentes Therapeutics (an Astellas company), a gene therapy company focused on developing and commercializing
innovative products for patients living with serious, life-threatening rare neuromuscular diseases. From 2012 to 2016, Mr. Wuchterl served
as Senior Vice President and Chief Operating Officer at Cytovance Biologics, a leading biopharmaceutical contract manufacturing company.
Prior to Cytovance, Mr. Wuchterl held positions of increasing responsibility with Dendreon, Shire HGT, Amgen, Biogen Idec and Roche.
Mr. Wuchterl has a B.S. in Business Administration from Colorado Technical University and an M.B.A. from Fitchburg State University.
Mr. Wuchterl&rsquo;s qualifications to serve on Abeona&rsquo;s Board include his over 29 years of experience in the life sciences industries,
with senior roles in operations and CMC across several different product types. He also brings significant experience building out and
leading new current Good Manufacturing Practice (&ldquo;cGMP&rdquo;) organizations and facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors
Whose Terms Expire at the Annual Meeting and Who Are Not Standing for Reelection</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Paul
Mann</I>, 47, became a director in June 2020 and serves as Chair of the Audit Committee. Mr. Mann has over 20 years of experience in
the financial and biotechnology industries. Mr. Mann is currently the Chairman and Chief Executive Officer of ASP Isotopes since September
2021 and the Chairman of Varian Biopharmaceuticals since June 2020. Prior to this, Mr. Mann was a consultant and analyst for DSAM Partners,
a global hedge fund, from April 2020 to March 2022. Prior to DSAM partners, Mr. Mann served as Chief Financial Officer at PolarityTE,
Inc., a biotechnology and regenerative biomaterials company, from June 2018 to March 2020. From August 2016 to June 2018, he served as
the Healthcare Portfolio Manager for Highbridge Capital Management. From August 2013 to March 2016, Mr. Mann served as an analyst with
Soros Fund Management. Prior to joining Soros Fund Management, Mr. Mann was an analyst and portfolio manager with Lodestone Natural Resources
and UBS from September 2011 to March 2013. Prior to moving to the buy-side, Mr. Mann spent 11 years as a sell-side analyst at Morgan
Stanley and Deutsche Bank. He started his career as a research scientist at Procter &amp; Gamble and he has an MA (Cantab) and an MEng
in Chemical Engineering from Cambridge University. Mr. Mann is a CFA charter holder. Mr. Mann&rsquo;s qualifications to serve on our
Board include his extensive experience in the financial and biotechnology industries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Todd
Wider, M.D.,</I> 58, became a director in May 2015 and currently serves as a member of the Compensation Committee. Dr. Wider is a surgeon
and has served as consultant to numerous entities in the biotechnology space. He has served as the Chairman and CMO of Emendo Biotherapeutics
since 2019. In addition, Dr. Wider served as a director of ARYA Sciences Acquisition Corp. I (Nasdaq: ARYA) from October 2018 to March
2020, ARYA Sciences Acquisition Corp. II (Nasdaq: ARYB) from June 2020 to November 2020, and ARYA Sciences Acquisition Corp. III (Nasdaq:
ARYA) from August 2020 to June 2021. Dr. Wider holds an M.D. from Columbia College of Physicians and a B.A. from Princeton University.
Dr. Wider&rsquo;s qualifications to serve our Board include his biotechnology expertise as well as his experience as a surgeon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
with Respect to Executive Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section above under the heading &ldquo;Information with Respect to Other Directors&rdquo; for information related to Mr.
Amoroso.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Brendan
O&rsquo;Malley, J.D., Ph.D.</I>, 54, became our General Counsel on September 20, 2021. Dr. O&rsquo;Malley joined Abeona in 2019 as Chief
IP Counsel, bringing significant technical and legal expertise to the Abeona team. Prior to joining Abeona, he was a partner at the prominent
New York patent litigation firm Fitzpatrick Cella Harper &amp; Scinto, where he started his career as a summer associate in 2006, and
then at Venable LLP, which merged with Fitzpatrick in 2018. While at Fitzpatrick and Venable, Dr. O&rsquo;Malley litigated a wide variety
of biopharmaceutical patent cases in the United States District Courts, at the Federal Circuit, and before the U.S. Patent and Trademark
Office, negotiated numerous settlement and license agreements, and provided many patent opinions in connection with M&amp;A due diligence
in the biotech space. While attending law school at Benjamin N. Cardozo School of Law, Dr. O&rsquo;Malley served as a judicial intern
to Judge William H. Pauley in the U.S. District Court for the Southern District of New York. Before law school, he earned a Ph.D. in
Molecular Biology &amp; Microbiology from Tufts University School of Medicine, where he studied the role of protein-protein interactions
in hepatitis virus assembly, and a B.S. degree magna cum laude from the University of Massachusetts Dartmouth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Joseph
Vazzano</I>, 39, was appointed our Chief Financial Officer effective March 14, 2022. Before joining Abeona, Mr. Vazzano served as Chief
Financial Officer of publicly-traded Avenue Therapeutics, Inc. (&ldquo;Avenue&rdquo;) from February 2019 to January 2022. Prior to that,
he served as Avenue&rsquo;s Vice President of Finance and Corporate Controller since August 2017. During his tenure at Avenue, Mr. Vazzano
secured multiple equity financings for Avenue and served in a leadership role for signing a complex, two-stage acquisition of Avenue
with future contingent value rights. Prior to joining Avenue, Mr. Vazzano served as Assistant Corporate Controller at publicly-traded
Intercept Pharmaceuticals, Inc. from October 2016 to July 2017, where he helped grow the finance and accounting department during the
company&rsquo;s transition from a development-stage company to a fully integrated commercial organization. Mr. Vazzano has held various
other financial roles at other publicly traded pharmaceutical companies such as Pernix Therapeutics, and NPS Pharmaceuticals. Mr. Vazzano,
who is a Certified Public Accountant, began his career at KPMG LLP. Mr. Vazzano has a Bachelor of Science degree in Accounting from Lehigh
University and is a Certified Public Accountant in the State of New Jersey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>PROPOSAL
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF THE ABEONA THERAPEUTICS INC. 2023 EQUITY INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are asking our stockholders to approve a proposal to adopt the Abeona Therapeutics Inc. 2023 Equity Incentive Plan (the &ldquo;2023 Equity
Incentive Plan&rdquo;) at our Annual Meeting. Our Board adopted the 2023 Equity Incentive Plan on March 31, 2023 upon recommendation
of the Compensation Committee, subject to stockholder approval at the Annual Meeting. If approved by our stockholders, the 2023 Equity
Incentive Plan will become effective as of the date of the stockholder approval (the &ldquo;Effective Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan is intended to replace the Abeona Therapeutics Inc. 2015 Equity Incentive Plan, as amended (the &ldquo;Prior
Plan&rdquo;). No additional grants will be made under the Prior Plan on or after the effective date of the 2023 Equity Incentive Plan.
Outstanding grants under the Prior Plan will continue to be in effect according to their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stockholders do not approve the 2023 Equity Incentive Plan, we will continue to be able to grant awards under the Prior Plan. As
of March 29, 2023, 136,069 shares of our Common Stock are available for grant under the Prior Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is seeking stockholder approval of the 2023 Equity Incentive Plan in order to (i) meet Nasdaq listing requirements, (ii) allow
incentive stock options awarded under the 2023 Equity Incentive Plan to meet the requirements of the Internal Revenue Code of 1986, as
amended, and the regulations promulgated thereunder (the &ldquo;Code&rdquo;), (iii) continue to maintain a limit on annual compensation
of non-employee directors, and (iv) conform to good corporate governance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the New Equity Incentive Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
incentive compensation programs play a pivotal role in the Company&rsquo;s efforts to attract and retain key personnel essential to the
Company&rsquo;s long-term growth and financial success. We are asking our stockholders to approve the 2023 Equity Incentive Plan to assist
the Company in attracting and retaining qualified personnel. If our stockholders do not approve the 2023 Equity Incentive Plan we will
be limited in our ability to continue to issue awards in numbers sufficient to attract and motivate the highly skilled employees we need
to recruit and retain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive life sciences
industry. We use equity awards to increase incentives on the part of employees, non-employee directors, consultants, and other key advisors
who provide important services to the Company. We believe that providing an equity stake in the future success of our Company motivates
these individuals to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are critical
to our success. Accordingly, approving the 2023 Equity Incentive Plan is in the best interest of our stockholders because equity awards
help us to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 57pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract,
    motivate, and retain talented employees, non-employee directors, consultants, and other key advisors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">align
    the interests of award recipients and stockholders; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">link
    compensation with Company performance. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strongly believe that approval of 2023 Equity Incentive Plan will enable us to achieve our goals in attracting and retaining our most
valuable asset: our employees and other service providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
an appropriate reserve of shares of Common Stock (&ldquo;Shares&rdquo;) to grant competitive equity-based incentives, we would be forced
to consider cash replacement alternatives to provide a market-competitive total compensation package necessary to attract, retain, and
motivate the talent critical to our future successes. These cash replacement alternatives could, among other things, reduce the cash
available for investment in growth and development and cause a loss of motivation by employees to achieve superior performance over a
longer period of time. Equity-based incentives, by contrast, directly align a portion of the compensation of our service providers with
the economic interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
that reason, the Company has structured the 2023 Equity Incentive Plan to provide flexibility in designing equity incentive programs
with a broad array of equity incentives, such as stock options, stock appreciation rights (&ldquo;SARs&rdquo;), stock awards, and restricted
stock units and implement competitive incentive compensation programs for its employees and non-employee directors. The 2023 Equity Incentive
Plan will be the only plan under which new equity awards may be granted to our employees and other service providers. If this Proposal
2 is not approved, then we would be at a disadvantage against our competitors for recruiting, retaining, and motivating individuals critical
to our success and could be forced to increase cash compensation, thereby reducing resources available to meet our business needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Highlights
of the 2023 Equity Incentive Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan contains a number of provisions that we believe are consistent with best practices in equity compensation
and which protect the stockholders&rsquo; interests, as described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    evergreen authorization.</I> The 2023 Equity Incentive Plan does not contain an &ldquo;evergreen&rdquo; Share reserve, meaning that
    the Share reserve will not be increased without further stockholder approval. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    liberal share recycling provisions</I>. The 2023 Equity Incentive Plan prohibits the re-use of Shares withheld or delivered to satisfy
    the exercise price of a stock option or base price of a SAR or to satisfy tax withholding requirements associated with any award.
    The 2023 Equity Incentive Plan also prohibits &ldquo;net share counting&rdquo; upon the exercise of stock options or SARs and prohibits
    the re-use of Shares purchased on the open market with the proceeds of option exercises.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Limit
    on awards to non-employee directors</I>. The 2023 Equity Incentive Plan imposes an aggregate limit on the value of awards that may
    be granted, when aggregated with cash fees that may be paid, to each non-employee director for services as a non-employee director
    in any year to $500,000 in total value.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Minimum
    vesting requirements</I>. The 2023 Equity Incentive Plan requires a one-year minimum vesting schedule for awards, except that up
    to 5% of the Shares reserved for issuance (subject to certain adjustments) are available for grant without regard to this requirement,
    and awards granted to non-employee directors on the date of an annual stockholders&rsquo; meeting satisfy this requirement if they
    provide for vesting at the stockholders&rsquo; meeting immediately following the grant date (but in any event not less than 50 weeks
    following the date of grant).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ban
    on in-the-money stock options and SARs</I>. The 2023 Equity Incentive Plan prohibits the grant of stock options or stock appreciation
    rights with an exercise price or base price that is less than fair market value on the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    repricing or grant of discounted stock options or SARs</I>. The 2023 Equity Incentive Plan prohibits repricing of options or SARs
    either by amending an existing award or substituting a new award for a cancelled award that has an exercise price or base amount
    less than the exercise price or base amount applicable to the original award.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    single-trigger acceleration</I>. The 2023 Equity Incentive Plan does not provide for automatic vesting acceleration of awards in
    connection with a change in control of the Company. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    dividends on unvested awards</I>. The 2023 Equity Incentive Plan prohibits dividends or dividend equivalents to be granted in connection
    with stock options or SARs and prohibits payment of dividends or dividend equivalents on unvested awards until the underlying awards
    have vested.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Subject
    to applicable clawback policies</I>. Awards granted under the 2023 Equity Incentive Plan are subject to any applicable clawback or
    recoupment policies, share trading policies, and other policies that may be approved or implemented by the Board or the Compensation
    Committee from time to time. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administered
    by an independent committee</I>. The 2023 Equity Incentive Plan will be administered by an independent committee of the Board. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Determination
of the Number of Shares Available for Awards under the Amended Equity Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Proposal 2 is approved by our stockholders, subject to adjustments as described below, the maximum aggregate number of Shares that
may be issued under the 2023 Equity Incentive Plan will be 1,700,000. In addition, subject to adjustments described below, any Shares
reserved for issuance under the Prior Plan that remain available for grant under the Prior Plan as of the Effective Date and Shares underlying
any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered, cancelled,
or forfeited or exchanged for any reason without issuance of such Shares will be available for new awards under the 2023 Equity Incentive
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the number of Shares to be authorized for issuance under the 2023 Equity Incentive Plan, the Board worked with Aon Radford
and considered a number of factors, including burn rate, the number of Shares needed for future awards, a dilution analysis, and competitive
data from relevant peer companies. As of March 29, 2023, 136,069 Shares remain available for awards under the Prior Plan and the Board
took such Shares into account when determining the number of Shares to be available under the 2023 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dilution
Analysis</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below shows our potential dilution levels based on our Common Stock outstanding as of March 29, 2023, the new Shares requested
for issuance under the 2023 Equity Incentive Plan and our total equity awards outstanding as of December 31, 2022. The Board believes
that the number of Shares requested under the 2023 Equity Incentive Plan represents a reasonable amount of potential equity dilution
and will allow us to continue granting equity awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Potential Overhang with 1,700,000 Requested Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%">Stock Options Outstanding as of December 31, 2022</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">240,770</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted Average Exercise Price of Stock Options Outstanding as of December 31, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">37.04</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted Average Remaining Term of Stock Options Outstanding as of December 31, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4 years</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Outstanding Full Value Awards as of December 31, 2022<SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">816,958</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total Equity Awards Outstanding as of December 31, 2022<SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,057,728</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Shares Available for Grant under the Prior Plan as of December 31, 2022<SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shares Requested for the 2023 Equity Incentive Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,700,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Potential Overhang under the 2023 Equity Incentive Plan<SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,867,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Shares of Common Stock Outstanding as of March 29, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,831,018</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fully Diluted Shares<SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,698,290</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Potential Dilution of 1,700,000 Shares as a Percentage of Fully Diluted Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.2</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 57.5pt; text-indent: -39.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Full
    Value Awards&rdquo; includes restricted stock awards granted under the Prior Plan and as inducement awards that qualify for the inducement
    grant exception to the shareholder approval requirements of the Nasdaq Stock Market set forth in Rule 5635(c)(4) (&ldquo;Inducement
    Awards&rdquo;). </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Total
    Equity Awards&rdquo; represents the sum of outstanding stock options and outstanding Full Value Awards, in each case as of December
    31, 2022. No additional awards will be granted under the Prior Plan upon approval of the 2023 Equity Incentive Plan. Any Shares that
    remain available for awards under the Prior Plan will be available under the 2023 Equity Incentive Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of the Effective Date, the Shares available for grant on the Effective Date under the Prior Plan will be available for grant under
    the 2023 Equity Incentive Plan and no Shares will be available for grant under the Prior Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Total
    Potential Overhang&rdquo; includes the sum of the total number of equity awards outstanding as of December 31, 2022, the number of
    Shares available for grant under the Prior Plan as of December 31, 2022, and the number of shares requested for the 2023 Equity Incentive
    Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Fully
    Diluted Shares&rdquo; reflects the sum of the total number of Shares outstanding as of March 29, 2023, the total number of equity
    awards outstanding as of December 31, 2022, the number of Shares available for grant under the Prior Plan as of December 31, 2022,
    and the number of additional Shares requested for grant under the 2023 Equity Incentive Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Burn
Rate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. Accordingly, we closely monitor our past Share usage (referred to as &ldquo;burn rate&rdquo;) each year and over time. The table
below sets forth the following information regarding the awards granted under the Prior Plan and as Inducement Awards: (i) the burn rate
for each of the last three calendar years and (ii) the average burn rate over the last three calendar years. The burn rate for a year
has been calculated as follows: (1) all stock options and full value awards granted in the applicable year, <I>divided by</I> (2) the
weighted average number of Shares outstanding for the applicable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">3 - Year Average</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%; text-align: left">Stock Options/Restricted Stock Granted</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">787,482</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">310,719</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">317,418</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted Average Shares of Common Stock Outstanding as of applicable fiscal year-end</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,861,515</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,937,676</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,706,543</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Burn Rate</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">10.0</TD><TD STYLE="font-weight: bold; text-align: left">%</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">7.9</TD><TD STYLE="font-weight: bold; text-align: left">%</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">8.6</TD><TD STYLE="font-weight: bold; text-align: left">%</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">8.8</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
burn rate means that we used an annual average of 8.8% of the weighted average Shares outstanding for awards granted or earned over the
past three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
of Abeona Therapeutics Inc. 2023 Equity Incentive Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
material terms of the 2023 Equity Incentive Plan are summarized below. A copy of the full text of the 2023 Equity Incentive Plan is attached
to this proxy statement as <B>Appendix A</B>. This summary of the 2023 Equity Incentive Plan is not intended to be a complete description
of the 2023 Equity Incentive Plan and is qualified in its entirety by the actual text of the 2023 Equity Incentive Plan to which reference
is made. Capitalized terms used, but not defined, in the following summary have the meaning assigned to those terms in the 2023 Equity
Incentive Plan.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purpose
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan is intended to provide participants with an incentive to contribute materially to the Company&rsquo;s growth
by aligning the economic interests of the participants with those of the Company&rsquo;s stockholders. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Types
of Awards </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan provides for the issuance of stock options (including incentive stock options and nonqualified stock options),
SARs, stock awards, stock units, and other stock-based awards to employees, non-employee directors, and consultants of the Company or
its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Administration</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan will be administered by the Compensation Committee. The Compensation Committee can delegate authority to administer
the 2023 Equity Incentive Plan to one or more subcommittees of the Compensation Committee, as it determines to be appropriate. In addition,
subject to compliance with applicable laws and applicable stock exchange requirements, the Compensation Committee may delegate some or
all of its authority to our chief executive officer or our chief financial officer, with respect to grants of awards to employees or
advisors and consultants who are not executive officers or directors subject to reporting obligations under Section 16 of the Exchange
Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will determine (1) the individuals who will receive awards under the 2023 Equity Incentive Plan; (2) the type,
size, terms and conditions of awards under the 2023 Equity Incentive Plan; (3) when grants of awards will be made and the duration of
any applicable exercise or restriction period, including the criteria for exercisability and the acceleration of exercisability; (4)
determine the amounts payable based on whether performance goals were met, with discretion to make adjustments to the amounts payable
as the Compensation Committee deems appropriate and in the Company&rsquo;s best interests; (5) when to amend previously granted awards,
subject to the limitations set forth in the 2023 Equity Incentive Plan; (6) determine and adopt the terms and guidelines that apply to
individuals living outside the U.S. who receive grants under the 2023 Equity Incentive Plan; and (7) deal with any other matters arising
under the 2023 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;Committee&rdquo; in this description of the 2023 Equity Incentive Plan will refer to the Compensation Committee, our Board,
or any subcommittee, as applicable, that has authority with respect to a specific grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shares
Subject to the 2023 Equity Incentive Plan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment described below, our 2023 Equity Incentive Plan authorizes the issuance or transfer of up to 1,700,000 Shares. The 2023
Equity Incentive Plan also provides that Shares reserved for issuance under the Prior Plan that remain available for grant as of the
Effective Date and Shares underlying any outstanding award granted under the Prior Plan that, following the Effective Date of the 2023
Equity Incentive Plan, expires, or is terminated, surrendered, cancelled, exchanged, or forfeited for any reason without issuance of
such Shares will be available for new grants under the 2023 Equity Incentive Plan<I>.</I> Subject to adjustment, as described below,
the aggregate number of Shares available for issuance or transfer under the 2023 Equity Incentive Plan pursuant to incentive stock options
cannot exceed 1,700,000 Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares issuable under the 2023 Equity Incentive Plan may be drawn from Shares of authorized but unissued common stock or from Shares
that we acquire, including Shares purchased on the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
awards granted under the 2023 Equity Incentive Plan expire, terminate, or are surrendered, cancelled, forfeited, or exchanged without
having been exercised, vested or paid in Shares, subject to such awards will again be available for purposes of the 2023 Equity Incentive
Plan. Shares surrendered in payment of an option&rsquo;s exercise price, including options granted under the Prior Plan, are not available
for re-issuance under the 2023 Equity Incentive Plan. Furthermore, Shares withheld or surrendered for payment of taxes with respect to
awards, including such awards granted under the Prior Plan, are not available for reissuance. If SARs are granted, the full number of
Shares subject to the SARs are considered issued under the 2023 Equity Incentive Plan, without regard to the number of Shares issued
upon exercise of the SARs. If grants of awards are settled in cash rather than Shares, any Shares that were previously subject to such
awards will again be available for issuance or transfer under the 2023 Equity Incentive Plan. If we repurchase the Shares on the open
market with proceeds from an option&rsquo;s exercise price (including options granted under the Prior Plan), then such Shares cannot
be made available for issuance under the 2023 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of Shares available under the 2023 Equity Incentive Plan will not be reduced by the Shares that are issued or transferred under
awards made pursuant to an assumption, substitution, or exchange for previously granted awards of a company that we acquired in a transaction.
Additionally, subject to applicable stock exchange listing and Code requirements, Shares available under an acquired company&rsquo;s
stockholder approved plan, as adjusted, may be used by the Company for grants of awards under the 2023 Equity Incentive Plan, and they
will not reduce the 2023 Equity Incentive Plan&rsquo;s Share reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-Employee
Director Limit</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment, as described below, the maximum aggregate grant date value of Shares (as determined for financial reporting purposes)
granted to any non-employee director in a calendar year, taken together with any cash fees earned by such non-employee director for services
rendered as a non-employee director during the calendar year, cannot exceed $500,000 in total value. This calculation excludes the value
of any dividend equivalents paid pursuant to grants of awards from any previous year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Adjustments
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is any change in the number or kind of Shares outstanding because of (i) a stock dividend, spinoff, recapitalization, stock split,
reverse stock split, or combination or exchange of shares; (ii) a merger, reorganization, or consolidation; (iii) a reclassification
or change in par value of Shares; or (iv) any other extraordinary or unusual event affecting the outstanding common stock as a class
without the Company&rsquo;s receipt of consideration, or if the value of outstanding Shares is substantially reduced because of a spinoff
or the Company&rsquo;s payment of an extraordinary dividend or distribution, the Compensation Committee will equitably adjust the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    maximum number and kind of Shares available for issuance under the 2023 Equity Incentive Plan, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    maximum grant date value of awards that a non-employee director may receive in a year (calculated as described above),</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number and kind of Shares issued and to be issued under the 2023 Equity Incentive Plan, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    price per Share or applicable market value of awards will be equitably adjusted by the Compensation Committee, and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercise
    price of options, base amount of SARs, performance goals or other terms and conditions that the Compensation Committee deems appropriate
    and subject to the 2023 Equity Incentive Plan&rsquo;s repricing restrictions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will make adjustments to reflect changes in the number, kind, or value or Shares issued to prevent, to the extent
possible, the enlargement or dilution of rights and benefits under the 2023 Equity Incentive Plan and for any outstanding awards, in
each case subject to and consistent with applicable law. The Compensation Committee will eliminate any fractional Shares resulting from
adjustment. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may also make adjustments to the terms and conditions of outstanding awards in recognition of unusual or nonrecurring
events, including acquisitions and dispositions of business assets, which affect the Company, its subsidiaries or business units, or
any financial statements of the Company or its subsidiaries, or in response to changes in applicable laws, regulations, or accounting
principles. In the event of certain transactions that represent a change in control (as described below), the change in control provisions
of the 2023 Equity Incentive Plan apply. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lastly,
the Compensation Committee has sole discretion and authority to determine the adjustments to be made, and adjustments by the Compensation
Committee are final, binding, and conclusive. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eligibility
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
employees and non-employee directors, and certain key advisors (including consultants and advisors of the Company) that provide services
to us and our subsidiaries are eligible to participate in the 2023 Equity Incentive Plan. The Compensation Committee will select which
eligible services providers will receive grants of awards under the 2023 Equity Incentive Plan. As of March 29, 2023, approximately 73
employees, 8 non-employee directors and 30 consultants and advisors would have been eligible to participate in the 2023
Equity Incentive Plan if the 2023 Equity Incentive Plan were in effect on such date.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Vesting
and Minimum Vesting Requirements </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee determines the vesting and exercisability terms of awards granted under the 2023 Equity Incentive Plan and such
awards will have regular vesting schedules that provide that no portion of an award will vest earlier than one year from the draft of
grant. However, (i) awards granted to non-employee directors will be deemed to satisfy this minimum vesting requirement if granted on
the date of our annual meeting of stockholders and vest on the date of our annual meeting of stockholders immediately following the date
of grant (but in any event, not less than 50 weeks), and (ii) up to 5% of the Shares reserved under the 2023 Equity Incentive Plan as
of the Effective Date (subject to adjustment described above) may be granted without regard to this minimum vesting requirement. The
Compensation Committee may accelerate vesting of any award in its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Options
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2023 Equity Incentive Plan, the Compensation Committee may grant incentive stock options and nonqualified stock options. Incentive
stock options may be granted to employees of the Company or any parent or subsidiary of the Company, according to Section 424 of the
Code. Nonqualified stock options may be granted to employees, non-employee directors, and key advisors. The exercise price of an option
granted under the 2023 Equity Incentive Plan will be determined by the Compensation Committee but cannot be less than the fair market
value of a Share on the date the option is granted. If an incentive stock option is granted to a 10% stockholder, the exercise price
cannot be less than 110% of the fair market value of a Share on the date the option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will determine the term of an option, with a term limit of no more than 10 years from the date of grant. However,
an incentive stock option that is granted to a 10% stockholder, cannot have a term that exceeds five years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the minimum vesting requirements of the 2023 Equity Incentive Plan, options will become exercisable according to the terms and conditions
set by the Compensation Committee in the award agreement. The Compensation Committee may accelerate the exercisability of any outstanding
options at any time and for any reason. The Compensation Committee will determine in the award agreement under what circumstances and
during what time periods a participant may exercise an option after termination of employment or service. Any options granted to non-exempt
employees cannot be exercisable for at least six months after the grant date, except as determined by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant can exercise an option that has become exercisable by delivering a notice of exercise to the Company. The exercise price
for any option is generally payable in cash or check. In certain circumstances, as permitted by the Compensation Committee, the exercise
price may be paid by the surrender of Shares with an aggregate fair market value on the date the option is exercised equal to the exercise
price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding Shares subject
to the exercisable option that have a fair market value on the date of exercise equal to the aggregate exercise price; or by such other
method as the Compensation Committee approves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may grant stock awards of our common stock to anyone eligible under the 2023 Equity Incentive Plan. Stock awards
may be subject to restrictions as the Compensation Committee determines. The restrictions, if any, may lapse over a specified period
or based on the satisfaction of pre-established criteria, as determined by the Compensation Committee, including, but not limited to,
restrictions based on the achievement of performance goals. The award agreement will set the period of time during which the stock awards
will be subject to restrictions, during which time a participant cannot sell, assign, transfer, pledge, or otherwise dispose of the shares
of a stock award, except as permitted by the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a participant ceases to be employed by or provide services to the Company during any restricted period, or if other specified conditions
are not met, any unvested portion of the stock award will be forfeited, unless the Compensation Committee determines otherwise. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Compensation Committee, a participant will have the right to vote and the right to receive dividends or other
distributions paid on the shares, subject to any restrictions, including the achievement of performance goals, that the Compensation
Committee may determine. Dividends with respect to stock awards will only vest if and to the extent that the underlying stock award vests,
as determined by the Compensation Committee. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Units </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may grant stock units to anyone eligible to participate in the 2023 Equity Incentive Plan. Stock units represent
hypothetical Shares, and each represents a right that a participant has to receive a Share or amount of cash based on the common stock&rsquo;s
value, if and when specified conditions are met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
units become payable if certain conditions or circumstances are met, including specified performance goals. The Compensation Committee
may accelerate vesting or payment for any reason and at any time, provided that the acceleration complies with Section 409A of the Code.
Payment for stock units can be made in common stock, cash, or any combination of the two as determined by the Compensation Committee.
All unvested stock units are forfeited if the participant&rsquo;s employment or service is terminated for any reason, unless the Compensation
Committee determines otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Appreciation Rights </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may grant SARs to anyone eligible for the 2023 Equity Incentive Plan separately or in tandem with any option.
Tandem SARs for non-qualified stock options may be granted at the time an option is granted or while an option is outstanding. In the
case of incentive stock options, SARs may only be granted at the time the incentive stock option is granted. The Compensation Committee
will establish the base amount of the SAR at the time the SAR is granted, which will be equal to or greater than the fair market value
of a share of our common stock as of the date of grant, as well as the vesting and other restrictions applicable to the exercisability
of a SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of Shares that the participant may purchase upon exercising the related option during such period. Upon exercising the related option,
the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent of an equal number of
Shares. Generally, SARs may only be exercised while the participant is employed by, or providing services to, us or during an applicable
period following termination. If a SAR is granted to a non-exempt employee, it may not be exercisable for at least six months after the
date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying common stock over the
base amount of the SAR. The appreciation of a SAR will be paid in Shares, cash or both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of any SAR cannot exceed 10 years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the Compensation Committee
determines otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Stock-Based Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may grant other stock-based awards that are based on or measured by our common stock to anyone who is eligible
to participate in the 2023 Equity Incentive Plan, subject to terms and conditions set by the Compensation Committee. Other stock-based
awards may be subject to the achievement of performance goals or criteria, and may be payable in cash, Shares, or a combination of the
two, as determined by the Compensation Committee. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividend
Equivalents </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may grant dividend equivalents in connection with stock units or other stock-based awards, either in the award
agreement or at any point following the grant of the stock unit or other stock-based award. Dividends and dividend equivalents granted
in connection with an award of stock units or other stock-based award will vest and be paid only if and to the extent that the underlying
award of stock units or other stock-based award is vested and paid. Dividend equivalents may be payable in cash or Shares and upon terms
and conditions set by the Compensation Committee. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
and dividend equivalents may not be granted in connections with options or SARs. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Prohibition
on Repricing </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in connection with a corporate transaction involving the Company, the Compensation Committee may not (i) amend the terms of any outstanding
stock options or SARs to reduce the exercise price or base price, as applicable; (ii) cancel outstanding stock options or SARs in exchange
for stock options or SARs with an exercise price or base price that is lower than the exercise price or base price of the original option
or SAR; or (iii) cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock
price in exchange for cash or other securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Change
in Control </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience a change in control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the Compensation Committee determines otherwise, all outstanding grants that are not exercised, unvested or paid at the time of
the change in control will be assumed by or replaced with grants (with respect to cash, securities or a combination thereof) that have
comparable terms by the surviving corporation (or a parent or subsidiary of the surviving corporation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the Compensation Committee or applicable award agreement provides otherwise, if a participant&rsquo;s employment or service to the Company
is terminated involuntarily upon or within 12 months following a change in control, the participant&rsquo;s awards become fully vested
as of the date of such termination. For awards that become vested based, in whole or in part, on performance, the applicable award agreement
must specify how to calculate the portion of such grant that becomes vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a change in control and all outstanding grants are not assumed by or replaced with grants that have comparable terms by the
surviving company, then the Compensation Committee may (but is not required to) adjust the terms and conditions of outstanding awards,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that outstanding options and SARs will automatically accelerate and become fully exercisable and the restrictions and conditions
    on outstanding stock awards, stock units, other stock-based awards, and dividend equivalents immediately lapse; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that participants will receive payment, in an amount and form determined by the Compensation Committee, in settlement of outstanding
    stock units, other stock-based awards, or dividend equivalents; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by the Company, in cash or Shares,
    equal to the difference between the exercise price and the fair market value of the underlying Shares; provided, however, if the
    per Share fair market value of our common stock does not exceed the per Share stock option exercise price or SAR base amount, as
    applicable, we will not be required to make any payment to the participant upon surrender of the stock option or SAR; or </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the Compensation Committee. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general terms, a change in control under the 2023 Equity Incentive Plan occurs if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    consummation of a transaction where a person, entity or affiliated group, with certain exceptions, acquires more than 50% of our
    then-outstanding voting securities; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    sell or dispose of all or substantially all of our assets; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    consummate a complete liquidation or dissolution; or </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Deferrals</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may permit or require participants to defer receipt of the payment of cash or the delivery of Shares that would
otherwise be due to the participant in connection with a grant under the 2023 Equity Incentive Plan. The Compensation Committee will
establish the rules and procedures applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Valuation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair market value per Share on any relevant date under the 2023 Equity Incentive Plan will be deemed to be equal to the closing sale
price per Share during regular hours trading on the relevant date on Nasdaq (or any other national securities exchange on which our Common
Stock is at the time primarily traded). If there is no closing selling price for Common Stock on the date in question, then the fair
market value shall be the last reported sale price during regular trading hours on the last preceding date for which a sale was reported.
On March 29, 2023, the fair market value per Share of our Common Stock was $2.81.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
awards under the 2023 Equity Incentive Plan are subject to applicable U.S. federal (including FICA), state and local, foreign or other
tax withholding requirements. We may require participants or other persons receiving or exercising awards to pay an amount sufficient
to satisfy such tax withholding requirements with respect to such awards, or we may deduct from other wages and compensation paid by
us the amount of any withholding taxes due with respect to such grant. We may also take any other actions that the Compensation Committee
deems advisable to enable us to satisfy our withholding tax and other tax obligations with respect to any award made under the 2023 Equity
Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may permit or require that our tax withholding obligation with respect to awards paid in our common stock be paid
by having Shares withheld up to an amount that does not exceed the participant&rsquo;s minimum applicable withholding tax rate for U.S.
federal (including FICA), state and local tax liabilities, or as otherwise determined by the Compensation Committee. In addition, the
Compensation Committee may, in its discretion, and subject to such rules as the Compensation Committee may adopt, allow participants
to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection with any
particular grant.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transferability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as permitted by the Compensation Committee with respect to non-qualified stock options, only a participant may exercise rights under
a grant during the participant&rsquo;s lifetime. A participant cannot transfer those rights except by will or by the laws of descent
and distribution or, with respect to awards other than incentive stock options, pursuant to a domestic relations order. Upon death, the
personal representative or other person entitled to succeed to the rights of the participant may exercise such rights. The Compensation
Committee may provide in an award agreement that a participant may transfer non-qualified stock options and stock awards to family members,
or one or more trusts or other entities for the benefit of or owned by family members, consistent with applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment;
Termination </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may amend or terminate the 2023 Equity Incentive Plan at any time, except that the Board must receive stockholder approval to do
so if required to comply with the Code, applicable law, or applicable stock exchange requirements. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Equity Incentive Plan will terminate on the day immediately preceding the 10th anniversary of its Effective Date, unless terminated
earlier by the Board or unless the Board, with stockholder approval, extends the term of the 2023 Equity Incentive Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a termination or amendment occurs after an award is made, it will not materially impair the rights of a participant with respect to the
award, unless the participant consents or the Compensation Committee acts in compliance with applicable law or other exceptions set forth
in the 2023 Equity Incentive Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Establishment
of Sub-Plans</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may from time to time establish one or more sub-plans under the 2023 Equity Incentive Plan to satisfy applicable blue sky, securities
or tax laws of various jurisdiction. The Board will establish sub-plans by setting forth the Compensation Committee&rsquo;s discretionary
limits under the 2023 Equity Incentive Plan and any additional terms and conditions not otherwise inconsistent with the 2023 Equity Incentive
Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clawback</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
grants of awards under the 2023 Equity Incentive Plan will be subject to any applicable clawback or recoupment policies, share trading
policies, and other policies that the Board or Compensation Committee may implement or approve at any time. We may offset any payments
due under the 2023 Equity Incentive Plan to a participant where repayment is required by an applicable clawback or recoupment policy,
subject to applicable law. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable law, the Compensation Committee may provide in any award agreement that if a participant breaches any restrictive covenant
obligation or agreement between the participant and us, or otherwise engages in activities that constitute misconduct either while employed
by, or providing services to, us or within a specified period thereafter, all awards held by the participant will terminate, and we may
rescind any exercise of an option or SAR and the vesting of any other award and delivery of Shares upon such exercise or vesting, as
applicable on such terms as the Compensation Committee will determine, including the right to require that in the event of any rescission:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    participant must return the Shares received upon the exercise of any option or SAR or the vesting and payment of any other grants;
    or </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the participant no longer owns the Shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the Shares (if the participant transferred the Shares by gift or without consideration,
    then the fair market value of the Shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
by the participant will be made in such manner and on such terms and conditions as may be required by the Compensation Committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Federal Income Tax Aspects </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain federal income tax consequences of awards under the 2023 Equity Incentive Plan. It does not purport
to be a complete description of all applicable rules, and those rules (including those summarized here) are subject to change<I>. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Options
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the Shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&rsquo;s tax basis in any Shares received upon the exercise
of an option will be the fair market value of the Shares on the date of exercise, and if the Shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such Shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the Shares are a capital asset of the optionee) depending
upon the length of time such Shares were held by the optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within 10 years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the Shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
Shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the Shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Awards </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the Shares at the time the Shares are no longer subject to a &ldquo;substantial risk of
forfeiture&rdquo; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&rsquo;s tax basis in the
Shares will equal their fair market value at the time the restrictions lapse, and the participant&rsquo;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the Shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such Shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the Shares equal to their fair market value on the date of their award, and the participant&rsquo;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Units </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Appreciation Rights </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any Shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&rsquo;s tax basis in
any Shares received upon exercise of a SAR will be the fair market value of the Shares on the date of exercise, and if the Shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
Shares on the date of exercise will generally be taxable as long-term or short-term capital gain or loss (if the Shares are a capital
asset of the participant) depending upon the length of time such Shares were held by the participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Stock-Based Awards </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to other stock-based awards granted under the 2023 Equity Incentive Plan, generally when the participant receives payment with
respect to an award, the amount of cash and/or the fair market value of any Shares or other property received will be ordinary income
to the participant, and we generally will be entitled to a tax deduction at the same time and in the same amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impact
of Section 409A </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2023 Equity Incentive Plan are intended to be exempt from the requirements of Section
409A or to satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the
holder of the award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
162(m) of the Code</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code generally disallows a tax deduction to a publicly held company for compensation in excess of $1 million paid to its
&ldquo;covered employees&rdquo; which generally includes all NEOs. While the Compensation Committee considers the tax deductibility of
each element of executive compensation as a factor in our overall compensation program, the Compensation Committee retains the discretion
to approve compensation that may not qualify for the compensation deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Plan Benefits </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
benefits under the 2023 Equity Incentive Plan generally will be granted at the discretion of the Compensation Committee and are therefore
not currently determinable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
future grants of awards under the 2023 Equity Incentive Plan, if approved, would be subject to the discretion of the Board or Compensation
Committee, the amount and terms of future awards to particular participants or groups of participants are not determinable at this time.
No awards have been previously granted that are contingent on the approval of the 2023 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
2 will be approved upon the affirmative vote of a majority of the outstanding Shares present through virtual attendance or by proxy at
the Annual Meeting and entitled to vote on the proposal. Stockholders may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST,&rdquo; or &ldquo;ABSTAIN&rdquo;
from voting. Abstentions will have the effect of a vote &ldquo;AGAINST&rdquo; this proposal. Broker non-votes, if any, will be disregarded
and will have no effect on the outcome of the vote for Proposal 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation
of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Board recommends that the stockholders vote &ldquo;FOR&rdquo; the approval of the 2023 Equity Incentive Plan as set forth in this Proxy
Statement for the Annual Meeting</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_010"></A>PROPOSAL
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&emsp;ADVISORY
VOTE ON THE COMPENSATION OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &ldquo;Dodd-Frank Act&rdquo;) enables our stockholders to vote
to approve, on an advisory (nonbinding) basis, the compensation of our named executive officers as disclosed in this proxy statement
in accordance with the SEC&rsquo;s rules. Our executive compensation programs are designed to attract, motivate, and retain our management
talent, including the named executive officers, and to reward them for strong Company performance and successful execution of our key
business plans and strategies. Under these programs, our named executive officers are rewarded for the achievement of specific annual,
long-term and strategic goals and the realization of increased stockholder value. The Compensation Committee of the Board of Directors
regularly reviews the Company&rsquo;s compensation programs to confirm that they are achieving these goals. Please read the information
under the heading &ldquo;Executive Compensation&rdquo; above for additional information about the compensation of our named executive
officers in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are asking our stockholders to indicate their support for our named executive officer compensation for fiscal year 2022 as described
in this proxy statement. This proposal, commonly known as a &ldquo;say-on-pay&rdquo; proposal, gives our stockholders the opportunity
to express their views on our named executive officers&rsquo; compensation for the most recently completed fiscal year. This vote is
not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the
philosophy, policies and practices as described in this proxy statement. While this vote is non-binding on us, our Compensation Committee
values the opinions of our stockholders and will take into consideration the outcome of the vote when considering future executive compensation
arrangements. Accordingly, our Board recommends stockholders to vote &ldquo;FOR&rdquo; the following resolution at the Annual Meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;RESOLVED,
that the compensation paid to the Company&rsquo;s named executive officers during the fiscal year ended December 31, 2022, as disclosed
pursuant to Item 402 of Regulation S-K, including compensation tables and narrative discussion, is hereby APPROVED on an advisory basis.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
3 will be approved on an advisory basis upon the affirmative vote of a majority of the outstanding shares of Common Stock present in
person or by proxy at the Annual Meeting and entitled to vote on such proposal. Stockholders may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST,&rdquo;
or &ldquo;ABSTAIN&rdquo; from voting. Abstentions will have the effect of a vote &ldquo;AGAINST&rdquo; this proposal. Broker non-votes,
if any, will be disregarded and will have no effect on the outcome of the vote for Proposal 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation
of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Board recommends that the stockholders vote &ldquo;FOR&rdquo; the advisory approval of the compensation of our named executive officers
as set forth in this proxy statement for the Annual Meeting.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>PROPOSAL
4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&emsp;RATIFICATION
OF APPOINTMENT OF WHITLEY PENN LLP AS OUR INDEPENDENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED
PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whitley
Penn LLP, an independent registered public accounting firm, has been our independent registered public accounting firm since September
2006. The Board has recommended that the stockholders ratify the reappointment of Whitley Penn LLP as the Company&rsquo;s independent
registered public accounting firm for the current year, fiscal year 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of Whitley Penn LLP is not expected to be present at the Annual Meeting but will be available to respond to appropriate
questions in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratification
by stockholders is not required. If Proposal 4 is not approved by the stockholders, the Board does not plan to change the appointment
for fiscal year 2023 but will consider such vote in selecting our independent registered public accounting firm for fiscal year 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
4 will be approved upon the affirmative vote of a majority of shares of Common Stock present through virtual attendance or represented
by proxy at the Annual Meeting and entitled to vote on such proposal. Abstentions will have the effect of a vote &ldquo;AGAINST&rdquo;
Proposal 4. Brokers may vote on Proposal 4 absent instructions from the beneficial owner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation
of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Board recommends that the stockholders vote &ldquo;FOR&rdquo; the ratification of the appointment of Whitley Penn LLP as our independent
registered public accounting firm for the fiscal year ending December 31, 2023.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
Auditor Fees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents fees for professional audit services rendered by Whitley Penn LLP for the audit of our annual financial statements
for the years ended December 31, 2022 and 2021, and fees billed for other services rendered during the respective periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Types of Fees</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">190,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">153,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">47,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">74,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees for 2022 and
    2021 were for professional services rendered for the audit of our financial statements for the fiscal year and reviews of our quarterly
    financial statements included in our Form 10-Q filings.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related fees are for services related to our
    registration statements on Forms S-3 and S-8 and other fees.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax fees are for professional services rendered for
    tax compliance, tax advice, and tax planning service.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other fees are for services, other than those described
    above, rendered to us.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
decisions regarding the selection of an independent registered public accounting firm and approval of accounting services and fees are
made by our Audit Committee in accordance with the provisions of the Sarbanes-Oxley Act of 2002 and related SEC rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee selected Whitley Penn LLP to serve as the Company&rsquo;s independent registered public accounting firm for the fiscal
year ending December 31, 2023. Whitley Penn LLP has served as Abeona&rsquo;s independent registered public accounting firm since September
2006.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and non-audit services provided by the independent registered public accounting firm prior to
the engagement with respect to such services. The Audit Committee approved all of the services listed under the preceding captions &ldquo;Audit
Fees&rdquo; and &ldquo;Audit-Related Fees.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_012"></A>OTHER
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement, the Board is not aware of any matters to be presented for consideration at the Annual Meeting other
than those referred to above. If (i) any matters not within the knowledge of the Board as of the date of this proxy statement should
properly come before the Annual Meeting; (ii) a person not named herein is nominated at the Annual Meeting for election as a director
because a nominee named herein is unable to serve or for good cause will not serve; (iii) any proposals properly omitted from this proxy
statement and the form of proxy, subject to applicable laws and our Certificate of Incorporation and Bylaws, should come before the Annual
Meeting; or (iv) any matters should arise incident to the conduct of the Annual Meeting, then the proxies will be voted by the persons
named in the enclosed form of proxy, or their substitutes acting thereunder, in accordance with the recommendations of the Board, or,
if no such recommendations are made, in accordance with their best judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBMISSION
OF NOMINATIONS AND PROPOSALS FOR THE 2024 ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2024 annual meeting of stockholders is expected to be held on or about May 31, 2024. The Board will make provisions for the presentation
of proposals submitted by eligible stockholders who have complied with the relevant rules and regulations of the SEC as well as those
contained in our Certificate of Incorporation and Bylaws. These requirements are summarized above under the heading &ldquo;Nomination
and Election of Directors.&rdquo; A stockholder may nominate directors at the 2024 annual meeting of stockholders by submitting the nomination
to the Company not later than 120 calendar days in advance of such meeting in accordance with our Certificate of Incorporation. Additionally,
with respect to stockholder nominations and proposals to be included in the Company&rsquo;s proxy statement under Rule 14a-8 under the
Exchange Act (&ldquo;Rule 14a-8&rdquo;), we must have received such nominations or proposals no later than April 13, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDERS
SHARING AN ADDRESS OR HOUSEHOLD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
one copy of our Annual Report and Proxy Statement is being delivered to multiple stockholders sharing an address unless we have received
instructions to the contrary from one or more of the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will deliver promptly upon written or oral request a separate copy of our Annual Report and Proxy Statement to any stockholder at a shared
address to which a single copy of any of those documents was delivered. To receive a separate copy of our Annual Report and Proxy Statement,
or if two stockholders sharing an address have received two copies of any of these documents and desire to only receive one, you may
write to the Company at c/o Investor Relations, 6555 Carnegie Ave., 4<SUP>th</SUP> Floor, Cleveland, OH 44103 or call the Company at
646-813-4701.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COST
AND METHOD OF SOLICITATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of Abeona
in person or by telephone, email or other electronic means. As required by the SEC, we also will reimburse brokerage firms and other
custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners of our Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
annual report on Form 10-K for the 2022 fiscal year is available without charge to each stockholder, upon written request to the Company
at c/o Investor Relations, 6555 Carnegie Ave., 4<SUP>th</SUP> Floor, Cleveland, OH 44103 and is also available on our website at www.abeonatherapeutics.com
under the heading &ldquo;Investors &amp; Media&mdash;SEC Filings.&rdquo;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="S_2"></A>APPENDIX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Abeona
Therapeutics Inc. 2023 Equity Incentive Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC.<BR>
2023 EQUITY INCENTIVE PLAN<BR>
<BR>
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
1. Effectiveness and Purpose</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Effective Date, the Abeona Therapeutics Inc. 2023 Equity Incentive Plan (as may be amended from time to time, the &ldquo;<B><U>Plan</U></B>&rdquo;)
is hereby established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to provide employees of Abeona Therapeutics Inc., a Delaware corporation (together with its successors, the &ldquo;<B><U>Corporation</U></B>&rdquo;),
and its Subsidiaries, certain consultants and advisors who perform services for the Corporation or its Subsidiaries, and non-employee
members of the Board, with the opportunity to receive grants of equity awards in the form of incentive stock options, nonqualified stock
options, stock appreciation rights, stock awards, stock units, and other stock-based awards. Capitalized terms used in the Plan and not
otherwise defined herein shall have the meaning assigned to them in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation believes that the Plan will encourage the participants to contribute materially to the growth of the Corporation, thereby
benefitting the Corporation&rsquo;s stockholders, and will align the economic interests of the participants with those of the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan is intended to replace the Prior Plan. No additional grants shall be made under the Prior Plan on or after the Effective Date. Outstanding
grants under the Prior Plan shall continue in effect according to their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
2. Definitions</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall have the meanings set forth below for purposes of the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &ldquo;<B><U>Affiliate</U></B>&rdquo;
means, when used with reference to any Person, any other Person that directly or indirectly, through one or more intermediaries, controls,
is controlled by or is under common control with, or owns greater than 50% of the voting power in, the specified Person (the term &ldquo;control&rdquo;
for this purpose means the ability, whether by the ownership of shares or other equity interest, by contract or otherwise, to elect a
majority of the directors of a corporation, independently to select the managing partner of a partnership or the managing member or the
majority of the managers, as applicable, of a limited liability company, or otherwise to have the power independently to remove and then
select a majority of those Persons exercising governing authority over an entity, and control shall be conclusively presumed in the case
of the direct or indirect ownership of 50% or more of the voting equity interests in the specified Person).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;<B><U>Award</U></B>&rdquo;
means an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;<B><U>Award
Agreement</U></B>&rdquo; means the written agreement that sets forth the terms and conditions of an Award, including all amendments thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &ldquo;<B><U>Board</U></B>&rdquo;
means the Board of Directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &ldquo;<B><U>CEO</U></B>&rdquo;
means the Chief Executive Officer of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &ldquo;<B><U>Change
in Control</U></B>&rdquo; means a change in ownership or control of the Corporation effected through any of the following transactions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) any
&ldquo;person&rdquo; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &ldquo;beneficial owner&rdquo;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Corporation representing more than fifty
percent (50%) of the voting power of the then-outstanding securities of the Corporation; <I>provided</I> that a Change in Control shall
not be deemed to occur as a result of a transaction in which the Corporation becomes a direct or indirect subsidiary of another Person
and in which the stockholders of the Corporation, immediately prior to the transaction, will beneficially own, immediately after the
transaction, shares of such other Person representing more than fifty percent (50%) of the voting power of the then-outstanding securities
of such other Person;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) the
consummation of (A) a merger or consolidation of the Corporation with another Person where, immediately after the merger or consolidation,
the stockholders of the Corporation, immediately prior to the merger or consolidation, will not beneficially own, in substantially the
same proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than fifty
percent (50%) of all votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where
the members of the Board, immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation,
constitute a majority of the board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all
of the assets of the Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) a
change in the composition of the Board over a period of twelve (12) consecutive months or less such that a majority of the Board members
ceases, by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals
who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) the
consummation of a complete dissolution or liquidation of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may modify the definition of Change in Control for a particular Award as the Committee deems appropriate to comply with Section
409A of the Code. Notwithstanding the foregoing, if an Award constitutes deferred compensation subject to Section 409A of the Code and
the Award provides for payment upon a Change in Control, then, for purposes of such payment provisions, no Change in Control shall be
deemed to have occurred upon an event described in items (i)-(iv) above unless the event would also constitute a change in ownership
or effective control of, or a change in the ownership of a substantial portion of the assets of, the Corporation under Section 409A of
the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &ldquo;<B><U>Code</U></B>&rdquo;
means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &ldquo;<B><U>Committee</U></B>&rdquo;
means the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee shall
consist of directors who are &ldquo;non-employee directors&rdquo; as defined under Rule 16b-3 promulgated under the Exchange Act and
&ldquo;independent directors,&rdquo; as determined in accordance with the independence standards established by the stock exchange on
which the Common Stock is at the time primarily traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &ldquo;<B><U>Common
Stock</U></B>&rdquo; means common stock, par value $.01 per share, of the Corporation, and such other securities as may be substituted
for Common Stock pursuant to Section 5(c) or Section 5(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &ldquo;<B><U>Disability</U></B>&rdquo;
or &ldquo;<B><U>Disabled</U></B>&rdquo; has the meaning set forth in an applicable Award Agreement or employment or services agreement
with a Participant, and in the absence of the forgoing, means (i) the Participant&rsquo;s becoming disabled within the meaning of the
Employer&rsquo;s long-term disability plan applicable to the Participant, or (ii) if no long-term disability plan is applicable to the
Participant, the Participant&rsquo;s inability to engage in any substantial gainful activity by reason of any medically determinable
physical or mental impairment that is expected to result in death or has lasted or can be expected to last for a continuous period of
six months or more.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &ldquo;<B><U>Dividend
Equivalent</U></B>&rdquo; means an amount determined by multiplying the number of shares of Common Stock subject to a Stock Unit or Other
Stock-Based Award by the per-share cash dividend paid by the Corporation on its outstanding Common Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Common Stock in consideration other than cash. If interest is credited on accumulated divided
equivalents, the term &ldquo;Dividend Equivalent&rdquo; shall include the accrued interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &ldquo;<B><U>Effective
Date</U></B>&rdquo; means the date the Plan is approved by the Corporation&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &ldquo;<B><U>Employed
by, or providing service to, the Employer</U></B>&rdquo; means employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&rsquo;s relationship is
with a Subsidiary and that entity ceases to be a Subsidiary, the Participant will be deemed to cease employment or service when the entity
ceases to be a Subsidiary, unless the Participant transfers employment or service to an Employer. If a Participant has military, sick
leave or other bona fide leave, the Participant will not be deemed to cease employment or service solely as a result of such leave; <I>provided
</I>that such leave does not exceed the longer of 90 days or the period during which the absent Participant&rsquo;s reemployment rights,
if any, are guaranteed by statute or contract. To the extent consistent with applicable law, the Committee may provide that Awards continue
to vest for all or a portion of the period of such leave, or that vesting shall be tolled during such leave and only recommence upon
the Participant&rsquo;s return from such leave.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &ldquo;<B><U>Employee</U></B>&rdquo;
means an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &ldquo;contractor&rdquo; or &ldquo;consultant,&rdquo; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &ldquo;<B><U>Employer</U></B>&rdquo;
means the Corporation and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &ldquo;<B><U>Exchange
Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &ldquo;<B><U>Exercise
Price</U></B>&rdquo; means the per share price at which shares of Common Stock may be purchased under an Option, as designated by the
Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &ldquo;<B><U>Fair
Market Value</U></B>&rdquo; means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
the Common Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Common Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Common Stock is not principally
traded on any such exchange, the last reported sale price of a share of Common Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) If
the Common Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &ldquo;<B><U>Incentive
Stock Option</U></B>&rdquo; means an Option that is intended to meet the requirements of an incentive stock option under Section 422
of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &ldquo;<B><U>Involuntary
Termination</U></B>&rdquo; has the following meaning with respect to each Award made under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Involuntary
Termination shall have the meaning assigned to such term in the Award Agreement for the particular Award or in any other agreement incorporated
by reference into the Award Agreement for purposes of defining such term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) In
the absence of any other Involuntary Termination definition in the Award Agreement (or in any other agreement incorporated by reference
into the Award Agreement), Involuntary Termination means such individual&rsquo;s involuntary dismissal or discharge by the Employer for
reasons other than Misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &ldquo;<B><U>Key
Advisor</U></B>&rdquo; means a consultant or advisor of the Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &ldquo;<B><U>Misconduct</U></B>&rdquo;
has the following meaning with respect to each Award made under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Misconduct
shall have the meaning assigned to such term in the Award Agreement for the particular Award or in any other agreement incorporated by
reference into the Award Agreement for purposes of defining such term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) In
the absence of any other Misconduct definition in the Award Agreement for a particular Award (or in any other agreement incorporated
by reference into the Award Agreement), Misconduct means the commission of any act of fraud, embezzlement or dishonesty by the Participant,
any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation or any Affiliate, or
any other intentional misconduct by such person adversely affecting the business or affairs of the Corporation or any Affiliate in a
material manner. The foregoing definition shall not in any way preclude or restrict the right of the Employer to discharge or dismiss
any Participant, employee or other person in the service of the Employer for any other acts or omissions, but such other acts or omissions
shall not be deemed, for purposes of the Plan, to constitute grounds for termination for Misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &ldquo;<B><U>Non-Employee
Director</U></B>&rdquo; means a member of the Board who is not an Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &ldquo;<B><U>Nonqualified
Stock Option</U></B>&rdquo; means an Option that is not intended to be taxed as an incentive stock option under Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &ldquo;<B><U>Option</U></B>&rdquo;
means an option to purchase shares of Common Stock, as described in Section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &ldquo;<B><U>Other
Stock-Based Award</U></B>&rdquo; means any Award based on, measured by or payable in Common Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) &ldquo;<B><U>Participant</U></B>&rdquo;
means an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &ldquo;<B><U>Performance
Goals</U></B>&rdquo; means the business criteria selected by the Corporation to measure the level of performance of the Corporation or
an Affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: (i) cash
flow; (ii) earnings (including earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation,
amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation and amortization, and net earnings);
(iii) earnings per share; (iv) growth in earnings or earnings per share; (v) stock price; (vi) return on equity or average stockholder
equity; (vii) total stockholder return or growth in total stockholder return either directly or in relation to a comparative group; (viii)
return on capital; (ix) return on assets or net assets; (x) invested capital, required rate of return on capital or return on invested
capital; (xi) revenue, growth in revenue or return on sales; (xii) income or net income; (xiii) operating income, net operating income
or net operating income after tax; (xiv) operating profit or net operating profit; (xv) operating margin or gross margin; (xvi) return
on operating revenue or return on operating profit; (xvii) market share; (xviii) market capitalization; (xix) application approvals;
(xx) litigation and regulatory resolution goals; (xxi) product sales or milestones; (xxii) budget comparisons; (xxiii) growth in stockholder
value relative to the growth of a peer group or index; (xxiv) development and implementation of strategic plans and/or organizational
restructuring goals; (xxv) development and implementation of risk and crisis management programs; (xxvi) improvement in workforce diversity;
(xxvii) compliance requirements and compliance relief; (xxviii) productivity goals; (xxix) workforce management and succession planning
goals; (xxx) economic value added (including typical adjustments consistently applied from generally accepted accounting principles required
to determine economic value added performance measures); (xxxi) measures of customer satisfaction, employee satisfaction or staff development;
(xxxii) development or marketing collaborations, formations of joint ventures or partnerships or the completion of other similar transactions
intended to enhance the Corporation&rsquo;s revenue or profitability or enhance its customer base; (xxxiii) merger and acquisitions;
(xxxiv) strategic goals or objectives (including objectives related to qualitative or quantitative environmental, social or governance
metrics); and (xxxiv) other applicable criteria as determined by the Committee. Performance Goals applicable to an Award shall be determined
by the Committee, and may be established on an absolute or relative basis and may be established on a corporate-wide basis or with respect
to one or more business units, divisions, subsidiaries or business segments. Relative performance may be measured against a group of
peer companies, a financial market index or other objective and quantifiable indices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &ldquo;<B><U>Person</U></B>&rdquo;
means any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) &ldquo;<B><U>Prior
Plan</U></B>&rdquo; means the Abeona Therapeutics, Inc. 2015 Equity Incentive Plan, as amended through the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) &ldquo;<B><U>SAR</U></B>&rdquo;
means a stock appreciation right, as described in Section 10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) &ldquo;<B><U>Stock
Award</U></B>&rdquo; means an award of Common Stock, as described in Section 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) &ldquo;<B><U>Stock
Unit</U></B>&rdquo; means an award of a contractual right to receive one or more shares of Common Stock, cash or combination thereof,
as described in Section 9, and denominated in a number of shares of Common Stock specified in an Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any corporation (other than the Corporation) in an unbroken chain of corporations beginning
with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination,
stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
3. Administration</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Committee</U>.
The Plan shall be administered and interpreted by the Committee; <I>provided, however</I>, that any Awards to members of the Board must
be authorized by a majority of the Board. The Committee may delegate authority to one or more subcommittees of the Committee or as set
forth in Section 3(b), as it deems appropriate. Subject to compliance with applicable law and the applicable stock exchange rules, the
Board, in its discretion, may perform any action of the Committee hereunder. To the extent that the Board, the Committee, a subcommittee
or the CEO, as described below administers the Plan, references in the Plan to the &ldquo;Committee&rdquo; shall be deemed to refer to
the Board, the Committee, or such subcommittee or the CEO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Delegation
to CEO or CFO</U>. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all
or part of its authority and power to the CEO or CFO of the Corporation or a committee comprised of executives of the Corporation, as
it deems appropriate, with respect to Awards to Employees or Key Advisors who are not executive officers or directors under Section 16
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Committee
Authority</U>. The Committee shall have the sole authority to (i) determine the individuals to whom Awards shall be made under the Plan;
(ii) determine the type, size, terms and conditions of the Awards to be made to each such individual; (iii) determine the time when the
Awards will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, which criteria may be based on the attainment of Performance Goals; (iv) determine the amounts payable
based on attainment of Performance Goals, including discretion to make such adjustments (positive or negative) to the amounts payable
as the Committee deems appropriate and in the best interests of the Corporation; (v) amend the terms of any previously issued Award,
subject to the provisions of Section 18 below; (vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the
Plan and applicable law, that apply to individuals residing outside of the United States who receive Awards under the Plan; and (vii)
deal with any other matters arising under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Committee
Determinations</U>. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&rsquo;s written interpretations
of the Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding
on all persons having any interest in the Plan or in any Awards granted hereunder. The Committee may rely on internal or external advisors
in determining appropriate interpretations of the Plan or Awards granted hereunder. All powers of the Committee shall be executed in
its sole discretion, in the best interest of the Corporation, not as a fiduciary, and in keeping with the objectives of the Plan and
need not be uniform as to similarly situated individuals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Indemnification</U>.
No member of the Committee or the Board, and no employee of the Corporation or any Affiliate shall be liable for any act or failure to
act with respect to the Plan, except in circumstances involving such person&rsquo;s bad faith or willful misconduct, or for any act or
failure to act hereunder by any other member of the Committee or employee or by any agent to whom duties in connection with the administration
of this Plan have been delegated. The Corporation shall indemnify members of the Committee and the Board and any agent of the Committee
or the Board who is an employee of the Corporation or a Subsidiary against any and all liabilities or expenses to which they may be subjected
by reason of any act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&rsquo;s
bad faith or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
4. Awards</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>General</U>.
Awards under the Plan may consist of Options as described in Section 7, Stock Awards as described in Section 8, Stock Units as described
in Section 9, SARs as described in Section 10, and Other Stock-Based Awards as described in Section 11. All Awards shall be subject to
the terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Award Agreement. All Awards shall be made conditional upon
the Participant&rsquo;s acknowledgement, in writing or by acceptance of the Award, that all decisions and determinations of the Committee
shall be final and binding on the Participant, the Participant&rsquo;s beneficiaries and any other person having or claiming an interest
under such Award. Awards under a particular Section of the Plan need not be uniform as among the Participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Minimum
Vesting</U>. Awards granted under the Plan shall include regular vesting schedules that provide that no portion of an Award shall vest
earlier than one year from the date of grant. However, (i) for purposes of Awards granted to Non-Employee Directors, such Awards shall
be deemed to satisfy this minimum vesting requirement if such Awards are granted on the date of the Corporation&rsquo;s annual meeting
of stockholders and vest on the date of the Corporation&rsquo;s annual meeting of stockholders immediately following the date of grant
(but not less than 50 weeks following the date of grant), and (ii) subject to adjustments made in accordance with Section 5(e) below,
up to 5% of the shares of Common Stock authorized under the Plan as set forth in Section 5(a) as of the Effective Date may be granted
without regard to this minimum vesting requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Dividends
and Dividend Equivalents</U>. Notwithstanding anything to the contrary herein, any dividends or Dividend Equivalents granted in connection
with Awards under the Plan shall vest and be paid only if and to the extent the underlying Awards vest and are paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
5. Shares Subject to the Plan</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Shares
Authorized</U>. Subject to adjustment as described below in Sections 5(b) and 5(e) below, the aggregate number of shares of Common Stock
that may be issued or transferred under the Plan shall not exceed 1,700,000 shares of Common Stock. In addition, subject to adjustment
as described below in Sections 5(b) and 5(e) below, shares of Common Stock reserved for issuance under the Prior Plan that remain available
for grant under the Prior Plan as of the Effective Date and shares of the Common Stock underlying any outstanding award granted under
the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered, cancelled, or forfeited or exchanged for any
reason without issuance of such shares shall be available for new Awards under this Plan. Subject to adjustment as described below in
Sections 5(b) and 5(e) below, the aggregate number of shares of Common Stock that may be issued or transferred under the Plan pursuant
to Incentive Stock Options shall not exceed 1,700,000 shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Source
of Shares; Share Counting</U>. Shares issued or transferred under the Plan may be authorized but unissued shares of Common Stock or reacquired
shares of Common Stock, including shares purchased by the Corporation on the open market for purposes of the Plan. If and to the extent
Awards granted under the Plan expire, terminate or are surrendered cancelled, forfeited, exchanged or without having been exercised,
vested or paid in shares, the shares subject to such Awards shall again be available for purposes of the Plan. Shares of Common Stock
surrendered in payment of the Exercise Price of an Option (or an option granted under the Prior Plan) shall not be available for re-issuance
under the Plan. Shares of Common Stock withheld or surrendered for payment of taxes with respect to Awards (or awards granted under the
Prior Plan) shall not be available for re-issuance under the Plan. If SARs are granted, the full number of shares subject to the SARs
shall be considered issued under the Plan, without regard to the number of shares issued upon exercise of the SARs. To the extent any
Awards are paid in cash, and not in shares of Common Stock, any shares previously subject to such Awards shall again be available for
issuance or transfer under the Plan. For the avoidance of doubt, if shares are repurchased by the Corporation on the open market with
the proceeds of the Exercise Price of Options (including options granted under the Prior Plan), such shares may not again be made available
for issuance under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Substitute
Awards</U>. Shares issued or transferred under Awards made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Corporation in a transaction (&ldquo;<U>Substitute Awards</U>&rdquo;) shall not reduce the number
of shares of Common Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as
appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and shall not reduce the Plan&rsquo;s share
reserve (subject to applicable stock exchange listing and Code requirements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Individual
Limits for Non-Employee Directors</U>. Subject to adjustment as described below in Section 5(e), the maximum aggregate grant date value
of shares of Common Stock subject to Awards granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non-Employee Director for services rendered as a Non-Employee Director during the calendar year, shall not exceed
$500,000 in total value. For purposes of this limit, the value of such Awards shall be calculated based on the grant date fair value
of such Awards for financial reporting purposes and excluding the value of any Dividend Equivalents paid pursuant to any Award granted
in a previous year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Adjustments</U>.
If there is any change in the number or kind of shares of Common Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, reverse stock split or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification
or change in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Common Stock as a class without the
Corporation&rsquo;s receipt of consideration, or if the value of outstanding shares of Common Stock is substantially reduced as a result
of a spinoff or the Corporation&rsquo;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of
Common Stock available for issuance under the Plan, the maximum amount of Awards which a Non-Employee Director may receive in any year,
the number and kind of shares covered by outstanding Awards, the number and kind of shares issued and to be issued under the Plan, and
the price per share or the applicable market value of such Awards shall be equitably adjusted by the Committee to reflect any increase
or decrease in the number of, or change in the kind or value of, the issued shares of Common Stock to preclude, to the extent practicable,
the enlargement or dilution of rights and benefits under the Plan and such outstanding Awards; <I>provided, however</I>, that any fractional
shares resulting from such adjustment shall be eliminated. In addition, the Committee is authorized to make adjustments in the terms
and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation,
events described in the preceding sentence, and acquisitions and dispositions of businesses and assets) affecting the Corporation, any
Subsidiary or any business unit, or the financial statements of the Corporation or any Subsidiary, or in response to changes in applicable
laws, regulations, or accounting principles. In addition, in the event of a Change in Control, the provisions of Section 13 of the Plan
shall apply. Any adjustments to outstanding Awards shall be consistent with Section 409A or 424 of the Code, to the extent applicable.
Subject to Section 18(b), the adjustments of Awards under this Section 5(e) shall include adjustment of shares, Exercise Price of Options,
base amount of SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the
sole discretion and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee
shall be final, binding and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
6. Eligibility for Participation.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Eligible
Persons</U>. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Corporation&rsquo;s securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Selection
of Participants</U>. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Awards and shall determine
the number of shares of Common Stock subject to a particular Award in such manner as the Committee determines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
7. Options.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Number
of Shares</U>. The Committee shall determine the number of shares of Common Stock that will be subject to each Award of Options to Employees,
Non-Employee Directors and Key Advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Type
of Option and Exercise Price</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Corporation or any of its parent or
subsidiary corporations, as defined in Section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee
Directors and Key Advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Exercise Price of Common Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Common Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to an
Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock of
the Corporation, or any parent or subsidiary corporation of the Corporation, as defined in Section 424 of the Code, unless the Exercise
Price per share is not less than 110% of the Fair Market Value of a share of Common Stock on the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Option
Term</U>. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Corporation, or any parent or subsidiary corporation of the Corporation, as
defined in Section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option
is prohibited by applicable law, including a prohibition on purchases or sales of Common Stock under the Corporation&rsquo;s insider
trading policy, the term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the
Committee determines otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Exercisability
of Options</U>. Subject to Section 4(b), Options shall become exercisable in accordance with such terms and conditions, consistent with
the Plan, as may be determined by the Committee and specified in the Award Agreement, including upon the attainment of specified Performance
Goals. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Awards
to Non-Exempt Employees</U>. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&rsquo;s death, Disability or retirement, or upon a Change in
Control or other circumstances permitted by applicable regulations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Termination
of Employment or Service</U>. Except as provided in the Award Agreement, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Award Agreement under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Exercise
of Options</U>. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Corporation. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash or by check,
(ii) unless the Committee determines otherwise, by delivering shares of Common Stock owned by the Participant and having a Fair Market
Value on the date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership
of shares of Common Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through
a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by
withholding shares of Common Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to
the Exercise Price, or (v) by such other method as the Committee may approve. Shares of Common Stock used to exercise an Option shall
have been held by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Corporation
with respect to the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes,
must be received by the Corporation by the time specified by the Committee depending on the type of payment being made, but in all cases
prior to the issuance or transfer of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Limits
on Incentive Stock Options</U>. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Common Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Corporation or a parent or subsidiary, exceeds $100,000, then the
Option, as to the excess, shall be treated as a Nonqualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
8. Stock Awards.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may issue or transfer shares of Common Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>General
Requirements</U>. Shares of Common Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. Subject to Section 4(b), the
Committee may, but shall not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period
of time or according to such other criteria as the Committee deems appropriate, including, without limitation, restrictions based on
the achievement of specific Performance Goals. The period of time during which the Stock Awards will remain subject to restrictions will
be designated in the Award Agreement as the &ldquo;<U>Restriction Period</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Number
of Shares</U>. The Committee shall determine the number of shares of Common Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Requirement
of Employment or Service</U>. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Award Agreement as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Award as to which the restrictions have not lapsed, and those shares of Common Stock must be immediately returned
to the Corporation. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Restrictions
on Transfer and Legend on Stock Certificate</U>. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 16 below. Unless otherwise determined by the Committee, the
Corporation will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each
certificate for a Stock Award, unless held by the Corporation, shall contain a legend giving appropriate notice of the restrictions in
the Award. The Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions
when all restrictions on such shares have lapsed. The Committee may determine that the Corporation will not issue certificates for Stock
Awards until all restrictions on such shares have lapsed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Right
to Vote and to Receive Dividends</U>. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right: (i) to vote shares of Stock Awards and (ii) subject to Section 4(b), to receive any dividends or other distributions
paid on such shares, subject to any restrictions deemed appropriate by the Committee, including, without limitation, the achievement
of specific Performance Goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Lapse
of Restrictions</U>. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
9. Stock Units.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Common Stock, to an Employee, Non-Employee Director
or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to Stock Units:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Crediting
of Units</U>. Each Stock Unit shall represent the right of the Participant to receive a share of Common Stock or an amount of cash based
on the value of a share of Common Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping accounts
established on the Corporation&rsquo;s records for purposes of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Terms
of Stock Units</U>. Subject to Section 4(b), the Committee may grant Stock Units that vest and are payable if specified Performance Goals
or other conditions are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other
period, or payment may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any
or all Stock Units at any time for any reason, provided such acceleration complies with Section 409A of the Code. The Committee shall
determine the number of Stock Units to be granted and the requirements applicable to such Stock Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Requirement
of Employment or Service</U>. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&rsquo;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Payment
With Respect to Stock Units</U>. Payments with respect to Stock Units shall be made in cash, Common Stock or any combination of the foregoing,
as the Committee shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
10. Stock Appreciation Rights.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>General
Requirements</U>. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; <I>provided, however</I>, that, in the case of an Incentive Stock Option, SARs
may be granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR
at the time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Common
Stock as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the
foregoing, in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law,
including a prohibition on purchases or sales of Common Stock under the Corporation&rsquo;s insider trading policy, the term shall be
extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Tandem
SARs</U>. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Common Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Common Stock covered by such Option shall terminate. Upon the exercise
of SARs, the related Option shall terminate to the extent of an equal number of shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Exercisability</U>.
Subject to Section 4(b), a SAR shall be exercisable during the period specified by the Committee in the Award Agreement and shall be
subject to such vesting and other restrictions as may be specified in the Award Agreement, including the attainment of specified Performance
Goals. The Committee may accelerate the exercisability of any or all outstanding SARs at any time for any reason. SARs may only be exercised
while the Participant is employed by, or providing service to, the Employer or during the applicable period after termination of employment
or service as specified by the Committee. A tandem SAR shall be exercisable only during the period when the Option to which it is related
is also exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Awards
to Non-Exempt Employees</U>. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&rsquo;s death, Disability or retirement, or upon a Change in
Control or other circumstances permitted by applicable regulations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Value
of SARs</U>. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Common Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in Section 10(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Form
of Payment</U>. The appreciation in a SAR shall be paid in shares of Common Stock, cash or any combination of the foregoing, as the Committee
shall determine. For purposes of calculating the number of shares of Common Stock to be received, shares of Common Stock shall be valued
at their Fair Market Value on the date of exercise of the SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
11. Other Stock-Based Awards.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 7, 8, 9 and 10 of the Plan) that
are based on or measured by Common Stock, to any Employee, Non-Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Subject to Section 4(b), Other Stock-Based Awards may be awarded subject to the achievement of Performance
Goals or other criteria or other conditions and may be payable in cash, Common Stock or any combination of the foregoing, as the Committee
shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
12. Dividend Equivalents.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards in an applicable Award Agreement
or at any point following the grant of such Award. Subject to Section 4(c), Dividend Equivalents may be accrued as contingent cash obligations
and may be payable in cash or shares of Common Stock, and upon such terms and conditions as the Committee shall determine. For the avoidance
of doubt, dividends or Dividend Equivalents shall not be granted in connection with Options or SARs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
13. Consequences of a Change in Control.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Assumption
of Outstanding Awards</U>. Upon a Change in Control where the Corporation is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Awards that are not exercised or paid at the time
of the Change in Control shall be assumed by, or replaced with grants (which may be in respect to cash, securities, or a combination
thereof) that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change
in Control, references to the &ldquo;Corporation&rdquo; as they relate to employment matters shall include the successor employer in
the transaction, subject to applicable law. For purposes of the foregoing, an Award under the Plan shall not be treated as continued,
assumed, or replaced on comparable terms unless it is continued, assumed, or replaced with substantially equivalent terms, including,
without limitation, the same vesting terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Vesting
Upon Certain Terminations of Employment</U>. Unless the Committee determines otherwise or the applicable Award Agreement provides otherwise,
if a Participant&rsquo;s employment or services terminate by reason of an Involuntary Termination upon or within 12 months following
a Change in Control, the Participant&rsquo;s outstanding Awards shall become fully vested as of the date of such termination; <I>provided
</I>that if the vesting of any such Awards is based, in whole or in part, on performance, the applicable Award Agreement shall specify
how the portion of the Award that becomes vested pursuant to this Section 13(b) shall be calculated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Other
Alternatives</U>. In the event of a Change in Control, if any outstanding Awards are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Awards, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Awards, without the consent of any Participant: (i) the Committee
may determine that outstanding Options and SARs shall automatically accelerate and become fully exercisable and the restrictions and
conditions on outstanding Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents shall immediately lapse; (ii)
the Committee may determine that Participants shall receive a payment in settlement of outstanding Stock Units, Other Stock-Based Awards
or Dividend Equivalents, in such amount and form as may be determined by the Committee; (iii) the Committee may require that Participants
surrender their outstanding Options and SARs in exchange for a payment by the Corporation, in cash or Common Stock as determined by the
Committee, in an amount equal to the amount, if any, by which the then Fair Market Value of the shares of Common Stock subject to the
Participant&rsquo;s unexercised Options and SARs exceeds the Option Exercise Price or SAR base amount, and (iv) after giving Participants
an opportunity to exercise all of their outstanding Options and SARs, the Committee may terminate any or all unexercised Options and
SARs at such time as the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change
in Control or such other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the
Common Stock does not exceed the per share Option Exercise Price or SAR base amount, as applicable, the Corporation shall not be required
to make any payment to the Participant upon surrender of the Option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
14. Deferrals.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Award. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
15. Withholding of Taxes.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Required
Withholding</U>. All Awards under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Awards or exercising
Awards pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Awards, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Awards,
or the Employer may take such other action as the Committee may deem advisable to enable the Employer to satisfy obligations for the
payment of withholding taxes and other tax obligations relating to any Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Share
Withholding</U>. The Committee may permit or require the Employer&rsquo;s tax withholding obligation with respect to Awards paid in Common
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&rsquo;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Award. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&rsquo;s minimum applicable tax withholding amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
16. Transferability of Awards.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Nontransferability
of Awards</U>. Except as described in subsection (b) below, only the Participant may exercise rights under an Award during the Participant&rsquo;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Awards other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Corporation of the successor&rsquo;s right to receive the Award under the Participant&rsquo;s will or under the applicable
laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Transfer
of Nonqualified Stock Options and Stock Awards</U>. Notwithstanding the foregoing, the Committee may provide, in an Award Agreement or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; <I>provided</I> that the Participant receives no consideration for the
transfer of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions
as were applicable to the Option or Stock Award immediately before the transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
17. Requirements for Issuance or Transfer of Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Common Stock shall be issued or transferred in connection with any Award hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Common Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Award on the Participant&rsquo;s undertaking in writing to comply with such restrictions on the Participant&rsquo;s
subsequent disposition of the shares of Common Stock as the Committee shall deem necessary or advisable, and certificates representing
such shares may be legended to reflect any such restrictions. Certificates representing shares of Common Stock issued or transferred
under the Plan may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable
laws, regulations and interpretations, including any requirement that a legend be placed thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
18. Amendment and Termination of the Plan.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Amendment</U>.
The Board may amend or terminate the Plan at any time; <I>provided, however</I>, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>No
Repricing of Options or SARs</U>. Except in connection with a corporate transaction involving the Corporation (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Common Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Common Stock or other securities, or similar transactions), the Corporation may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Options or SARs to reduce the Exercise Price of such outstanding Options or base price of
such SARs, (ii) cancel outstanding Options or SARs in exchange for Options or SARs with an Exercise Price or base price, as applicable,
that is less than the Exercise Price or base price of the original Options or SARs or (iii) cancel outstanding Options or SARs with an
Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Termination
of Plan</U>. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Termination
and Amendment of Outstanding Awards</U>. A termination or amendment of the Plan that occurs after an Award is made shall not materially
impair the rights of a Participant with respect to such Award unless the Participant consents or unless the Committee acts under Section
19(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Award.
Whether or not the Plan has terminated, an outstanding Award may be terminated or amended under Section 19(f) below or may be amended
by agreement of the Corporation and the Participant consistent with the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
19. Miscellaneous.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Awards
in Connection with Corporate Transactions and Otherwise</U>. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Awards under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Awards to employees thereof who become Employees, or (ii)
limit the right of the Corporation to grant stock options or make other awards outside of the Plan. The Committee may make an Award to
an employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Corporation, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Awards as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Governing
Document</U>. The Plan shall be the controlling document. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Corporation and its successors
and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Funding
of the Plan</U>. The Plan shall be unfunded. The Corporation shall not be required to establish any special or separate fund or to make
any other segregation of assets to assure the payment of any Awards under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Rights
of Participants</U>. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive an Award under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>No
Fractional Shares</U>. No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan or any Award. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Compliance
with Law</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Plan, the exercise of Options and SARs and the obligations of the Corporation to issue or transfer shares of Common Stock under Awards
shall be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required.
With respect to persons subject to Section 16 of the Exchange Act, it is the intent of the Corporation that the Plan and all transactions
under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Corporation that Incentive Stock Options comply with the applicable provisions of Section 422 of the Code, and that, to the extent
applicable, Awards comply with the requirements of Section 409A of the Code. To the extent that any legal requirement of Section 16 of
the Exchange Act or Section 422 or 409A of the Code as set forth in the Plan ceases to be required under Section 16 of the Exchange Act
or Section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Award if it is contrary to
law or modify an Award to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Plan is intended to comply with the requirements of Section 409A of the Code, to the extent applicable. Each Award shall be construed
and administered such that the Award either (A) qualifies for an exemption from the requirements of Section 409A of the Code or (B) satisfies
the requirements of Section 409A of the Code. If an Award is subject to Section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under Section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &ldquo;separation from service&rdquo; under Section 409A of the Code, (III) unless the Award specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of Section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with Section
409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Any
Award that is subject to Section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Award shall be postponed for six months following the
date of the Participant&rsquo;s separation from service, if required by Section 409A of the Code. If a distribution is delayed pursuant
to Section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&rsquo;s death. The determination
and identification of &ldquo;<B><U>Key Employees</U></B>&rdquo;, including the number and identity of persons considered Key Employees
and the identification date, shall be made by the Committee or its delegate each year in accordance with Section 416(i) of the Code and
the &ldquo;specified employee&rdquo; requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Notwithstanding
anything in the Plan or any Award agreement to the contrary, each Participant shall be solely responsible for the tax consequences of
Awards under the Plan, and in no event shall the Corporation or any Subsidiary or Affiliate of the Corporation have any responsibility
or liability if an Award does not meet any applicable requirements of Section 409A of the Code. Although the Corporation intends to administer
the Plan to prevent taxation under Section 409A of the Code, the Corporation does not represent or warrant that the Plan or any Award
complies with any provision of federal, state, local or other tax law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Awards
in Foreign Countries; Establishment of Subplans</U>. The Committee has the authority to award Awards to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&rsquo;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Company
Policies and Clawback Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) All
Awards under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other policies that
may be approved or implemented by the Board or the Committee from time to time, whether or not approved before or after the Effective
Date. The Corporation may offset any payments due under this Plan or in connection with an Award to a Participant by any required repayments
that such Participant under any applicable clawback or recoupment policy; <I>provided</I> than any application of a clawback policy or
offset in respect thereof will be applied consistent with Section 409A (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Subject
to the requirements of applicable law, the Committee may provide in any Award Agreement that, if a Participant breaches any restrictive
covenant obligation or agreement between the Participant and the Employer (which may be set forth in any Award Agreement) or otherwise
engages in activities that constitute Misconduct either while employed by, or providing service to, the Employer or within a specified
period of time thereafter, all Awards held by the Participant shall terminate, and the Corporation may rescind any exercise of an Option
or SAR and the vesting of any other Award and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (A) the Participant shall return to the Corporation the shares received upon the exercise of any Option or SAR and/or the
vesting and payment of any other Award (including pursuant to dividends and Dividend Equivalents) or, (B) if the Participant no longer
owns the shares, the Participant shall pay to the Corporation the amount of any gain realized or payment received as a result of any
sale or other disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration,
the Fair Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&rsquo;s
Award Agreement containing restrictive covenants) or activity constituting Misconduct), net of the price originally paid by the Participant
for the shares. Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee.
The Employer shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the
Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Governing
Law; Jurisdiction</U>. The validity, construction, interpretation and effect of the Plan and Award Agreements issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the State of Delaware, without giving effect to the conflict
of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Awards made hereunder shall
be brought only in the United States District Court for the District of Delaware, or if such court does not have jurisdiction or will
not accept jurisdiction, in any court of general jurisdiction in the State of Delaware, and the jurisdiction of such court in any such
proceeding shall be exclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="proxy_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="proxy_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 62; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -D IX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBLK7-4M=%T?5-6O;ZTTNS
MTW3K[4+K4K]2UCI]M96LMS/?7BK/;,UK:1QM/.BW$#O%&ZK-$Q$B@&K17SA#
M\7/B!#X?L?'%M\.[CX@> M0LKK4[/4/!226'CR^TDKXBOM'U?2?AKJ][>OJE
MCK]C#X2BT6#_ (2ZTUV==8U/6-8T+P_;Z?'ILWKO@7QWX>^(OAS3_%7A>ZFN
MM)U'SUC^UV5WI>H6ES:2M;WNG:GI6HPV]_I^HV%TDEK>6MS C1RH2I:-HV8
M[*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCQ%!J\?@N+Q5\(?%7@G5_!/CK5+6U\*VEIK_ (1\#^(O&%A\0_#6G^,+R_\
M%>K^'_ LT?C#7/"OA/P;JEQXFUL3M8B[Y[X;7.N_ ;0_B1XF\3?!GQ=:W'Q
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M !#'XVT[X)7?PSTP0)\._&;'3-<\::7K$IT.5(-.E>_TA-1]V^-G_!<WXE?
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M9>'?V?=,\%:OX&TGQ!X(TO3-<\&V_@;5[^TU_P ,SZS>Z%9Z==Z;8Q7M[?\
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M?^Q5^UG8_LS?%KX1?%O7]*\0?LX:%\9O!OQ$^$_AO5_B3J'BGXI>+_B+X_\
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M)\.K'X<^-/A+XJL_$-]-X:_:&O&\.W\4X)W=M+))V5]DW??=Z]3]C*R]<_Y
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M0_#7PMO[*QBM6\9EM272?$/BKXEZ'J_BY98K+4KSX60:1-X2\(:SXR6U\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%?@_1K36?$/B?4/B+\0?%UMX \(?$?Q=\0_!=YXN\=2Z/!X)UR\TSP1IGAD
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M^&5Y\+IO#<=WX?M]0T:37M=L?"NC1Z!!\,/V1_@-?>"='TKP/\3?%?C[X?\
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M>#/C7K6@?M1>&?&'Q)\/:-<_LJ^/M>UN'QS?_%_PSX7\=ZAX5^*WP,UU]/\
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MK!9>$++1](U_QEX2^.WQ TC7O$GA/2_#^H:9IVJRVGA ^&O.FE;[ZHH \O\
MA+\,K3X5^&]2T=-;UCQ1J_B#Q9XG\;^*/%'B"87.LZ[XB\5ZI+J-T\US(]Q>
M?V5HEF;#PKX0TZ^O]2E\-^"- \->%;:^ETS0K!(O4*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXN_:
MA_9B\7?'[QU\(_$.@^.['P/IOP]L->6\NGLM4UC4AJ]Q\3?@5\3] U*S\.KJ
M6F^&?$"6FH?!6/29;/Q4\]E81^(9=<L[2[U+2[2W?[1KR#XF_&OPG\*KB>U\
M1V^MW$MO\+/BA\7I%TFP@O-WA3X1WG@.R\50QF:^LPVLRS?$70#H]@=L-\D>
MI&6\LVMHEN0#X(TW_@GOX]T^WEUD_&K4]9\=:MX=\)^#]9UCQGK7BSQ!)'HF
MAZ3\=[&\-IK_ (/O?A9K=Q:-XS^*7@3XZ-H<D=G>:[\5OA:M_J7BZQUSQ%I_
MC[PA[+\,/V1/&_@/XP>"_B5J_P >/B1XFTS1?#^J7_BCPQ/XGE.E^+/BEXBU
M3XL7'BWQ)KEMK&E:[J6I>&?$>G_$SPQ;V'A/2/$?@S0O!S? ;X.0:?HNK:5X
M>TG3/#GN^A?M-?!3Q+-I-KH?C*74KO7_  K=^,_#T-OX4\: ^(_#]NGB:YL[
MKPYYOAV/^W[OQ'I7@WQ9XD\$Z-HYO=;\?>$/#FM>,O!&G^(/"NG7.LQ^:^&/
MV[/V=?$>D:_K=QXE\0^%+'0-.\+:R(O&/@3QCH6JZYHOBGX6?#SXQ_VMX;T*
M31Y]:UF'PCX&^)OAO5?B7I]K8'6OAA9?:]=\>Z;X?\*G3_$&H 'B?B#]@_QO
MJ$VNZIX7^-EU\._%=_;_ !A?PUXQ\&:=K6D:[X"UGXX^./V@OB#X\U;0!8>)
M[*PU&2]UCQW\ ]*M&\06FH7>G^'?@4MI87=I<:]%+IW7ZQ^QMXOU/3OV?9=/
M^+NLZ1XG^!A^)MYI?B#6Q:^--9TG4?C9XGT:R\=3^#[^STGP'H6E7?@?X)ZQ
M\6?A3\"K]?!EGI7@ >)O!]]>>$]9\.>%-3\&^)_;=9_:P^#?ASQ-XM\(:]K6
ML6&N^$-6U'2+JVMO"GB7Q#%JLVF?#WX7?$:2XTFY\*Z9KEL8+_3_ (R_#[PS
MX=BU2;3+_P 7?$#7+7P-X2L=<U^^TBVU/$?]M[]F2W\/P>)M1^(TVD:9-I=K
MK,G]K>"O'UE>6EA+X#\<?$G49KRQD\+_ &F!?"GA;X9_$5O'CF-HO &O^!_%
M7@_QG)H?BW1+[1(0#XTTG_@FO\2?#VA:?X6\-?M-?$#P7X3T_2?"NA_\(A\,
M]3TGP-X7.B3_  QT/POX[T_1+'4?!'CC4?#FHZ3\7])U+]HKX;^([W5_%SZ=
MXK\:>-O#C:)H6I^(=0^)4_I,'[#OCS2/$-[XFTKXKW^D:?'XH\>>-(?!O@N?
MQ1HUG>>*?&'[47_"_;SQTFG2^--.\-3_ !*O/"7B'XB_#N.Y\01:AX6AGU;P
M1->6MSHG@S[+?_1VL?MD? +24TG;XJUK4KO6==\+>&+?2=)^'WQ$U#6[?Q)X
MM^)^E?"&U\-ZII$/A<7VC>*M#\:ZM%!XQ\&:M#9^,_"&D6NH:_KWA^STBSEN
MAOV_[47P:?Q?JG@2]\1:KHGB73/B+-\+)+7Q#X*\;:%9R^+$A\!"T:+5]3\/
MVVDKX;UW5_B=X&\*>$O&-U?6OA7QIXU\0V'@_P (ZOK?B"YMK&< \<_9/^!W
MQ<\%_"RZ@^(WC7Q_X0\8Z[\4-#\;WUD=?T+QMK4F@^$? _P^^'M[X<U^Y\=:
MK\=M)T>S^,5_X!U;XJ_$"T\#>+9M8B\7?$KQ3K=CXXMO&NL>(O$&H9/C#]E+
MXI:IXD\87/A3XE>'-#\,>)_&6I?$+6XI-!OK3QI\3I=7\>?"SQA?_"[XK>,M
M+O!JE_X/3P[\.M1^#6A^*-$GM9M)^!NO^'_AIK/@#Q?IW@)+[Q9Z[IO[8OP#
MOXO%,LWB3Q'I(\#WVOVOC-M8^&OQ*T^W\)67AWXM^-_@C<>)/$U]-X2_L_P]
MX1U#Q_\ #?QS::+XIUJ[L-$U/1/"OB#Q1!>#P_H>LZAI]Q/VOOV>)(;VX3Q]
M,T>G:)XX\3WV/!?C\R6WA3X<Z!HOB7Q;XPDA_P"$6\X>#K/3/$?A^+3?%HC/
MASQ+K>M:7X9\,ZGK'B6^MM)D /%_&'[(?C37K?X":@OC_3/$7B[X/?![5_A5
MXIUSQ4/&-I=?%/3M6\>_L_\ CG5='U77M+\4WOBVP\+>)!\$[SP_K<6KZWXN
MUC4[/Q)877C2^^(-A8^+/#/COYI_:B_8;_;7\?'X4S?L^_M47/@OQ%X ^ _@
M3PEXB\=>+?B)\4=,E\=?'/X/WNJVOPS^(^M^!]$L_%5C>^%M3T#XF_'5_C%X
M<U;Q9J>K?%/7->^#E[K>M_:O@?H.IZI]S7/[9_P(2XT2VL=;\3:M+KFO6/AF
M*TL/A]XY.MV.L:G\2_AO\(K7^T?"EYH-EXNMM'@\?_$_1?#FL>)O[";PQX>U
MG1O%WA_7]:TSQ)X:U'1H^OO_ -J#X$Z7KB>&;_X@V,6OBZO+>[TV'2?$=W)I
M4&F>/O$OPMU?7-<EM-&G@T#PAHGQ#\)ZOX1USQOK<NG^$-%UB30X-5UNS7Q3
MX7?6 #\D!_P37_;4C\;:D+7]I*[L?@ZVJ_&6S\/^!K?]I+X\S^)-#\">(-$\
M;Z]^SWHZ>+M2\#W_ )_B7X ?&WXU_&+QK:^*I-.-WXQ\$:'^SG\-/$$=SHWP
M-TF;4\P?L3_\%._!WP2^)'A9OC'X&^,7Q#^)?BK]F1I]9?X]_';P?_PBFE>%
M_B_9?'#X_P!YX:FATS0-<TG2O'7QJ^)?QTU"ZMO#WCO0/$.B_LK67PI_9]\)
M37VJ?#/POJ%Y^P5M^U%\!KTWYL_B'8W4.D^#+SXB:S>6^D>(YM-T/P3I_A#P
M-X^N_$FNZG'HS:=HFG1^#OB3X)\0*^JW5I)+8ZY&T,<DMEJ4=EB:W^UY\!=%
MU670D\7:CKFM6_C7PQ\/KC3_  SX,\;>(VA\4^*?'O@KX=VFG&[TGP_<Z;))
MIFM?$;P+J?B$07LLF@^#O%WACQOJ$4?A;Q)X?U/50#\D=7_X)J_M[ZCX*\0:
M5IW[3-AH7C'7;BXM-,UJW_:7_:UG\.?#_P /:G\*_'O@[0+7P=X>LY=%U"XU
M7X ^/?&7A_XB?"36O$/B'4=9\8+\,?".G_$O5+CQ5#H'Q \$WM<_8>_X*%6?
MC=Y-/^)%EK&B?%7]L36?BGXON](_:1^+UOHOPS_91\96/Q&G^*7[)BG7=*T_
M6;#P1J<-[X;F^$GC+X7^%+KQ3X+^+?B;Q)=Z9H'PU^%-IX>L/"'Z=#]NS]F*
M'P3=>/M3^(<NG:#I^BV.OW[KX1\::U-%IEUX<\7^++ZZTS_A&O#^MV_BVR\,
MZ#\/_'>H^,-9\$W/B30/"MIX/\07FN:K8V=A)/7<>*?VI?@GX#\0^*/#7COQ
MC#X4O?"%SK46N7FH:?JESH>F6?A[P3X%\>ZKJVMZ]I5GJ.C^%-.CTCXD>$-.
ML7\7WN@7&N^)-7L- \/V^J:AJNBQ:D ?E=X=_P""?/[>6B:]\/\ 4[S]I:W\
M16GA/XH66J7D>M_M"?M#/<K\*/ 7B?\ 9HT[X9:1IRZ=X>TS3-7^(FM_ G]G
M'7OA;\</$/C33_$'ASX@>,_VG/CU\5=-\.^']*\0^)OA7\06?LL?\$^?VX?V
M6]2^$4?AWXP^!=1\&_"CX&?#GX#:3\/+3XQ^/]-^&]EH'A%_#7A#Q1XAT_P/
MJGP'\2-<>(_$_@[1]8^)_AQM1\4/IW@3XW>([G37L_%OPSMAH]Q^GVC_ +7_
M ,"M7\7S>!7\0>)=$\3#Q3IGA"STSQ1\-?B5X7FO]5U;0O@QKEI-$=>\)V"V
MFE!_V@_A!X=NM6U?^S+*R\9>-M&\(W4D6N7EK:W&=XH_;1^ GANUT^\A\0:_
MXDLM2%V(-7\,^!_&&I^%+>>T^"WBK]H$V.K^/'T:U\!^'K]_A=X1OM?GM-=\
M2Z?<:0FI>'_[>BTJ#6;.=@#\H-1_X)Q?\%%-1\$Z;X7@_::\,^'M6L?V=O$_
MP>N/%6@?M%?M7)K5]XMU+X-_M!_"RX\9_:M3M]1=/^%C^.?C'X(_:7\=:QJ@
MU[XHZ#\6O@OX<TO0/B3K.G_\(%XA^$OTG\,OV&OVIO#?AW]JWP?JG[0=_P"%
MM)^-_A+3M*^%^HZ9\9_CM\6-0^&&JZ1^T=^TW\2+2T23QA=^"/$NC:#?_ +X
MK_!+]FW5]2^&_CCP;XSC\(_ VPOO#.O>&=5/A;4/"WW)<?M@?LX6>LZ?H-Y\
M3+.RU+5;B9=/%YH'BZTL;G2DU_0/"=IXQ75[CP_'I"?#;7?%?BG0/"OA3XI2
M7R?#GQCXFU*'P_X5\4ZQJZ3V<6YXB_::^"?A'P+X7^)OBKQ=>>&O /C#0=:\
M3:'XIU[P=XYTG2CHN@^'KKQ5=W>L2WWAJ!_#+WF@V<]]X>LO$L>D7WBQO)L_
M"]MK%_<VUK, ?%OP[_8$^*GAGP5^T%I7C+]I7XB>+/$_Q<^!^O?"'P)?:-\1
M_C%X3M?@M:>)?BA\=OB(UOX!N[KQ]XLDTV?P7H7Q-^&WPI\#?$.72KWXA)X+
M^"'A-]?N]1M+N?PO:^:ZY_P3Q_:[U+P/JOA:W_;:6V\4:MXA^"'BF?XH:;X1
M^(.@>(+&3X2_LZV'PJ?P9X5\,6_Q=U/P=X!\#2?%O1IOCCIUAX+T[1[FYU#Q
MYXETK6S<^(M)N/'GCC]!;7]JOX/ZMXN^'_@GP[JFOZ_KOQ#U36M(LX;/P=XI
MLXO#5]X?T+XK:SJ>G^-7UK2M);PUXCMKKX,^._#LO@*[C;XC0Z[I<ZS>$(]*
MT_6M4TKD_ /[</[/_CWPOX5\3)KWB'PS/XQT7P1K>C^$_$_@GQ;:^,3'\1[K
MP)!X-TB71]-TG54G\5ZC:_%/X8:OJ?A'3+K4?$/A?1/B)X,UKQ-8:5I/B#3;
MVX /E%O^";OC?4OV8_VA_P!G;Q?\>]9\?P?'+X.?"KPM!J/CS4OBAXTTO1/B
M_P" '\1WGB3XD7-KXE^)^H:W#HGCZ]7X=6^H^$?"NN>'+*PTOP5':VZNDT<4
M?F%S_P $KOCI!I_B72_!7[:?Q+^$^B>*OBG=_%35O#7PSUSQKIMBNL>)/C+^
MWQ\1O$__  C]WXI\3>,K#PK=6]A^UI\%;[2K_2_"Y:_\9?LG^"M4U"VM;R]\
M+^(/AW^CVL?M=_ W1_%VH^#F\4SZEJ.B3ZE8Z]+HNBZMJZZ;JMCXIA\!6.C6
M6GV-I+KOC'5/$?Q$36_AMX=MOA_I'BT:A\2O"/C'X>.]OXS\,:OHEK5U/]LW
M]GO3H_#NH1>+M;U[PUXKO-7L/#_CCPC\.?B5XQ\ :O>:)I;:E?0:3X\\+^$M
M6\(ZU(;A?^$9MHM$UG4I[SQWN\ 6T,OC&&XT6$ ^,/VJ?^"=?CWXX?&7Q-XZ
M\(^(?@O%H?Q;\:_!WQ'XX\7^//!.L3_M!?!G3O@=X'\5:;HGASX"_$K2KN_M
M+CX<_$#Q#-I&B>/_ (4:MI7A"W'@7XJ_M4K:>/=0O?C)!IN@>=:S_P $D-4?
M]BNR_9$TSXB^"-6CTW]H&\^,K^*_$7@_7/#X\7:5KG@'5O"FIZ-XNL?A?XC\
M$K9:[I%QXCN]-T/6O J>$[;4O!_A7PK;^)-/O?%6H^+_ !/K7Z7I^UA\ YM;
MT[PU;>/5FU_6=;L=#TG35\+^-3)?G5O$VG^"M&\26[IX;:)_AWK?C'4[;PIH
M?Q25S\-M:\21ZAHFE>*KS4M)U6VLK'A[]I[X/>)O /\ PLC3->U2;PML\$0)
MJ5GX3\5ZW9ZAKGQ ELK'0/"OA74/#FC:SI?Q#\40ZWJ$'AO7=$^'-_XMO/#W
MB19M"UI+'4H7MP ?G$/^":/[2>H>*Q>:U^W)XQTSPC;W7PYDTS1_A;H_BOX1
M+HTGPL^ G[2/PO\ !NLZ#X>\'_$>#P[I%S8>.?B[\(?B#K?A6=]:\$>,'^ &
MD:#K>DCP7KGA_P $_#RMJ7_!-G]J#4ETI[3]L"\\)1Z<O@*XN]'\-ZI^T5<Z
M=K^@>"M"\,Z/XD^ &I7VN?M!WM^OP0^-.M^'M5^)7Q#\6W":I^T;8^,_'GB7
M2[#XO:KX4M[/3I_MG1?V\O@%X@\._#OQ%I6IZ[/'\0K#P%J<=@VE1+=^';/X
MB:%)K6D2:E.M_)I?B)M-NX+CPAXBC^&NH>/I=&\>V\W@RXC.O(;2NYO/VPOV
M;[.:]@3XF6>K-8W>D:89/#/A_P 7^+;:_P!<U[Q;X2\#:7X9T*\\+^']7M/$
M?BVX\4>//!FG/X1T"?4_$MI'XFT;4KS2K?2KZ&^8 ^+/V1/^">7QK_9F^(ND
M^+M6_:J\2^,O#.C?#WQAX=TWX:6<.O6?PST_Q)XJUZ_UV2ZN/"OB;Q!XN\2^
M*-*AUJ_N/&D>I>(/B4_C0>+-1\0?VAXBUF'6[B_7P70_^"4'[4MGJ'@76KW]
MO+Q#:>,_#-O?:8WQ3T+0_B!9_$'POHFH_$3X'_$K5M(\"PI\5K?P5>Z/K]Y\
M+_'_ (5U'P[\1?"_C#P];Z%\:_$-W::;G3-8T;QW^MC_ +37P+^P:'JD'Q#T
MR_TSQ'/;II.I:5I^NZQI\NGSZ-X/UZ;Q/>7NE:7>6VE>!-)T[X@>"/\ A(_B
M'JLMEX&\+7WBK0](\2>(=*U?4+>Q?@=._;0^#DO@;P'\1/$;^+O ?AWXD:!X
MA\5>%[;QCX+\16?BN?PUX>FUB>36+WP/IUEJ?B_3+.[\+Z'J/C\W%]HL-KHW
M@>SN];\27.C+:SQ1 'P?IG_!,[]IN"TM[)?V[_'?A2UU33/B=IWB>P\)CXN:
MM:Z5=WOP7\'^#?@1XA^'>J?$3X\>,/%NDZM\*OCYH7B_]J?Q /$7B+77\?>+
MOB=KWP^UV]NO".D6%U>?HK^RA\&/&'P"^"7AGX9^._B7XE^+?B;2=2\8:G?>
M,/%.J+K%V(_$_B_6?$=EX?TF[.DZ/<0>&?#EEJ4&C>'M*GM630]*L[71=.>/
M1].TRUMN9TW]MKX!RVWB6Z\2:_KG@-?"^L?%W3;Z'QCX2\1Z?</8?!CQ#\3O
M#7B;Q$5L].U&*PTK7+SX+_%:]^']KJ\VG^(?'VD> O%%]X9T.^.AZM!9=)I7
M[7'P"US5-:T/2_&&L76MZ!#XADU'1C\.?B?!JOF^%[KQA8ZQI^GZ=<^#8;S6
M=9BU#X<_$O3;'0M&AO\ 6M9U+X7?%+3M&L-0O?AKXY@T  ^DJ*^1+7]N+]G:
MZNI$3Q;JO]GLVI#2M6_X0WQ<T/BJ+3?A]\*?BM/J'@73(]&D\2>/=#C^''Q@
M\->-+SQ'X.T+6O#VC>&M,\6:WKVJ:5I7AR\O7]I^'/QK^%_Q:O?%>G_#SQ7;
M>)+KP5JUYHWB%(=/UBQCAN;#Q'XJ\'7-WIMQJNG6-OX@T+_A+? OC;PQ!XF\
M/2ZIX<O-?\(>)M(L]5GO]"U.WM0#U*BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT5MXJU?0_ =_K7P\T3XLZ=X4E\*-\/\ 5M9\:T ;]K\2_P!D_P 5>.+6YC^
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MGXG\#>)//_\ AJ"[\.ZI\7=>N_V4_AMJ_@[Q%XHU?6/[$L_#T.AZ=XQUZ]^
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MVK?$NMZ?<Z+;?!?3!HVD^+[+X+W>L>/O&%KXT37=8\6?$^PBUSPYXJNKR_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!\.?#5OK,VKW=IXQT3PWX#\5ZEX*MKNT\2^"[#PGI?AWXC:SXET*Z?P;\2?
ME[\2/'NO_$W5?#<.J?!/4_"N@>"O%7PVU7Q=JND^$_''BNC>+?V[?!MGX"CL
M?A7HFA1>&_AQ;Z[J7PV^&?P<E\/>!M:UOQ;HW[/7B/6-$TR73?B;K^B>'?'-
MU\0/$O[1OP\\)Z%XA#^'/"TW@W2OB)\8/%O@OP9KMK\0/&'ZYZCJ^E:18W.I
MZOJ%GI6FV2[[O4=3GCT^PM$W*F^YO+MH;:WC+LB!Y944NR*"690;OFQX)(?
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M]?P7);P^,DM+(WGVFY;PC+=VL?B@0QN?#[W-NNK?9#-&&X?2_P!HS]GS7!X
M.B?';X-ZP/BO>ZSIGPM.E?$[P3J(^)6I>'+@6GB'3OA^;/6YAXROM"NF6VUF
MS\.?VE<:7<,L-]'!(P4@'LM%>3:7\>_@9KEOH5WHGQF^%.LVOBCQ=?\ P_\
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MC-K@ .4\3_L5WWB;X?\ PC\,3>/O#D?BCX4>,_BIXGTOQ/>?"^XU#2;;P_\
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M6-7^,WP^ETNTF\,P75_HGB/2?$]C;W?AF]75XP+OR^XP_P!A']GKQM^R_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7Q)^U;\9K3X=^-O@QX8N/@W<?%"^U6^3Q
M9X?OUUSP_8PZ-J6I?&+X"_LL:OI5MHVN:WH=KK&L:_X*_:Y\5C3)-9O8/"]I
M<V$5GK.8]6&H:/\ ;=8FJ>&_#^MW>E7^L:)I&J7VAW!N]%O-1TRPOKO2;HO!
M*;G2[F[MYI].N/.M;2?S[*2";SK2V??F!, 'Y+?#+XE_LD:_\3OV>/"7PE^
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M6VO-4EAM/#WB?Q%XTN[/#^*.I?L^:;X6^#^F^&?V7-?\7:#^T)!H7Q.ABO\
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M7NE:63I]C-!9LT)@\1_![X:>++[^U==\(:5<:M)XD\">+K[5K2-](U76M?\
MAAK=GXD^'MWXCU'1Y+"\\3VW@_7].T_6-#TCQ#-J>BV>H6%C=+IQEL[9H@#\
MV/BQI/[/6C?M&ZI\./%'[*VKZGH4/ABYUGQ=\0- ^(EM9O<Z+\6(?#?A;QQJ
MUUX27XH^&;Z3P>(++PWI7Q5L38ZSXD\=)X4^'#Z)X0\7)\./#,N@2^*_C?\
ML5>-_P!G5/VK?&?P,^+=IX2\/^+-6\;^"[?5= U_P9\3O$5UXA^&US^T%XB^
M('PK@M_&NC76OZ/??"SQ#XS\0^)[OPYKIM[7P]IOQ6\+>(;>UTC0O&^G6_ZD
MW7@_PK?:M/KU[X<T*[UVZTFVT&ZUJYT?39]7NM#L[R[U"TT6YU*6U>]GTFUO
M[^^OK;39)VLH+R\NKJ*!+B>61LI_AE\.I-(G\/R^!/!LF@W6N2>)[O0W\+:
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MV:UN+OP-X/N;BRFU*XLKBX\+:!//9W&L9_M:XM)9M.>2WGU3)_M&6)DDO?\
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M&?P;^,7PPNM,L=-^(>I?#R/3OB0^A?"VSUS2_B1XC\%1>#M-T.+7/B/9^&?
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M2\3^$M*\.?#/X:7,_@_QCK-YHVG>,/ /Q,\&7^H^%XM0T/PO\1M<TOXCZ/\
M#C54\8>&= UWQ$FNZ+\/_C!X?\?ZG\)]937++4/%=Y]+Z[^RO\ ?$K7<FL?#
MFPN+B\UR3Q.][;ZMXDT[4;;Q,_B'XM^+8?$6F:EINLVE_H^O:=XI^.OQ5\1Z
M+K&E7%EJ.A:YXLDU71KFPOM'\/SZ5ZIIG@#P/HNI3ZSH_A#POI6L74EM+<:K
MIOA[1K'4YWL]-71K1IM0M;&*\E-KHZ1Z1;&29FM]+1-/A,=HBPCKJ /ERY_8
MO_9JNX;.*3X<21/IMC_9^F7MGXU^(6GZMI5O+X.\(_#O47TG6;#Q7;:MI5[K
M_@#P+X7\#^*]2T^]MM1\7>$+"X\-^)[K5]&U?6;+4/7_  7\)OAU\.]0U?5/
M!/A73_#EYKL M=4?3WNUBN+5?&7Q!^(*6R6LMS+:6L$?C'XJ>/\ 6HH;."WC
MBE\1W%K&J6%IIUI9^B44!N%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7Y^_MI?"_P#:<\:^-?@+?_L\
M>*?%NG>&O$VK:Q\"/VBM-T7XGW7P[M_!OP.^)'BGX:^.?&7[0'A4PZA;7=W\
M:_A_X<^#WB+X0?"F]\+P_P#"5Z#<?M%Z[XJMIEL?#-PT'Z!5\2?M7?#EOB!X
MN^'>@6OC7X:^'-3^*7PT^/?[-MOH?CC4[BP\1:OI?Q8M_AOX]\6>(_AQIMK;
M7TOC?Q-X%\(_ [6]2G\ 3QZ'IVK66H-K^I^,]!LO"LVG^( #\Y)_V6?V_/&O
M@KX@:/XA\1?M'>'_ !A#X2T%_&WB&P_;6\::%HWQV_:-A^,NB75Q\6_V9T^'
M'Q>T'6/V?/@%;?!J[^*%CJ?P5US_ (51H&HWOBOX<Z5_PJ35?$/PAT[XBZ[Z
M9I_P'_;4T?X,_P#!4;P;H[_'\_$;QSI?Q"TO]CSQ5KO[0?B;6IKS0YH?B98_
M">R^&/C?Q)^VAXPOO _B;1-(N?"::[XCN/AI^R%XB.J7FE/XF\>?%S7-*F^(
M_AKTZ.P\41^+?AG\7Y_VN[+_ (4IK/[1/Q>UKPK9>%/CMXT\8?\ "9Z9XJ\4
M>'O&FC^$(+]?#FL^%_B9I^A6WPI^-G@VW^%UAX5T#PC\-/A)KEXOA7Q5?>-_
MAUJGQ3\2^C_&/PW\0?VB?B+XKF^!'[3>A^%O"G@[X8?$+X6^)M.\&?$KQEI>
MK:'\1?%G@CXV^"AJ/B/2O#,S:3%/X>\=:K\,O$7@[QWHVI>&O&'@G7OA/\0]
M!M;CQ)>ZO#'X& /#?V6?V<?VT-%^)7[./B;XR_$OXWZ=\.K+P-\=_%'Q<^'F
MO_&VX\8'3?B3X%^+OB/0/V1_#&M7-Q\2OB7K]UH?CK]GCX\^+]8^,O@:U^)'
MQKT2'XA_LQ? 5?%?QT^)GB'1_%7Q ^.W@NL_LC_\%2]+M/BGXM\"?M*^,CXD
M^)_[37[;/B30_ /B;Q=XR\4^%OA?\%;^V_;_ -._9S-G/JO[3U@\^J^.;'XG
M?LM6_A#P_P##S4/A;\._@1_PKOX:ZOJWP9E\:^$?B#XPUG]#_AU\*_B[X)^-
M/A2Z\1?%7Q?K7P8T/P=\5==DE\1?$OQ!J=I>^(I_BW\4M4^"&@VUQKGB_4?$
M7C&U\+_ 7XK^*M.^,-SXVL+G3;[7/AU^SKXB\/>)-<N_!>I'1/.?CA\'_&7@
MWQ=\2/'5K\=W^&>A?&/XNVFM^'A-\5?B_H%]I'CJ]^"'PP^'^A^)=)\+^')+
MZT\=:G\*U^#/C'QGIOP&D>+X/_&'1O&VKW'Q1T[1_P#A6>CZU> 'QK\0_P!F
MO_@I'XOL_&?AO1O&/[2'@GQKXDN_$.G^-?C?X>_:LTBV\":O\#_$=IX7TSX:
M^"/@-\,IO'$\?PJ_:(^#9_LS6?'OQ<F\!>#XO'-[\/OB/<S^/_BM;_&NT\-Z
M!Z-^RI\+_P#@H3;?M1?#?X@?M*R>/-?\#+IGQSM-8O\ P+\:M1\2? NSU^[^
M.O[4VH^&?%2^"[7]K/P''9>%/&/PMUOX)S_#7P_XH_9S_:CU+P7H]QX>\!S/
M\#];^'FI>,;KZIUCX<_&'P]XFU+Q[XV^.N@6OPX\.?$V#Q ?#^H_'_XG>!-(
MOO &@>-_VF_$NI'Q+XKL;>!?#.H>'++XS_"G3=0\&HGB#PGXFT_X"Z%X4\5Z
MU;^'M0T:/P?VGPJ_9\\2_#?PMJG@?4OC9JT/@W4]%EM=4T6+Q9XBUA)M9N/"
MOB30O&:>']9\4:Q+XD^&'AZUENO#NO:'X:^%FO\ @_3?"MYH4\FE6.@-J6HW
M.H@^FWS-#]H/P%^T?\0/A)\,(O"_BB[\.?%3PI^UA^S/XZ\3V_P;\777@KP_
MXK^"/A3]J;P-=_%;PMXEU#Q.]OJVJ>'+K]G1O%>I^,O"-EJ5C)XQ\0:0?#%E
M_;6BZG)X:UW\^/CY\%/^"GGB3]I+7_&GA[6?%]U\*-1\%_"O3/$_@_X.?'34
M? /AC7/!NA_&[X;>)/C)X:^%,FN_%_P1=^"_C7X\^"_AWQ[\/?"9N/AQX&U3
M2_$WCF[^):?M]^#-*M= ^"'ACU^3X6^+_A7K?@#P'\0OVD=0\)V>O_#WX3>%
M]!\(>&_C7^T=J6M>(-/^&5E^S>WQ"\'^"[2QDL[EKQ-!^"OQHU2V^)GA][#X
MM>.A\9[VP\30Z38>']7O?%GTK\#?@S\7OAO\4G\5_$;X]ZUX\\(Z3\'=$\%P
M:!??$KQ+J.EZ=JGAWPQ\+=$US4O$/A7Q+8ZG;ZYJT&N^"_%GC7_A<%[XLT[Q
MU?R_%36O#'C+2M9M--TC6801\;?LJ?!__@J!X'\02W?Q2\<6^KZ^GPITWP_X
MT\2_%3XHZAX\^%_C#Q#<>%OV?[/X=7GPP\$^']:U:Z\'>.OA&?#7[0^C?&;Q
M-<>"/ 6E?&GQCX_\+^-9KCXBV,=O;?#WY@T']GC_ (*]:G\/OAT_AGXE>-O#
MOC*W^$?QOL/^$@\2?&/4M>\/W7B75_V?OBG8>'_&/BVZN?VMOC?8W_Q ^*O[
M1OCWX?:KX'L=-\+_ !*^$OPI^%GP4\-?$/X<W7[-&L>.?'/[-FH?HGXX^$OB
MSPU^T/9Z]8?M'/X \.>)_P!H2P^+NM?#*T^,GC2Q\3^+--UCP]^S5X6T^35-
M-UK3O%UK<>$HM2^!/Q4^':?#(V>E_#'4O"_Q@O=7T;Q)X!\;^%-($?"C]E']
MIKP+X+30-"^+NN>+M.\/^%/V4/AWI7@OPQ\=OB'\&O"NBZ#\,]0_9=M/BO:W
M5QH%E#K'@.UE\/?"KXK>)[7QWX*\11>+=?\ #'QI\1>#/$?P\\70:?X=60 \
MC\7?"[_@I;=_ [X3>&O EU)J-UX.^/?Q5\57/P[\3?'7QLWQKMOA_JOB_P".
M7B7]FOX7?M)?'#P/^T3X(UK4_"GPV\$>*OV?=-^+^L^"/C!\8O&VIG0+G4[W
MPS^U%I":GH?Q!X_PU^SO_P %1].^*7AB_O\ XC?%C7/AO8_M-W.M02:S\6[#
MPSKIT:Q^+_[)VKZ_\6_B;X;L/CO\2M U7X->/O@AX,_:Z\$^&?V=_!FH7?A7
MPYXL^)OP^\0Z5^SS\'+O43K/P+^J? G[-7Q0G_X3+Q+X7_:<O/%&K^)+33O"
MOCZ[T_XA?%#PA%X_\9_"'3?V2_A+XMDU2'2=8O1\._$GBS5OV5/VD_ 6N_%C
MPCIU]X^\,:5\3UU+2+_Q+=^$_L4>M8_ SXQW^G?$73M'_:EUE/'VCZ1>>#M=
MBD^+7Q>O=#\(^%[KP!\(/$^E^!EDUC7IEL-9L[1-1L6_:3M=";XV#P_XYMO'
MNI>)+_QQ/JFCW !ZW^P5X(^.W@/X8?$:S^.\?Q#L+C6OC?XU\2?##P]\5?B'
M=_$GQ]X3^%&I:/X3BT7P[XAU6\^-/[3%UILMGXFL_%UQ9Z;)^T?\9([S3;RS
M\3VFH_#6Q\1VWP(^$WW$6 &XGCKGKU^E?#MYX);XC_ _P_\ !2#XGWGBGXD?
M!+XF_L_/XWUK6?B+XT@N;GQC\'?&OPJ^.^M^#]7^(^A:+X6UGQ?<7'@F&TTV
MYUV;0[^[NVU/3]4^(&FW&MQ:M&O6?!'PKXM^"WAWXD>(OC/\9K/Q#X?LM'T?
M5=8\0:]\0_$6N:3"?#>F:UJ7C;XU:SJWCO4$LOA##\1M/O--U74?@]X-NH?@
MY\*+#PI#/X'U&XAUW6KH 'UN#GG^8(_0\T5^36@_LU?%J?\ 9^/P_P#A/^T/
M?Z?J&@_"+P%^RU9:]8?&_P".UNF@^)/@1XS^+OACQKXP\-ZQ>WVIW/AKXDZY
MXR'@F]U>YN_"OC#4[OPUX*UWX$+XC?P;/X8\?V'KEQ^S[\<K2_\ %=QI_P >
M->O/$_B+Q_HOCRVM=6^,/Q8M-!T6UTWXS_&;Q380R>$H;S4A_P (%%\,/%_@
MCP1KWPL\$S_"W1/'MS\/)+6^\9^&X[+3]?4 _0*YNK:SA>YNYX;:WCV^9//(
MD42;F"+ND<JB[G947)&YF51EB 9@0W3MP>"". >0<'H0?H<U^;_AC]GWXC2S
M:[XP\,?M*ZUXET_Q)/X@T2[FO?C;\5_'?A5->3XE-)JMEH^F:SXKUWPGX>U/
M1M>T.U\&BR\,Z=I5SX?N=/U7P;IUKIFGZKK^FZE/X*O1:? 'X_\ PB^!WC>\
M\<_&GPSXM_:9^)G@>+P]XO\ &6K:E8^(O$G[3?QLU;X=Z?XD\4_$#4O#=F;.
MQ^)_AS7_ (=>*?#VI^-AX3\26_P_^(&B6NIZGX9M]8C@ /T:HK\L]"^'7Q1T
MZ\NO'UO^UO;:_P"'M'E\!>']/U3Q1\8OB%H.C^*?'GPW\:_ ?X>ZY\,?$.AW
M<]WX.\,Z1\0/C7\&/BIH&J?$_0=(UWQAX@O?C[J?@"W\):SX8\.PZ%X\^KO@
M!\._&WPZM?$OB#XJ_$J[\9^(-7TKP3I=S<2>/_&VO>$-#;PKX<M=(\00Z7I'
MBO53HNF7=]XU/B.]O==M-)T[7]:MKC3++Q+<RSZ39V5B ?3U5EO+5[E[-+B%
MKN***>6U616N(8)WGC@FFA!,D44[VMRD$DBJDS6\ZQ,YAD"_GK_PSO\ M P:
M]X1U%_VD-8O=*\,?%;7KV?3KGXD?$S2O[(^'=GXN^#$GPRT[4TMM5NX/B=XJ
MT[X7?"_Q;X8\:Z'\12/#OC3QI\<?%WQ"U*]OY=#T[2-=X^\_9*^+UO\ "WP]
MX%\*_'[6O! \&^!8]%T'4]'^-?QH>ZGO_!7@G]JGPSHGC'7?$C^(;3Q)J6ES
M^,OB_P#!?X@^*?"FLZCX@\/:5<?#IO"%Q<>)]+\,^#[J\ /U"9@H+'@#KP3^
M@!)_ 5#;W5M=Q">TN(;F%BP6:WD2:%BCO$X66,LC%)(WC<*QV2(R-AE('P=^
MS?:_$+0?V@/VJY/'?BG6]>\)W>O:1I?A%]=^+.H^---L]8M?B'\8?B'JNG0>
M!F\8^*O#'P1GT7X8?&S]G_P;IWA>*U\)Z]X[T#PUH7C74=&'F#2_#N9>_LW?
M%^8>)+VW^.OBTZE/X,\2^"+VRT/XW_$_P99Z7I&M>'OB]<V\NG+Y7B_PGX%\
M<6?BCQC\-M=T[XI+\-M;\9:%I?@C[#:O>Z$R^']3 /T*W#=MS\V-V/;.,_GQ
M02!C/<X& 22>O  )/ )]@">@K\M]&^"WB34-*U_Q!<?M+V7AJZ^(GQ!TF^O_
M !AX/^+WQA\/6.H_%23]ERW_ &.(M#TKPQKWCM9KNPL?CCX,E\;>#O#^I>,-
M;?QIK<=DVI07OCGP7HOB:^W?''P4^,.O> /BWJWQC^+.AZ5X4\7?!;]H30];
MO=.^.OQCT3P-\"X?%B?%>]7Q=:2Z=9^%]/\ BKIEGX1\4>%-"U2\\:Q^!9?A
M+!\,&\1_#+[-=>)-1LK, _22WNK:Z$IMKB&X\B9K>?R9$D,-PBH[P3!23%,B
M21LT3A7574LH##-BOSZT_P"%'Q5UCX@Z'K&C_'""#2_#OQ$TR[U?P]I7Q@^)
MFK-X$_X1C7? .L>//!T^C8LM,^.DOCOPW;'X4ZLWQ<MK%_AM:ZSIOQ3\&01>
M-=>\0:#K#?@1^SQ\<?A?KOP77Q!\=_$'Q$T'X=1:QI_CC_A+/C%\7/&%QK]O
MXC^ /P9\*W8O]-\3WNJW7C#Q1>?'+P=XK^)?A;Q!\0/&%WI?@/P7X_\ $?A_
M0? VHZWXQTG7OAL ?H/17P/^T+\-/VA_%&H_$<_"_P ?%]%UK29-0T;P]IWQ
M8\;^ /%=AXBU'P=!X#3PU:7.@WFEVGAGP?$-/O?B*_BS1_%&G^)X];N-7DT'
MP\NMZ-:ZSJ?J,?@3XEZ=\!-&\':=\289OB/X?\=>%?%<&JZQX^\6W=K+I.@_
M&?2/BI!\&=:^)EY;WWCK7=%O/AW9Q_!6_P#'_B31=5\1^+/#=Q)XM\6>$M9N
M-7U3PY> 'U,6"C)]<="23Z  $D_051M]5TR\GFM;2_L[JYMQFXM[>XBGFMQ]
MJOK',\<;L\(^W:7J=EF0*/MFFZA;?Z^RN8XOS8UG]E3XO^)_AUXD\)^*?CUK
M/B#QAXH^ MQ\)M?M_P#A<_QOT?PWJ&M6OP2^''A4ZQ%IFG>)Q/H-_<?&C0KO
MQMK_ (XTO25^(-SX;\83Z)J]_K%EXFU[0=6^F/@W\*/%'@GXF?$OQSXF\3Z?
MXC?QYI5MHVGQP7=]?WVE6NB_'O\ :D^)UAITU[?C,MCH?AGXY^&?!MA:VP6/
M3KGPIJEK##;:8-+20 ^GJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O#/BM/X$;QM\$SXG\6#1O$?@_Q
M7XQ^*7A7P[:VT^HZAXEL]!^%/COX>>*KF\L+&VO+ZU\,^'M/^+%I=WVNB*&S
MM?$MYX0T![EM3\4:1I^H^YUXY\3_ (%> ?BY,\_BR/Q!%)=^"O&7PXU@>'_$
MVL^'H?$?@;QU:V\.N>&_$5OI=W!;ZO9QW=E9:IH]Q=Q/J.B7D5_;Z7>VND>)
M/%FF:^ ? _Q(OOV9M0^'VI^$(OCAX:EO;KXMZE=KK.C>"M,UCXT_#WX@?'[Q
M_P"/O%#?\()X@N;_ $F_^%GQ3\'6_P"TE:6/@W6M4M9-?^%MWXA\.3>(=!U'
M5_B/8>&]>-?^"'P=O?$_QK^#6@?$;P=!\:OBK\5/@ \_@CQ1<W.N^&-&^'/P
M=^+5W^TWX>\"^'OA]JWBGXAP:;9S>%=3^-6J:5X*U%_!7A_QOJ%AXKN= \$^
M#O >EWU[8_4&E_L-_LZ:%INF:7H'AC7] MM,\77'C'=H?C?Q;I,]]>ZA<?#2
M_P!8T6^FL=7A9_!^NZM\'?AGJNM>#K?[-X<U"Y\(V-K+IW]E76J:=?\ JL/P
M ^%\'Q)UGXM1Z)>CQSK_ (C\*>*]4U(Z]KC6L^N>"?!GB[P!X=NDTEK\Z7!'
M9^%_''B*RDM8+2.UO)[JWU"[AFO[&RN8 #X%\.?"W]ECXE:9\,8?$'C;0_$B
M_ ;XB^(_@_X<T;Q#\._"\"^'_%&J_M)_"O6-1T"6P-IKFE>#_"?C'XS_ +,&
MN?#WX>?V*_AWP;;Z3K:_!W3(I/%/@RQTE=>;5_@%XS^&_P"R)\(?!'[0.@^-
M[[P]XP\"6?P9U>QT>Z\1P>)+3PY\"_&/AG1;OQMIWA_QKX-UA])\5>!+GQ#X
M\\.>(-,\2^'U\76J:?XH\.V/B7X?V>L27?T]XB_8L_9Y\5>)O#GBW7/".HWN
ML^%?$6E>*M'DD\5>)C:P:WH?Q7\2?&[2+\6+:HUK'>Z?\3/%6K:[;:E;Q0:M
M'IEQ>>#!?_\ ""ZUXC\-:U9\-?L=? OP?XR\/^.O#6B^)=)UWP]/X)N8Q;^.
M_&+:;K4WPU^&2_"+X>GQ1ILNLR6OB2'P;X(DU*VT2RU=+JQ36=:U7Q1=VMWX
MEF@U6V /SH\7_!']EWPKI_C#5-=_:0M?&VL>-OB)>Z3XI>3P[H7CWQ=JGB[]
MK3PAX(_9Y\%Z5KO@Z[UN?2WTB]\2_"K3/C#K_A70?".B:CJOQ.\$ZQ;_  DL
MOAMX';6/@[K^GIW[/G[!WAR?2-7UWX\^!M?CM/&FG^*(=8US56\90^*D\8^+
M_P!G[]J&SU/5]3\9>(O'6B7D^M>#/V.(-8\=>+/ -KX,\)7/POT[7/&GBS0M
M)'@==?A_0FV_8[^ %GXSO/B!:>$=2@\5ZCXLU+QMJ.HIXQ\8M%?^)-4^+'@7
MXURZA=Z=)KKZ9-]C^('P[\/W^CP&S\C1-)N/$GAO28[/P_XM\3:;JO&Z3_P3
M_P#V6=$TO5-%TOX=BSTW5]&DT*[6WU?4H-4;3[OX2>,/@CJL3^)H)X_%=VNL
M^ ?'.O6VHP:AKEY9_P!O26WBRSMK/Q+"=4D!WTMW/-_BGX/_ &<]*^#W@G]G
MGQU\=['PG;_"?X9>,/@H&>YTK_A([ZTF_9RT[X;>(+Z]T00W)&I>%_AU\6O"
M_P 2-6CL[-['1=)U.SU[5S:^&8]3N;;RKQ9^R?\ LE>)M'^)>LZ=\5_#/AZ>
M#Q)9_$;Q]XF\-P>'](E:YL_V@?$7B:TTSQMK/@J]\,^*]=\->*?C7\,/$?A#
MQ5HVF^*='UKQS?\ AGQ!H>EZKIOB26#5+;['\6?LH>!/'OQ:\6?%[Q9J&N+X
MBU;0_ 'A_P )7?@_6/$/@?6/ =OX+TSXGZ3JNKZ/KVBZ_P#:U\5>/=)^+WBG
MPQXP\0:9#H4NH^#M&^'VCR6KZKX!T#Q'%-HO['OP)\.:;XXT?0/#NMZ1I7CE
M/!Z3:?8>,?%,%GX3/P^^(_C'XQ>"9?A_;KJOE>"KGPO\5O'_ (L\>Z/=Z$EM
M=6FKZA86"3?\(YX:\*Z'H8(^1?B-X'_94L]9^ GA?5))-=LO#/A[]GS]GZR\
M%:GX$_X3"_O=#NO&/AFV^"-UXFO?B]>WOC.7P>->EUK^T-4UZ]\=W&I>(_#N
MJO=:JWCKX?>*+34X]$^ G[+WP*T/XX_#/Q%\;IK?Q-\7M3^'VB>)=;^(^J^*
MM4\07E]!K7Q8^,WA2V\2>'?%WB75/A_XH\"OJ)^,;:E)X;\'^$?#&H_"#P+X
MJ\"?$W7O$EK\,M=U_2/JC2/V(_V?-(\5ZGXZ7PYKM_XRUKQAX%\>:SXDU'QA
MXEGU/5_%/PY\;:]\2/"^I:J\6HP0ZDUGXW\5>)-9:&]AGA%AJ=KX-MTM_ /A
MGP=X5\.WC^QC^SXWB?XH>,&\):B?$/QA-ROCS4?^$J\3"?5H+K1?C/H3VYD7
M5!(J0V?[07Q:33YG>6\TBT\1Z7H6DW-CX8\#_#_0_"P!^7=]^SK\"-37QCJO
MA7X[^(_$6F:+XT^'WPSUW5-!\*7MAX;\.^'/VM/C_P##F^\7^$_A7I'PV\,^
M,88[3QKH*^*?ASX*U'0_"WAZTTOP!^TAXRU'5/BOJWPWO?!4W@KU#XB^$/V/
M?VD-/_X7[J/Q^T7P!X=^(UOX ^-\-OJNGZ'X5U[PRWPJ^'GPS\:V.C>/O'&@
M:IH'C"W^"LG@*+PAXJ\8?#G_ (331M!\0OXET'QAX"\<V$FK:)JNK?HAX>_9
M9^$GA;P[KGA?1K7Q5#I6LW?PUN;9;KQOXHU&;PS%\&=3TW6/A-IGA!]0U.Y3
MP[HO@"^T?2YM'T:PC33KU[1Y?$-OK4^HZM+J'GU[^P%^RS?I;QW7PZ6X6#P4
M_P / ][K&JZK=_\ ")+\+_"?PALM/MM1UBYU#4](OM(\(>!_#!T?Q%H5YI7B
M;3M;L)]<M]86_P!6UF74 =W>_4^&/BA^S=^R79^$O"5G:?$76- \ ?&ZXUOX
M:Q>*?#WAC3=83X??\*/^$RP^(-7N?B3X^OKSQ/\ #+5M)_X4!=^&/C=>^*M;
M\1?$KXMW*#X9>/[?6M4\/VNM>&-_3_"_[%VE3?M6>!;?QO-X>\.?M*>!OB#\
M.M3\17=KJ[^'?#NAZ3X5\-7&M>#M(T*_\57O@R5?A19?':"#P?X9M_A%X3UG
MX6>'O GQ"\->+[R;1/!&I7=M^D>O?LZ?"GQ'X8M/"&J:+J;:-I_CKX@?$O3A
M:>)?$6GZAIWCKXEZQXV\0^)/$FGZM9:G!J=CJ,&O_$'Q'K?AN6VNHO\ A%-5
M;2K[PZ--N-#TA[/SM?V)O@-!-9:C8Z=XSTKQ)I_B#QWXNMO&&C_$7QII7BR+
MQ;\4K'2]-^)?B>'6;#68)K37/'%CIUS#K-]9);26SZ]X@N]#&D7VH_:801\@
M6W[*W[*7CWXA:;=Z-\:] \1>)[KXE:=\1M6\'>$]8O-'L==\4>(OB7^UQ\:K
M76H['X6>-/"?BFV\7!/%GQ>TWP%XCO\ Q)J][H.D_"B]%YIOB4IK]G<8/B1?
MV7OVEV^-7C'0OCG<>"+#XAR>'?&FHZGK_P +K?3?'EUHWQ:_9"^'?P0V>$CX
MDM]-\47WA[4?A?\ M!_#.\\,>!=7\)'Q=X6^.?BZPU+5M*\2^%O&GAOP=JGZ
M#?#?]D_X#?"/QFGCWX=^"?\ A&?$,5OXXM8OLFO>(I='BM_B#J/A+4]=CB\.
MW6JSZ#$+2?P9IL'A=H].5_!VGZGXNTWPLVDV/C;Q;!K/$WO["/[->H^%;;P?
M?>#+Z_T?3CIS:/'J?B+6=9.D/H>E_!S0_#9M[?6;O4-.O4\/:)\ OA3I%C;Z
MW8ZK:WVG^&[J#7X-9_X2;Q6VM@'S)\4_@=^S#JFG6?PD\0_&73?#-SXSU[Q7
M\0_!BIJ.BZ[X#U3PU^TSKW[1&AV\?A'X1:CXDUWX?Z7X@TB'XR^*V\-?&FQ\
M$^'1J?B.R^'NH>(]5^(&A:7XK\#WM72=-_8JTC3?VA/#\'QDAT/3/VD/A-?Z
M3JOB27PH?#NG7'@GXR>+_P!M_P#:(M/$?@'Q7JWA!/#GCVW_ .$8\4_&OQ.)
MH)/%&BP_#3X3P^.?$<4GAR]OM1O?O'4OV:_@YJ>MQ>()?"IL[VW^&'A_X-VD
M&C:MJVA:38?#KPKXFA\7:!X>T[1-'O;'2-.ATW6[>"6WFL;*WN%LX8M,\S^S
MHX[5>"A_8E_9^71Y] NO#_B#4-(O=(\0Z-J-E<^,_$]O#?0>+++X]Z=XBN"N
MEZEIW]FW&I6?[3/QD@"Z'_95IIZ^)-/.E6E@WA3PF=% /@Z?]G?]FKP9X@TV
MXU_X\Q>(];T[XAZA8:7X;\*?"EM3\!^%_B7\6?V\)/B9IGA77/ W@:/4O#>A
M?#ZT_:>LG\+V5EXOGM/'[QZ;XUN/$WQJU2UTVVO_  7T/P\\ _L>>!_@'8?"
MS0OCWX1%I)\4/!7CQ;_XC:M/\6;;Q+XFT_X8W'@[1F^*?A[Q5X^\;>"_B!:6
MG@?X(^-+OXD>(?A_J?A'X3:1\2/A#\3/B/IUIX#\5?#3QK=Z5]SZ'^R5\*/#
MEGJ=AI-U\0(+37_%>F_$+Q-!)\0_%%Q%XE^).E?%ZS^-UK\1-6CGOY$_X2Y_
M&]E!!=WVGK86M[X.@TSP#=V,W@SPYX6T30\+2OV'/V=-'T2;PY:^%_$$FA'P
M_K_A/3M+O/'OC:[M?#_A?Q7X>^(WAWQ/H7AT3ZZ[Z/9Z_'\6OB!JFIRVKK?W
M&K:QID@O$LO!G@2P\, 'E7@O]CSX >.?V8O#WP>\)>(G\9?#A?$_C[Q3_P )
MOJNA>&]?U'XAZKXGT#X@>$+;Q5X@U.[T*UTOQYJ6D67C.PU;PO\ $2.TNH=>
M;PKX2\0:/J%SI7V*4X/BC_@F3\)O$'B?7/$MIXCUW1%U"VTPZ%H6DW?BKP[X
M=\&W.@_$#7_B'I^BZ!X?\!>-O!'A_P#X5]XCU'Q9XFL/B7X2OM'NM3\4V^K2
MZIX7\6_#[Q.IUY_N'X<_"CPO\+1XC7PO-KGE^*]>U7Q1K-OJ>L7-_92>(]=U
MG5M=U[6K'3G\O3](OM>U#5Y)]<?2K6RBUF[MH=6U.*ZUVXU35=1]+H _-+4?
M^"97PBU"QL]'FU?[-X:TK3_$EGI/ARW\,V.JVEK)XD_9:\ _LO&\O=4\97_B
MWQ-XBOM#TSX>Z/XXT'5O$NO:OXCC\1D+J^O:RT*7S;/@']BB]TW5OVI1XBU#
MPII>@_&VV\(Z'X;;0[*R\2:[?V'@[XP_'CXSV_B3XO7>H>#/"-OX[OO$^O?&
MR71/%7@S6?\ A)-,U/P=HLV@Z]XH\2WGB/Q%K^K?HI10!^9</_!-/PFU\]]J
M'Q4\1730Z/;:1H=O8^&/#^A:=X/CD^*GPH^*VHR^"M"TAK?PWX4GTW6?AA>I
M\/=1T+1;#Q#X'D^(_C3SM>\2:'9>!/#?@WVCPG^QSX<\*?LQ?$3]E:S\12VO
MP_\ B+\.?'_@*^ETN+Q0]WI=Q\2K+QCI/BOQ)I1\8^./&]U93ZAIOB/2[@Z#
M8:A9>'K;Q)I6KZ]IUA81>*)]*TS[,HH _.7QM_P3J\*^*/$VG^(=$^*WCGP8
MGAS7O'?CKP-8V%OI^O?\()\3O%OAWQ]I>C^/='D\3/JEEK.H^%/$OC71OB'I
M]OXTTKQ.(/&/PI^%\WARX\*:/;^/M(^(.GH/[!WA3X2_#?\ :/\ #'P>NB=<
M^,/@5?"_A&\\6^)O&K3^%KO1&\;:M\/WO=8OM1\<Z! /AUXI\;7%YX&U[PQ\
M+])\0Z%HVD:#I^LR^,+_ $BTUA/T'HH _-:+_@G!X2L+>R?PU\2=:T#5=!\/
M^*=#\,>(/^$1\,7^NNWQ&\#)\.OB#JOQ#U*ZC^V_$_4X_#,NK0_"N?Q)<(_P
MNEUW4M-#^*O":V/A:SZ3XD_L+^'O$7PL\%_"/P[>^&+/P]!\?OC/\9/'FI^(
MO WAOQ#<:P?C/X2_:$TO4Y(/#-YH]SX=\0>)='UGXRZ/9Z-J7B01_9M*\.VN
MJW5SJ5]IEMHVI_H+10!^<^J_\$W_ (8W^J:[?6GB?4=/A\5/\3+CQ&Y\,^%[
M_7KJ]^)?B?\ :5US5+^Q\37MC)?VU]<:?^U1X]TOQ+?ZE%K>H^,;GPA\*K_5
MKQ+'P_XOT+Q_ZO\ LN_LP1_L^ZQ\2KW^UAJ=CK47PW\'>!+1'M$BT7X??#?P
M)INE^=<Z;I_AGPSI>C>*?'/Q$U/X@?$/QU!HT%]I>K>(/$*ZU'?*]R--TS[!
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPAX7O;*^DU#2WMK*&98193?,7ACXX_MMWG@'3?#<O@#6]"\3>'?V9/A'XO\
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M!?Q"\$_\*YNO WAWQ'X%\4Z_>0Z;IV@9'@_]@SXW>$+GQC?6_P"T3KL\VO\
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M;8VOQ>NK[7_CAX=\#:#^T)HOCFZ\1^'?%?PKU?QI:^ ]6T>QUZ/PSX8^X:*
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MX\/7GAS3]?\ !<_C_P )Q>+M#U#QAK/A;P[X2L-8\-OJXUG3+WQ1XA\<>"M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?Q)\+^*OB1X#E\>>"-$;XD>&O$.H>&+KX&:EX;^'/PX^%GAZ:XL/%+^(M/\
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MOC3PMILGBY)[;0/V8_'WQ-^)'CG5HIWAUCXL_$?5+/X@W$O@^_N=2TA?U;+
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MQ-X#_:E\>67@[_A//#.C^&_CIXMT\_"^7S-:TWX2^.-=UW0/'FN>/? _Q/\
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M$HH _,'Q;^QC^W;KWBOQ1KGA_P#X+"?M(>"?#^L^(]<U;0/!>D_LL_\ !/\
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MV]AJEK<S:#IOP4^%'@#0O$DE_>7UCJ<P\:Z;K\4$VBVEM:Q16EWJ4-Y];44
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MX[_M8P_"*3Q)X#M--\;:[KO[#^NOXBO]6C\5^)4\8 6=[=3]1O@Q^RE^V/\
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M [XE?#?X@_ML?$OXT_%CQ</&1\!?M&^)_A%^SEX2\:?"-?$'@W3?#_AO^P?
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MXD^!O&OAA-+^+4/A_P 174)NOK/X$#6OV=_B?XV\%?M*?M_?$K]KCQ+XFMO
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MK[3OVP/!=]X:U.6UUN/5[/P#\4[J\AT>V\/Z3-K_ *=XH_;<^ 7@^VO-4O\
M]D/2_$WACX<_!SX/_'O]H[QW\.E^"7BCP5\$_A?\<O'?CSP/X'\0:??:I?\
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MAVVU[Q OP>\#^!?BW:_%#]H"V_96\<>+O#OC#Q!,EIX0\&_LZ_M 0>)?A_\
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MOG^ GC7Q%IW@;PIHD=M;Z%/X>@NO$B^(_$&D:#> >[_+/_P.'^1YI_Q$L?\
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M%M-\0^(-;T'PGK0'NZ^[/3?WH_Y%W_B)8_X(C_\ 1\>C_P#AC?VG/_G*T?\
M$2Q_P1'_ .CX]'_\,;^TY_\ .5K]9/!GPX\":]X9T35/%7P%^'O@GQ)?:;;W
M6M>$Y-!\$>(FT#4)-ZW&G#7M'TYM,U9('C/EWMF(XYHV1FBAD\R&/J?^%/\
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M_P $1_\ H^/1_P#PQO[3G_SE:/\ B)8_X(C_ /1\>C_^&-_:<_\ G*U^QO\
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MB/\ ]'QZ/_X8W]IS_P"<K7[&_P#"G_A+_P!$N^'7_A$^&O\ Y64?\*?^$O\
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M_P $1_\ H^/1_P#PQO[3G_SE:/\ B)8_X(C_ /1\>C_^&-_:<_\ G*U^QO\
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M_J?B7P?X?\?1_ 7QA86>D?#7PEH_ASXA^.](^%/B+6_AUX@\!_$3XK^.=/\
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M>&?'/@:U\ ?"JSN="TCPE?>*I!\1[[Q]XOT#XP>!--@^'U]X C\0ZGWFO_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU'2/#G@7QEI>D^(=/\"> _!O@SX8Z[?ZQI>@_L9>)]0\=E=)\&>!-/\ #O\
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M &8] \5ZO-XI\#6/AM?!OBFZO?BSXJ^*>=.^$GC72KG0_AW\7]3O_#OA31?
MNKWEIZ?^S3^TI\8?BKXY\-^$_B)X7L]-LM7^$WBKQ!?:UX;^&'C70=%3X@>$
M/BE=>$=0<^(=:^(7B"PTSX>>(= FTF]^#.HPV^OWGQEL;#QGXHU#4OA+J'AQ
M?AG=?H$8D;J">0>6;JK%ADYR<,<C/<*?X5PI16Z@GKU9N^0<<\<$@8Z#@8%
M'YA:MX\^.6A_"/\ 9_C\;?%KXP:%+?\ [7G[1?PW^+_Q6T+X7^#IO'EW\(O
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MAK5K5OU9\M>>#R<GEN3@C/7J0<'U'7.!08T+!RH+# #')( [ YX'L,<\]>:
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M #Z_SH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH _E(_X/!O^4:/P2_[/C^'G_K._[3]?U;U\M_M;_L5_LQ_M
MV?#?1?A'^U=\*['XN_#OP]XVT_XBZ-X;U#Q%XR\,PV7C/2_#_B;PM8:VM_X'
M\1^&-6FDM] \8^)-/%I<7\VG2)J;S2V<EU;V<]O]24%7]V,>JE)_^!6_R"OY
MT_\ @CS_ ,I,/^#@3_L[CX)?^HC\2Z_HLK^=/_@CS_RDP_X.!/\ L[CX)?\
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MTW2KKQ3XO\8>*K[7/%OB[Q))H^BZ%H2Z]XEUO5=6A\/Z!H&@07D6C:'I5C:
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M ((\_P#*3#_@X$_[.X^"7_J(_$N@M?!4](?^E']%E%%%! 4444 ?S\?MU?\
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M_P"U#\&YH8_BW>_#>S\33?#D_P#!/C]CN+2)8$\92)JLG@@^(XO'T6FRP@Z
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MGPUX(L-4U"*W2TCO]1L_#.F:9;WMY':QQVR75S'+.EO&D*N(U51Z+0 4444
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M(?\ I1_1911100%%%% '\_'[=7_*?;_@A)_V(7_!2[_UG.TK^@>OY^/VZO\
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MW7+?PUXKLK.83W/A[7[OPUX>\8VVCZO$F6LM0G\*^+?#.OQ6TP61]*US3;P
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MXS_JY/RSMQGVZ]..13E8, PZ'U!!].0>0?4$ @\$ \4 +1110 4444 %%%%
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M=Z)I_B:QOO#M]JUM%+I]IKEE=Z3/<IJ%O-;)YQX9_9=\%>%]/^/,UEKOB_\
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MOB'_ (069/ G@^Y\9^%_&-Y>>/Y_'.--_P $T?A_KC^,-*\3_$+QY_PA=_\
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M>SN3X*\9/97-U;^%]:GL_F[6OV _!6O67PZT&_\ C#\=)O!7PG\?:7X]\">
M)=2^$ESX3T>;0/C%\//C9X:T*47WP?O-?U2W\-^(_AMI>@Z-XSU;7+[XMV_@
M[Q!XWT67XCSS^+=7U&:M\0OV#/!?Q-U3X=Z-XAUC6K3X>?#3]G/4_@KI3:7J
M=I'XYUSQ5Y.F:!\.OB;KDYT&/PK)XC^!_A ?$JR\"?VCHOB3P[JNH?M _$^W
MU3PAI^A+)8>)0#Z1U+]I;]G;1]/&K:K\=_@SIVEGPI8^/!J-_P#%/P%96'_"
M"ZIKNE^%],\:_;;KQ!#:CPEJ7B76]&\/6'B,S#1[S7=7TO1K>\DU+4;.UFV_
M%?QQ^#?@2_O=+\;?%;X;>#M3TWPY9>,=1TWQ7X]\(^&]0T_PAJ.NVOABP\5W
MUCK>LV-U:>&[WQ)?6>@6>MW$4>FW6M75MI,%S)J%Q!;2?)D7_!.GX3Q>*O"O
MBQ_''Q3NI_!WCCPK\1]'T60_"*TT.+QCX:\>>!OB?J&I0PZ3\(].U+2++Q[\
M0/ X\8_$+P[X:U70?#?B+QGXP\?>/ETJQ\?>)I_$\/HWC7]BSX5>-_B[??&7
M4M0\5)XAOO%_PC^(CZ0@\#WNAVOQ"^#6N^"M2\-^,]'O=>\$:UXR\/:MJOA_
MP'HOP^\36GA[Q9I6AZAX*NO$$-CI.E>(_$.K>)+L Z?Q5^U[\ O#.J?#?0;3
MXB^#O&.O?%?_ $OP5HW@_P >?#G4+O4O#3^"/B%X\M?'<DNH>,=)L;;X?ZAI
MGPR\4:;IWC*:\&AWWB&.RTBWNGEN)'@WY/VI_P!F6+07\52_M$? N+PO'XG'
M@I_$DGQ>^'B: OC)M+_MQ/";:RWB0:<OB9]%QJZZ ;D:L=+9=0^R"T/G5X/J
M7[ GP\O];GU.+XB_&'3M)O\ XQ_$'X_ZQX.LM3^&3^']:^+OQ(\)_$;P%K7B
M^\O=2^%FI>+[5K+P-\0_^$5TG0]'\5:9X:BM/!WA/5=0T74O$T_C/7?%W$_%
M+_@G];Z[X?\ #>B?#'Q]XI\):A#^S_X?_9#\1^)]4U3PA>2G]G*QL]1M_$ND
M+X:N/A5K>D:_XB\9RRZ-<:Y<:?=?#G4;.\\,Z!<^#?%O@VP;Q;HGC$ ^IM4_
M:6^'.B?$B_\ AMK%MXPTZ?3/%'@WP#?>,Y?"FI3_  \L?B)\0M,TG5_!/@75
M?%ED+JVT'6/%%MKV@V&AZKX@@TKP?JOBKQ!X<\ V'B>X\?>)- \,:GJ1?M+?
ML[3V6CZE!\>/@Q/I_B'2/%WB#0+V'XJ> I;37-!^']I>7_CS7-'ND\0M;ZGH
M_@FQT[4+SQ=J=E)-9>&K6PO;G6IK*"UGD3S+Q]^Q[X*^)WBGQ]JWC/QK\2]2
M\#?%#Q!X/\6>._@O!?\ @;3?AUX@\3^ /#V@:'X.UJ76=/\  5M\8+*?0KWP
MEX1\46UCI?Q3L='D\3^&=.OIM,DL)]4TC4?*;+_@FY\*-.T?7M&LOB+\6K0>
M-/"OP_\ #7Q&U.RA^".G:E\2+WX.ZSJ?B'X(^,O&#Z=\$K2TN?%_PAUK4H[G
MPU=Z39:/I/B32]$\.>#OBAHWQ \#:)8>&8 #Z8'[4W[,QU'3M''[1'P+.K:O
M'I$NE:7_ ,+>^'G]HZE#X@329-"FT^Q'B,W-['K,6OZ%)I+VT4JZE'K6DM9&
M<:C9&?+\$?M:_L[>//!'A[Q[IGQ>^'.F:3X@N/"NDFQ\0>/_  /I>M:!XN\9
MZ0^MZ'\/?%%@?$<XT/XASV4%YO\ !ES.=<$VG:E%#:3&PNC%X_9_L!?"2P\*
M>,_!]OKGCF/3_'>K?$[Q%K]S;'X;Z1<S>)/C#\"M(^ 7C[7X+/0OAOIGA^VU
M?6=!TNX\;W5ZFA/)?_$OQ!XE\0:S_:VF:O)H,7+7'_!-?X/ZG'HW_"1^.?BK
MXMD\/Z-X/\%:='XH'P;U?39?A3X)\._&3PQI?P@U;P[-\&U\*^(/!-_I?QW^
M(4.N:AX@T'5/B#J\=_;6MUXX_LU+O3[T ^FO%O[2OPG\+?#3Q#\7[+7?^%@_
M#SP?=^((/&7B/X5/8?$BT\)6W@VQU34_'5_K?_"*W^H-&O@BPT;49/$&DV0O
M?$OVZ.UT'2=#U7Q)JFE:/>]IX0^*_A#QSXK^)/@O0&U_^W/A1JN@:/XM36/"
MOB3P[9-=^)O#=CXKTB?PYJ&O:7IUKXNT>XTC48 ?$'AB35M!74XM1T3^TCK&
MD:M8V7BOQ _9"\#?$3]G_1_V;]1\4>+].^']C;R6>J30:3\(_$6N^(K.6#5E
M:+4YOB!\*_&FBV%^FH:NVN6?B?PGHGA?Q?IFMV%CJ.F>(+.07:7?H,?PBO\
M1OB#?>.O"/BZ_P!)'BWQ+X4U#XDZ1K-C8^)(O$?AGP5\.?%'A#0_#?AW4KD6
MNJ>%KRY\1ZCX7\4:[XFO[GQ7J%_9^'=1T*RMM,?Q(^L:0 <WXC_:I^&_A;Q/
MXG\$:MH_Q(7QKH-QX6@T7PI;_#_7[C6?B/\ \)CJGBG1-%G^'$20?9_$=M_:
M7@;QHVJ3RW.GIHGA[PQJ/CW6#9?#N;3/%NH5-,_:V^&?B!K9?"NC?$?Q2=>^
M&VC_ !>^'[Z7X&U2T@^*/PWU2;P5;W/BKP)=Z^VBVEU8^'YOB'X.'B&'79]
MO;"'68[Z*UNM/M;Z[M>3N?V.+&]\5^//'UW\<?C;-X]\7?$#2/B'X;\9S0_
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M3XIUS54\?^')?&/@ZRT+0/#OAW4]:U_7-;\(V6N^*8_#>BV%_P"([/P[X/\
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M>:]XS/P[UWX=?$GXQ?#K5_!/BG3-=D\8:K/\)OVJO&/[(\.I>$-"TG1[Z_\
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M_@D:6-6=/+? WQYW;&V@LN["YVDXSM4\<@'(H EHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYT_\
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M_'+XB?\ !';X/_%;6_B-XC\=7?@K5=9^*^KW^M^-[JUT'X_:-;ZC?7WA'7?
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MG_:,/ZNT4!=GXD:+_P $4_A)96WC/P[KFM>!O$OPRUO6O#M_X'^$-QX4^/\
MIGPY^$]AX3_9+^!G['/AIO!FA:9^US 6\<Z'\+?@C;1Z7\6M4GO/B-9W'C'Q
M)Y.O"?[%>0>\Z!_P3:T'PQ$%T;7_ (:6\OG?LX7DLH^&GQ2MHI]1_90^/_Q$
M_:=^"M\=.TK]I33-)M?[&^,7Q4\;:[K>G:78:?H_B#2=0LO"MQIT'AK1M)TR
MS_3ZB@.9]S\L?A=_P37C^'/[-/Q&_9=NO&?PH\1> ?C#\0/'_P 4/B0\'P>^
M*7A#4+GQ=XX\9Q>+M(3P-JGA7]J/3_$OPZT+X-66D>!? 'P"AT'Q(_B7X7_#
MWX5_#/2;3Q9JFN>&/^$EOLC7O^"5?@SQ7>:S?^*_&&C^)[CQ!K.K>+]7CUVT
M_:&O=*N?B3XC^%6G_!#Q7\7X?#B_M7P^&=-^+/BSX4Z;'X+U_P 8:5HUBTNG
MZKXRO=.T_3-;^(?C_5?$WZRT4!=_TC\E/%G_  2@^&_CE]1G\57?PSU>]O\
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M@C_A!/VBO''B#XD>/]%M/!'QELWTSQQXIO\ 2]=U[Q#\/M4A_:@&K> ;F_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC360D_6JBOQ"LO\ @L]X;UCX?)\0M(^!NI:=X=9O@[=ZKXX^(/Q(M?!/P?\
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MB?X,Z1=^*O'WP>\&_%:>/P/\6M5U'5H+?QU+^VE-93^%/!OQ(^#'PG\7>*/
M_@?0_P!B[Q%K'Q?\9ZUI7@O4_ J?$+PA%IG@GQ=$+J]<#E?;^OO/V/HK\O\
M0/\ @HU>Z_XO_91\!VW[/OCAO$?[:?PC^!GQJ^!-Q::];ZAX7O/!WBW29/%O
M[2W_  F_BF/P[!IO@2[_ &4/ 4WA?Q-JXU@O;?&'4OB7\,_!7P[NSXK\1:QI
MWA7U'QO^V3K6B?MN:;^Q5X4^&FBZYKES\!?"WQPN?&GB/QWXI\-6TR>-M3_:
M%T3P[X5T33/#WP=^(6CFZAU3]G^_?Q#J_C;QCX!L[;3/$]A)X6@\8ZYI]QX>
MN +/]3[OHK\0/ 7_  65T_XM?\*7E^'/P#NTMOC%\7O%?P)MKCQ_\2;W1QX?
M^*'PD^'?@[Q7\>_#EU:?#/X3?&2_OH?AMXZ\77GP:T?Q&EM:^%?'_C#P/XM\
M7Z9KFD_!^Z\!_$;QQ]'/_P %"-5FT.?XGZ9\"]4N/@+J'[7?@W]C'P3\0K_X
MB^'['Q=XP^)&K?MG^'/V*/&?BQ?AM9Z%JR:%\-_#/Q!O_%^L^'-3U/QE_P )
M7XST?P-<_;O!?@Z'Q#H.HW %GV/TQHK\@M1_X*;>.E\4Z19:%^SEHNJ>#=1U
M#_@HI#-XDU#X[2:-KUKI?_!-3]HOQA\ OC)?_P#")1?!?6;6:^\:#1?#GBOX
M;:6OBY8;U]>U30/$^J>&8O#EMX@\1<Q#_P %:/%+?#GX9?$N#]E\^)],\7_L
ML_M!_MG>+M"\$_&&[_X23PQ\"OV=M6^ NG^++3PO8_%;X.?"&S\<_%JYM_CM
M9:A:^$+_ %3P-X"N8?">LQ:-\6=>:_T1[X"SWL?M)17P/^U)^W5H'[.'AKX3
M>,K+P%KOQ*\,_&_P%\6M8^&6HZ-J]EX>;Q/\3?!?P>OOC3\*_A!;V>NZ89;7
MQ!\>?#GA[QGIGA74KYK:'1-=\/VMCJ6FW3ZL@M/C6+_@M7X+O/#&F>+M,^ _
MB^\T;4/ .D>*9A/XX\/6FHZ9XLN/A)^R#\7O%/PZO[%-&NS%JW@72_VRO ?A
MO7+\7&P>+?#'B_1I;*UN=.EBC L]['[A45\^?#;X[VGQ"^-W[2'P5A\/WVF7
MG[.]]\*M.O\ Q%<7]K<6?BB3XI> (?'MM+86$5K%/I@T:"X33;E+JXNOMDP^
MT0B"(B.OS1^*G_!8K3_A?\0/VH_ -S\ =7U8_LZ:MJ6A:;KR>/KFQM/&>I:%
M\5?V2?A1JTVL6P^&-]-H&FR:C^U_X0UK2SX"/QAUF/3/!/B^W\6Z!X/U+5?A
MO9^/@+,_;&BOCOQE^U+>?#SX(? WXV>+? T,NC?%+XF? #X=^,1X5\3ZE>:5
M\-H/VAO'.@?"_P *^,DOO&O@/X?^)/$GAK2_'_C7P-8:ZFK^"_ FL:9H&LZG
MXCU+3K"/P]?64_QO9_\ !6W2]9^'_C;XT^'/V??&.M? [X/?#OPK\=/C3\08
M_'OA"SO?#G[/WQ2\7>/C\'_B3X \)W=HE[\2K_Q#\!?!^C?M.>,O"K7_ (27
MPS\._'?A_P ,>"O$7Q2^)D&I>#[4"S9^QE%?C-XP_P""I/Q.^'^D>,[CQG^S
M/X*TC5?"W[9>C?L2V":?^T'XP\2Z'J7Q&G^"NM?';Q!XKU.[\/?LN:IXNT_P
M+IGA&#PUI^E3Z)X!\5>)M9\1ZWJL%[X:\.Z)X=77M8]W^&O_  4#E\5_M'2?
M CQ;\&-3\)Z%K7QX^+?[,W@#XH:7X[TOQ9IVO?&CX*?!O3_CMXN\.>)O"DWA
M[PKX@\(Z5KOP]7Q?JG@'Q%9CQ;9ZJ_@#7['Q='X#U/5/!]AXE L^Q^D5%?GW
MXL_X*$?#KPK^W /V*%\+ZUXA\2Q?!^R\=7OB?0-=\,7DB_$_Q)H/Q5^(7@'X
M Z;X(EO;?Q-J7COQC\'O@-\8_B@NL;K;POX?TGP]X6TK7;^TU+XC>$A<V_@-
M^W'I_P :/V1/B5^U3<>"].\.S_#+0?'.O>*?A%IOCO\ X2'X@^!]2\$?#_3O
MB)J/PK^,&EZIX-\':O\ "/XY:-8ZE;Z)X]^&'B3P]<77@_5GAO+#6/%7AG4]
M"\0:J"_4^^:*_#?Q_P#\%H;#X4_"C5O&GQ$_9M\3:-XZ\/>"M8^).J>!-)^)
MOAO7]#O_ (>W/_!/C]JK_@H%\//%7AGQU'X:L9]1A\8:%^R5\1?@SJVF:YX-
M\+ZUX1^(5M=:Q_9OB+P3!H.O>+_2?A+_ ,%43\8?BI\ OA9X:^#^AB?XPZE\
M=[:_\<P?%G6O$OPWGTG]G[XY>$/@5XK\3?!GQ/X,^"?B1OBGX?UW7O%<]]X5
MUKQU8? K1+F3PMXBT76M5T+4(M,&J [/L_Z_X8_7^BOR2O/^"C'QHU+X&?!#
M]IGP%^R?H6J_!7]ISQQ^S[X7^ ^I>//VC;3P5XU\0^&_VI?&?A[P9\%/'WC#
MP?X:^#7Q(LO!.D^(#XN\*^,-7T1/%/B7Q1X:\$Z]!)J6E'QQ8:UX%TS)T/\
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M.L^*M U"XUZ36?A9X%\/Z->ZA=^%9[RQM_!VM_$S1DT^_M3>^);?5H+S1K<
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M*O&LUC>SV<\%[JGACP:FNZU::8EK%-XBNM(71[26RGOTN( +/L?2M%?B//\
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M^"UROPML[[Q'K^J7GASP-I^B^'O"T^B6&@Z+%8 7[W?S_K^O+0_#'P1^V/\
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MS4O&OC7QIXGN?V?O@FEG\2O%6OZQ\1O"-E\,/!^F^"_%/A[3M(@M*^U:* /
M;/\ 9I^%I^&&B_"7Q+;>*/'_ (5T/XJ^'_C;;S^/O&OB?Q)XCN?B?X2^/UA^
MT]X3\3W_ (DFU.#5K@>&/C3I&B^*-#T%;B/PSI^GZ+I?@Z'1O^$*M$\/GL/
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M"'7;[2+K6])TQM8TO1=0T[3_ !)XBMM5];HH%<^6OAC^Q;^S;\'O$GP_\5^
M? .HV&J?"7X>:3\*_A1;:W\1?B?XU\.?"WP1HO@_PY\/[73OAMX.\;^,_$7A
M#P'J5WX(\)>'?"NO>)_"NAZ3XJ\3Z'I<.G^)-;U6"2X2;I_%G[+OP'\<>)_%
M'C+Q5\/K+5O$OC3Q-^SSXR\3:K+J_B*"35?$O[*7Q"C^*O[/NJR06FL6]I!)
M\-OB!$GB33[>TM[>SUBX7[)XGM];TTFR/OU% 'R?IW[$/[-FA^/O"WQ/\-^#
M/$_A'QQX/\2_%KQ9I>L^"OB]\9?!D-_JGQV^,5_^T!\7+3Q?HGA;X@:1X?\
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M^E?#_P"//Q"M/B#\0_#VG?"/Q5J?AK0?'^B_ ;5-1^$$N@P^-/#WQ&\.^*=
M\1VGB[2[>'5K6Q]8TG]A[]F/2O" \!3_  OL_%OA&'P//\--)T7XG>*/'GQ<
MM_"GP]NM*MM#N_!7@*7XI^*_&5W\//#%YI5CIMG=Z-X%NO#EI<QZ1HIG2231
MM+DM+NL?L;_ K7M:;Q1JFE_$.?Q>?%NE>-(?&\?QZ^/]IX\L-6T'P]\3?"N@
MZ=I/CRS^)]OXRT7P9H6A?&?XL66C?#G2-<L?AYIDGQ#\57]GX5AU+4Y;L@CG
M/B=^V+H'PN^,GQ)^#>K^!?$6HZIX+_9JT+]H'PQJFG7^E"#XCZWKWC/XD^"[
M#X*:!:W<MNUM\1]9O_ =E/X1M;FX>/Q5%KFI"RB@7PAK,K^4:W_P4=\$Z3X0
M\>^+(O ]W>0>!_V/]?\ VH&'_"6Z+!8WOB_PC\(_#?QR\4_L^W-P+:?5=.\;
MZ9\+OB'\+O'%IKL6@:EH^M>&?%^HZCI=M//X,\1V-O\ 6/B[]G;X/^//&^F?
M$?QAX'TG7O&>BWG@#4=)UJ\GUA'T_4?A;_PM0^ +ZVL[;4X=/CN_#+?&SXGR
M6%PMH)FE\67,MX]Y)IFA-I?!R_L1_LL3^%(?!T_P6\)2Z5#8^)-*^V%M9_X2
MJ?2?%OP]\2_"?7=+O?'9U4^.-0TZ;X9^+M<\!Z?97_B*YM="\)RZ;H>@Q:98
M^'_#\.E@U;KJ>4_"/]O'3OB]\1M ^$.A?#:Y;Q_K7A!?B$YL?%<5WX+A^'?A
M_P".7QD^"/Q(^(-CXFU/P]X?U/5O#'A[5?A3HMWX.MHO"]MXQ^(%W\6O ,)\
M)>%O#%A\0?&O@GZ!^*WQPE^&7COX/>#9?#-I)I_Q3O\ 6+*Y\<>)O$-SX3\'
M:#?Z9J7@[2]*\$V>M1>&_$5EJ_Q;^($_B^2;X7?#_4[CPM;^.(?"'C*VLO%%
MMK.FZ;I.L5I?V6/@HNMZSXJTSP=;Z#XPUGQ'HGC)?%NBZCK5GK>A>,/#_BGX
ME>-+#Q)X3:34;FP\+WUYXE^,WQ=OO$]KHUA;:-X\M/BA\0] ^(.E^+?#'C;Q
M1H>J[VK? /P%XDT;X6:)XMF\;^,;7X11>'G\/#Q-\3?B+>0>(=6\*R^'+[0?
M$GQ/TJU\366@_%WQ+IFN>%-$\4:?K7Q,TCQ3=:7XKMIO$FD'3]8O;R[F =NB
ML?'E[_P49T>+X2:G\:+?P#X<T_PQ;?![QGX^\,^&?&?QC\->#_B9\5_'G@+]
MFU?VE_%/PV^#O@ZXT34;;QI;^&_#;S^'?$_BF\\0>'M1T75/#OC7Q"O@J_\
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MN]:\(.-!7J+#]F[X-:=\._''PGM?!-G'\/?B/X)B^'?C+PV-6\226^N>#H?
ML7PSCT6XO)]:FU.W1? UO;Z ;[3[ZRU*2"-;J6[?45%[0&EO,\,\0?MH3> $
M\<3?$7X2:Y%;_#CXLZ1\!_%5Q\--:?XAH_Q;\:?!CX,_%CX6>'O#T>I>'O M
MYJ.E_%/Q!\8-,^"'A/6=7M/#L[_&&\\!Z!<Z0FF>/3K'AGT+QO\ M*'X>_\
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M\%CXWO\ 1]7@TGPN^J:OJUJ U;M\C^CVBOYY;7_@EIXX\1ZM\,OBC\0_@?\
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M=^S=X6^(O[+G@KXPZ-\*_%/Q+U+]HO\ 9O\ %^O?LV^'/"'Q[\9^+OA?X/\
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M/X2T[0_$GQ,\+W?A'QWX:L=#T/2M-\;:9;Z7;0Q?H_\ LF_LA>//A/\ &_\
MX*%^-O&GPXU#2-1_:+^)OQ9\2>#/B9X8U/X#:/?>(/ ?BS5Y[KPGHFD?$7P=
MX2T_]IW0O%5FEU)<2Q_$CQEXA\$^"KRVT^Z\ :9HTL$ZR@'Z[45_/;^SI_P2
M\\8Z#KW[#>N_%#X ?L\64O[,'Q"^/T.B>,K_ ,#?!G5OC;I'PI_X0^^N_P!F
M3Q-\8=4\&^#-(^'/Q _:!\._&F_U;XG:]XD^&^EZ1X7C\87UM\3DL=/^(>J^
M*+^7SK0/^":?[85E\-O#7AG0O!OPZ^&'BOPC^SIX$^%_[5>J:3^T3XT2V_X*
MD_$WPW^TM^R_\4_B!XR^*/C/0O!3^,O#\?Q6^#?P@_:0^&&I_%7XGV.N?%2$
M_MA^+/!NJ:-?^ O"MUJ7B< _I7HR/7V_'TK\$?A?^PE\8_#?[=O@S]I&Q_9V
M\ _#K]EK3;OP'IVB_LB:5XD^'VAZ-\'/&FG^"OB+H&G_ +4/AC1OAW]G\ :S
MXS^&%WJ^J>'8OAU=S7^D_P#"/_'[QC\3/ 6H67Q.^&]II?CCY_\ A#_P2Y_:
M^^'WPN^!_AWQ[?0_'#1O G[&/_!)7X6_%#X'_$+QM\-=$\-_$ _LC:]^T9??
MM ?LFZ9J/P^^'/AG2-9^%VC'XC_#WQAX'N_BP/&>F_&?6?"2?#+XL^/IO ?B
M/7-;TH _INR/7V_'THK^:CQ+^P'^VIIGPB_:7^&NB?"_1M7C_:1_X)[?MU?L
MR?#K1/#OQFT*[\,?LT:E\>/C'^TC\2OV?/A)?:GXVE\+:QJW@3X7^!/B7\/O
MAJFH^"](U71? [Z;<^%_ ^G-\-_"OAJ1K'Q+_P"";7QD\9^(/!^OZ9^S3X3\
M%_L[:?\ ME:+\9-*_8L\ Z[^SAXWL/AMX'T7]COXJ_!K6_$]AX)^/?@OQ-^R
MIX;UOXG?&+Q9X.UKQ5\+? >BZSX?\+Z+X3_X6KX5\4#XR>,?$5QI8.WI]Y_2
M?17XF_\ !.3]A'XX?LH?M'?&KXE_$'2?!7_"-_&K0OC+J4E[X%U#2]%O=)\8
MZO\ MI_'3XHZ2/BG8:5;0S_&WQ!XR^#?Q)^&MSX&^)GB66X\4?"?3_!7C?X8
M74G]F>(M,DE_;*@04444 %%%% !1110 4444 %%%% !7\Z?_  1Y_P"4F'_!
MP)_V=Q\$O_41^)=?T65_.G_P1Y_Y28?\' G_ &=Q\$O_ %$?B706O@J>D/\
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M\8> O'W[3W]I:[I7@>VU:?6/&GC?PF?&*64VI31_$+Q3::=X@\07EEJJ+=P
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M;J_:M\1?%ZZUSQ7\5+OXF:1\:?VF_P!I#X[_ +./A&W^%O@C7O@CXH\)^(?
M'B;XY^!/C*WBYOBQ#_PAGQ9_9^\&-9:9XQTC4;JQ /FUZ>MO7Y_\#YGL?[>G
M[#7QP_:(^+OQA\6>#O WPL^(4WQ*_9E^'WP=_9K^+_C[X@ZIX2\:_P#!//XY
M^%_%_P 8=:U[]I7X2:3;^ /%%V?$-_'\0?AOX[M->^&OB#PI\1/%7B_X%>#O
MAKXLU/3? UQI'B_P5>^#W_!-Z[^'_P"R=^W[\.?%%A>W_P 0_P!M3XI?MH^)
MO%6F_#.^^#?PK\0W7A+XM_M&?M#^,/A5!I/QJ\._!JT\5:SXAO\ X7?$W0+F
M^C^/^I?&[0?"&N7FI^ M.M++X;?;O"]S\L_&O_@E#\4?C3H7[1/Q+UW]G_\
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MX%^'?A)XD7]G_P ;^+M(O_AAH/Q/\'3V^O:-XC\2^-9?&8\?_#OX>6]][/\
ML#_\$[/CQ^S!\=](U?X@GX<:[\!+7]GS]I30[3PW:^(-3\1ZWX6^+/[3O[1G
MPT^(_P 3O!&F:/J?ARVTF;X->(]-^$]I\6R!?/=6OQ8^+?Q=T0Z,WAM?#+KY
M%H/_  1_\>^"1H<'P6LOA;^S#/;?%C_@JOXGUOQ1^S_X8^"VB>(=:^'O[3OQ
M.\4ZM^RSX$U*S\;? 3QWX8O= TGX;ZKI?@[Q)8MX>AU?X9:%:+X:\!^(H=*@
MVS@*7HM.W]/[M3D=?_X)R_MCZ1\)_C3\&K_X>> ?C1;_ !N_8O\ V-?@I>ZC
M<?%NVU#P?X5UC]FO]J7]LGX]ZI\%+NY^)VA6?C#Q_P##?0?AI\>OAW\ /ASX
MYU_PW:W_ (IT7PD==\;>%_#<<USIJ=#I'_!,WXS6W[1W[-?Q5U;X'_#70/@?
M\/?VE_C[\6O"'[-O@7Q'\%OB)X=_92\&_$:']@VW\'>'O!-K^T!\$=<\%Z/8
M:YXT_9P^.?QY\?Z7^S?HWPV\:?"CQ=\9M2\&_ OXK>6+[QOXD]\_X)C_ + '
MQ6_9(^.GQ>^('Q1\"^ K2?QO\*/@5X.T3QMX.NO@_K#6]I\./V6?V//@[KO@
M^36'^!^B_M%+!+X]^"'C74[;3[_XX:G\(9=!L/"^M6OPTL/&NJWNJV'R#\'?
M^"4/[6W@;X'Z?\)?!W@7]EW]FV/Q=^RKX!_8]_:)_P"$.\0^)/&?AW]I*WU?
MXN^!];^-G[07QF\ >#?"_P &-/USQ%H/P*\/?%/X4_"Q].\;+\7?&MY^TIXX
M_P"$P^(7@/2O _AV^U4"^N_SL_38\A\ ?\$6OVD?AG^S5I_PVC^'?P0\>_$6
MR^&7[&_BGPKHTT/P3\/_ +/%O^T9\(/@K^T_\-?B!H'[5'P9UKX/>,O W[3W
MP]L_%_Q8T'Q1XE^-]]X2@_:6^(V@Z[X=O]-\7:%\1OV;/AOX@\0?H'^U]^P-
M\>_CS^WW^SU^TIX?\)_#?6M)\ >"OV3]#U?Q9KNK>$M,TC0YOA?^T=\0_'_[
M0.ERVVI_#SQ/\>QHWC/X/^,[[1/ ^@_"/XH?#70_B)XKN-.\'?M*R>//@M_P
MD7A6_P W]ES_ ();_$GX:_&/]EW6_C _@76_!'[/W@[X@>$?&R>!=1U+1?!G
MQQUG]FWQWHVG?\$J/B1XE^$^OIXJN8M>_9W^ GQ1^.WAF]BU[Q[XGU[3/B'X
M$^!7BS4_%WCN\^&'PJU?P9P_[0?_  1O\1_&_P"+?[;WQQN[WPE'XT_:$_:A
M_9MU#P-HUSI'PWU;PKJ?[-GA'Q3_ ,$P?$?Q:U+XMV_B;X5>(-1^(WBK09_V
M.OB=)\+?@Q\0M2\9_ HRZNUWK/@Z?5OB!J6IZ&!?7RUZ=SZN_9J_X)\W/P5^
M 7[8OPOUA/%&I:C\6+'XH? 7X+R:/\6+S1?&'@+]B/P9H?C/PC^R+^SS\./B
M=8Z)%K'PJT3X2^%_''BA_!FHW%OXG\5>#O%WC#7?&6MZ_P"*M;F,TGPO=?\
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MQB^%7_!/W3+&XUS1]*\&7_Q<UOX$?M;?M ?&+]L3X5_%3QMX:^'7BOQ3X?\
M!7[6OP)\2?"[X#?$KQ;#I'C67QQX6EET'Q[X3\5^$/"2:!J4^I?\$Z?$_C/]
M@K_@I#^SEJWP7_9\\$0_M2M\7_$G[+W[,&ESZ=XL^!/[-OB/7/V9? GPO^'X
MT6]N/AIX:\/^#]:U7XY^#M;_ &B/$5Q\// <6A^ O'WQ%US5?#=YXF\3PZUX
MS\2@7NK:>>GH?+/@S_@BQIOA3X3_ +)NGVG[+_[)6D_%CX9?\$^_VN/A!\6?
M%6D^"/AW::QJ'[4OQ$\-_ C3_@?XZ3Q7:^![?5?$FI^'-0\)?$EHOB;=RIXB
M\)'69[BP;?XCU UCZS_P2F_;8/Q"\2>*/AK\0O"/PFO_ (C>+;6[OO&=KXXU
MZ_UGX2^(OA__ ,$0=+_82^ ?QV^&^B6%M9VMMXI\"?M(^./C5!XUM-/N=,\0
M^*_"&G_!SQ78:I:?\(7%82?0-_\ \$M_BKHGQL?Q;\*;_P %?"_X*Z9^T_\
M\$\/BOHW[/\ X"TOX3^%?A/J7AC]FRQ\+2_%+Q'J.DVOP/F\=>&O&>BZYIVL
M7W@+0_ 'Q%\)>%?$<TZW7B736?4=52XQOV9?^"=?[3GP5_X)/^/_ -A_PMIG
MP[^#'QY^*^@^"_@]XM^*NA'X23:%X>\)^+?!OPZ^$/QM^+_A>;X&?!?]G_Q1
MXT\2>$/AS:?$#Q-\,(_C'JOC#XW^*_':Z%8>.OC[]@NK?7/#8%TEHT_D>U?
M?]FK]JWX%_ C]L?PC\%?@3^S5^S'XL\?^$_"6D?LR>$OAQJ?A"_LO!7Q5O/
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M1?AC^SK^SY^S[^S;\*?VCOV*M(\&3?#E;KQ'\-_C0/A5\9OA3=^#-,\8:?\
M!+QM\//VC_'7Q6\?Z3)\2H=7\-^/,.[_ .".WQ=T;X9:IX/^"EE\/_V;]1U/
MX$_\%S_ WB&7X(:1\$M"M?B!>_MM?M5_";QS^R/\.O&R^+/@[XPTYOAW-\!O
MAOH_A'Q=J?A?3O#WC;X6Z5X-\(^ _!WC'2/#]BUI<=U\8?\ @FG^VM^U'>_$
MN/Q1K7P*_9HTCXV?%#PE\7O&D.A^(?B'\>Y-(UK]G7]D_P $_ ?]GW38I?#H
M_9EU._U:W^.&M>+/VE?"?BNUU:&+X9>(?V=/V?\ 5=1\/^+;[QIXK\$>"_T
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M-X<^.?@_5_"*:[X!\+_&?XC6WP&\>07NJ:O9>) =]-]?3^O\S]-OV3_V'6^
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M,? /Q6TCPO\ LWWGCCX9>-=?\,_#/X617VJ^'_!%IXHT/XB:2T&M>&.+LO\
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M9^$OPY\ _%O7K[X9VOC[PQKY_P"%Z>,_B%XNTW7FO]-\&>(=(T"S6S?]M:*
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M#P/!XCLGT+PG%K_@?7]&U#XW>(_&D_@+X>>&OB7X*MM.\$:1=)X=&CQZ%XK
M/VKHKX/\#WG[;.D^ ?C:VKQV/C+XD2? +1O''P9M_'EKX!T7P_:?M$ZPGQKM
MM2^$-Y+\/VT)C\._#+>'/@A>2ZKKTMYK,TGCCQ1<)X\U*U%OH_@[PNP\5_\
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MU5HWQLE^)4NZYBUWX!ZW\$M-N-6L-,UCXJW7AZ?7./\ $_P8_;A\/?";XI?
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M4/&6G6%WX<T6QBC\&7#0Z1KORI\)_$?_  4P\0^"OV<=5N]'^)]];>)?%OP
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M!:Q=_$;QS\'$T>VBTQ;4?M O\/O <_PL\927>G:/\)_#'Q)\1>!O$L6H^-?
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MDDD_B22?<UXY_8?[0?\ T4_X-_\ AB?&W_T1=']A_M!_]%/^#?\ X8GQM_\
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M[)WX1_\ 3'95ZY7D?P"_Y(A\)/\ LG?A'_TQV5 'KE%%% !7->,_^1/\6?\
M8M:[_P"FNZKI:YKQG_R)_BS_ +%K7?\ TUW5 &;\,_\ DF_P^_[$CPI_Z8;"
MNWKB/AG_ ,DW^'W_ &)'A3_TPV%=O0 4444 %%%% !1110 4444 %%%% !7C
M.A_\G"_%#_LC/P'_ /4W_:.KV:O&=#_Y.%^*'_9&?@/_ .IO^T=0![-1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D?BS_DKOPA_[!?Q,
M_P#3=X<KURO(_%G_ "5WX0_]@OXF?^F[PY0!ZY1110 4444 >1ZC_P EX\(?
M]DC^(_\ ZF7PLKURO(]1_P"2\>$/^R1_$?\ ]3+X65ZY0 4444 %%%% !111
M0 4444 %%%% !7\Z?_!'G_E)A_P<"?\ 9W'P2_\ 41^)=?T65_.G_P $>?\
ME)A_P<"?]G<?!+_U$?B706O@J>D/_2C^BRBBB@@**** /Y^/VZO^4^W_  0D
M_P"Q"_X*7?\ K.=I7] ]?S@?\%E/&G_#(G[?G_!(S_@I7\2?#_B2^_92_9L\
M6_M._!W]H;QMX9T74=?F^$:?M._#C1_ASX%\?^(]+T>UU#5Y?!]GJ,NK7.JS
MV&GW-W-/I-GX:T:VU3Q?XK\)Z%JWZ(VG_!9;_@E)>VEK>1?\%#?V1(HKNWAN
M8X[SXX^!]/NXXYXUE1+JPU#5+6_L;E5<">SO;:WN[:4-#<P13(Z*%6;M;6RM
M\]6?>7Q2\*MX[^&OQ!\#KJT>@GQGX(\6^$QKLMFNHPZ(?$?A[4M'&KS:>UWI
MXOX=,-X+V2S_ +0L/M*0&$WEL',J_C#X<\1_\%"/$?@K1_B:W_!6C]DCPE\-
M/$'AM?&&C^/?B;_P2X\0?"C0+_PO>7W@NPT#Q%;Q_$K_ (*#>%M:E\/^*[CQ
M_P"&(O#>OQZ0^B7UYJ$&D3:C:ZY=6.F7?U=/_P %B/\ @E3+&43_ (**?L>1
M-U$B_'SX=ED."%90=;*EE8A@&!4D8964D'\X=6_:>_X):>$Y?#_Q!^%O_!47
M]DG5OC#X,^(?C?XD>$6UC]HSX$?"KX>:)XD^*.C>$_"GQ!U#2_#'A;X8?$+P
MSH]KKWA_P[K6KZUHMMX&N;?Q'\2OB+X^^)U[J.F^-M6TO6]%!<KZI_B?37E_
MM^&/6YA_P6G_ .">1B\->'=#\7^(Y1^P-IAC\/\ A+Q/::3?^&O%&N2#_@HY
MMTGPYXAL=>T*]T/7+\V^F:O:ZUI%QI]U<1:E9//!X>;_ (* ^*]5^(.B>'?^
M"RW[!FK:I\*4\_XBVEK_ ,$Z9B_A&P'@_P )>/Y=9U=G_P""AR)!X=M_!WCO
MPAKMUXE5GT"UMM>M(KC4H[M+FW@^=?A_\=?^"/G@#P%X"\+Z5_P5M_9^TOQ)
MX,\"> ?!MYXL\)_'7X.^$/\ A)/^$+\"?L=^ M134]+TR]-T/"_C31OV,_!>
ME>+/"']M26FJ^%O&?C;PC=7LND2Z*FDUH?C'_P $;=*\":G\/?#/_!7;X*:%
MH^M?!R;X$ZMJ9^.7[.6J^(+KX?ZU\ O@O^SQXTMHIK_0'T&RU/Q9X5_9V^#O
MB)]1M/#L1T/Q=H7B&?18;;P_XKN?#UB!RN^SMWLSZPTOP[_P49USQ!:>$M$_
MX+&_L$:SXKO[[Q)IECX8TG_@GI!J/B*]U+P:(3XOT^TT2S_X*+3:G<WOA47$
M!\26L-J\^A":(ZI':B1"?GSQ#\;?V\?!UEXUU/QI_P %2?@1X6TCX>)XSNO&
M&MW?_!'3XI:SH.A:7X/^(WQ2^$\.J:IKWA+]NSQ%HVEQ^-O'GP:\?>'OAYI6
MJWUCXC\6ZII^E:58Z(NL>)_#6G:MTOAK]J[_ ((Q>%OB_P"%_C!8_P#!3/\
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M%_B?\,/B!X?TS7-?OK#3-;M/"'B#Q/H]Q?>$](U#7+:E>?MI?\$AK[]FV/\
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M^"7FOK*(;N"2WD,1?_@H"T8D"2$H9%>,-@NK)N4]Q_P^,_X)3_\ 21']CO\
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M;-KOAGX[_!K2_A?X8\&ZM\=](TKQ+?>(S>VE[/XIT*Z2_L[73=1 D_X?&?\
M!*?_ *2(_L=_^']^'?\ \NZ\(^,W_!1?_@DK\:=6^%E_J_\ P4W_ &3] MOA
M9X\T?XBZ;%HGQC^",NM7'B/P]JNDZGI<FF^+]8.I>)O!L%]9V.K>#/%Q\':A
MHUWXO^'/C3QKX+U.[6QUP3VH+E?9G*QZM^WG';7;ZQ_P6D_X)Z>&M1TCPKX<
M\:>)]!U_]@WPY::SX.\.^+(?"TF@ZGXJ@M_^"E-W:Z3IVI2^-_!]I8:N]Y+H
MFJ7/BGPXFDZG?QZ]H\M\_P 7:I^WAX$M#?>+/^"TO_!/[1K=3\/3)]H_X)Z(
M\T%M\6/$WA_P=\-]4N;:#_@HG+<VNA>,?$GBKP[INB^(+B*+0Y_[6M;U]0BT
M[S;R/Y1\!?'3_@E+X<\<>!;'4O\ @J#^R+'\%_@=I5I#\)M"/[1GP6\4>*];
M\17/[0?[*G[3>M^(_$MY/\/_  I-X3MYOB7^RSI1?P]!XF^(T<NF^.=2B\,Z
MM\/M.\'>"M"TON]-^/'_  1UTK4]$U6W_P""NWP;N9?!WA/P%X8^']GJO[1'
MP0U72?! ^'?B?]E[QMH9T+3[RVD2PT"7QA^R9X#\1ZCX.TN32M OM7\<?%_4
MKN&?4O%NB7OA$&HOJG]S/J*^\*_\%(-+;1TU/_@L-^P=IK^(3X>'A];_ /X)
MX1V;:Z?%QUE?"G]C"Y_X**1'5/\ A)V\.>(5\/&Q$XUIM!UH:;]I.EWP@J)X
M=_X*6WND> =>\._\%9?V-O&>C?%+Q1;^$/A[JO@G_@F=J'BK2O%NLM:Z_J>H
MIHFKZ/\ \%#+G2KZVT#0O"7B[Q!KUS!>NFGZ3X6UQSYEY:I9S?-%Y\;_ /@B
MYK>G>(=!\4?\%6?@+KWAO5?A'#\"="T=OCM^SUITG@KX7V/P^_:4^&6D:7H&
MKV6AKJEQX@TSPG^U#XWL!XJUV?5M0OO[#\,R7\4[R^+&\4>LQ?MU_P#!*W0?
M!WPVT?P;_P %2_V1M/\ &'P]^+7BSXO-XXU7XU?#?5[_ ,0^*_B#X+^)WP[\
M4Z]K-KJ7B/4A?ZS9Z#\5]8UO29M0N+V&_P#$7A[08M?%YIMUJPF!6?9_<R_X
M8UG_ (*!^-M!\*:[X/\ ^"O_ .Q+K[^,O"7PK\?Z1X<7_@FZVA^-H/ GQEU#
MPG8>!/%VM^"O%7_!170?$WA_2M3_ .$UT"98=9TRRU6>2\BT?3M-O_$EU8:)
M>:6AW?[>_BCQ+X/\'^%O^"T'[ 7BKQ+X_P#^$V7P5I/AC_@GFGB&?Q//\-[7
MPW?^/;+1Y='_ ."B=Y:WNI^$].\7^&]2UK28ISJ=GIFK6^HO:&R6>>+PK2/C
MC_P18T'2?!'AC3?^"JGP%/@_X;:U\(/%/@SP_>?'SX 7%Q8>*_@[I'P/\+Z/
MK.I>)K?1K/Q)KL&K^$_@+X:T?4M$U/4IM&MY_$GBC4=-M+4Z3\*[7X9>M_#+
M]M;_ ((]_"3Q3X*\4>#_ /@I]^S%;GP;X;LO!RZ+<?'+X*_V+J_A>R^%/PN^
M%JZ?=6MH+22RNO*^#/P^\10ZCI<UI+:WNGZCI,,0T'48["S L^S_ !#0?$'_
M  4*\0^,8_!-I_P5@_9AL-0OO$7BGP?X>UOQ%_P2,^*/A?P+XT\8^"?$:>$?
M%7@_P)\1/$7[<FF>!_&GBS2O$AN-*B\.>&]?U+6-:DTGQ'<>';/5[+PIXGN=
M'["[T_\ X*$6$WANWOO^"SG_  3[LKCQDNBOX0@N_P#@G_8VTWBM/$FK2:!X
M=?PU'-_P4:1]=37M=AFT316TL72ZIJ\,NFV)GO8W@7Q+Q/\ M/?\$A/%FAW/
MA74/^"N7P.M_"WA[7?'?CSX'Z/I_QU_9WAD^ /Q9\9ZMJ^NZ'\5?!&JW&A7>
MHZWXE^#NI^(/$"_!C2O&TWB+PAX;TO7=0T_Q1X=\;267AB]\.9>C_'7_ ((B
M>&]*^(N@^'?^"F/[-NE:)X_^'?[4?PKM--3X^_!*>/P)X%_:JU/P!KWB;PSX
M,N);7[;;:!X$\0>![[6_AWHFJW.JZ=I-YX\\9)J$&I0W>GI8 <K[/[F?0-_I
M_P#P4'TI-2EU3_@LY_P3ZTV/1_$>O>#M7DU#_@G_ &%FFE>+O"VG1ZQXG\*Z
MD]S_ ,%&HUL?$GAS2)H=5U[0[HQ:IH^G2Q7VH6MO;2)*=GP%X%_X*A?$VVUR
M]\#_ /!57]D/Q#8^']6L-(O=0TS_ ()AZU?Z7</K'A/PSX\T'4-(U:Q_X*#W
M.EZWHOB#P7XS\+>)M'U?2;R\L;O3M:ME,T=[#>6EM\X:!^T/_P $4O#EQK]W
M;_\ !2W]E;7[C5/#7Q(\$Z>WCOXW?"+QY'8>!_B!>:IJEEX-U&+Q/J-^-<\.
M>!M0\3>-8_"VFNUA"VF>-?$R:U_:FO:UK/B+5/>?@+_P4>_X)8_!FR\51:M_
MP5*_9@^)&K^(+OPG;1^*O&?[17@'5_%TWAWP/X!\,^"-%M_$OB";7(YO$VMW
MUYHNN>+M5U^]MDU*;4/%MUIEU=:I#I-IJ-R!ROL_N/4O^&>?^"N__23?]E'_
M ,5=^(?_ *8#1_PSS_P5W_Z2;_LH_P#BKOQ#_P#3 :ZS_A\9_P $I_\ I(C^
MQW_X?WX=_P#R[H_X?&?\$I_^DB/['?\ X?WX=_\ R[H'ROL<G_PSS_P5W_Z2
M;_LH_P#BKOQ#_P#3 :/^&>?^"N__ $DW_91_\5=^(?\ Z8#76?\ #XS_ ()3
M_P#21']CO_P_OP[_ /EW1_P^,_X)3_\ 21']CO\ \/[\._\ Y=T!ROL<G_PS
MS_P5W_Z2;_LH_P#BKOQ#_P#3 :/^&>?^"N__ $DW_91_\5=^(?\ Z8#76?\
M#XS_ ()3_P#21']CO_P_OP[_ /EW1_P^,_X)3_\ 21']CO\ \/[\._\ Y=T!
MROL<G_PSS_P5W_Z2;_LH_P#BKOQ#_P#3 :/^&>?^"N__ $DW_91_\5=^(?\
MZ8#76?\ #XS_ ()3_P#21']CO_P_OP[_ /EW1_P^,_X)3_\ 21']CO\ \/[\
M._\ Y=T!ROL<G_PSS_P5W_Z2;_LH_P#BKOQ#_P#3 :\/^,/PY_X*:?"_5?AA
MXF\;?\%-OV?[G6]<\3Z_X ^'^D>"O^"17Q+\=ZSKOB#4_ OB7Q_K5A'X?\(?
MMS:[JL@M/!'PQ\4ZY]I,%O!LTB2PBDNM5U#2M/NOIS_A\9_P2G_Z2(_L=_\
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M#J6JV>J^*KG6Y[[]H/XYR>,7UB31?#<6F1*GAM=!&G:D^[5#K&+'[2K\V?\
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M37WC10!\&?\ #J[_ ()@_P#2.']@S_Q$#]GO_P"=Y1_PZN_X)@_](X?V#/\
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M2K%!!"B10Q*D<:*BJHM44""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_002.jpg
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -D IX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\[^*WQ<^%_
MP)^'_B3XK_&GXA>#/A5\,O!]O:7?BGQ_\0/$>E>$O"'AZVO]2L]&L)=9\0:W
M=6>F6"WVK:CI^EV7VFYC-UJ-]:6, >YN88WR?$WQY^"?@OQ-\*/!GB_XM?#K
MPSXK^.]YJ>G?!;P[KGC#0=,U;XKW^C:7#KFJ6?P]LKR]AG\6W5EI%S;:E/!H
MBWL@L[FWG"E)XB\\R;LM7=1T5]9*3C'3K)1DU'=J,G%-1DXJ_P#Z3*7_ &["
MW/+_  PYHJ<MHN4>9Q<E?UJBOGF#]K3]F"[\7^%/A];?M!?!V7QSXZ^(?Q.^
M$G@SPDOQ"\,'Q#XJ^*/P5$?_  MSX>:!I(U(7NJ^,_ALTL2>-?#EE#-JOAUY
M8X]3M;=Y$5M;1OVEOV>_$/BKP_X&T+XU_##6/&/BOQA\6?A[X9\+Z=XUT"[U
M[7_'?P&N)+7XU>$-'TN"]>\U#Q'\*;F*2#X@:1;0R7OA65"FL0VC BFG?H]K
MK1NZ=K-6OH^9?^!+^:-QR2W:7JTNLEU?>,EZQDMXR2]PH&.WZ5X'K_[4_P"S
M7X3^&?Q"^-'BCX\_"7P]\(_A/XN\0^ ?B=\3-:\>>&]+\#> /''A3Q@OP]\2
M^$?%WB:]U&+2- \1Z'X[=/!VI:-J5U;W]KXFDCT66!=0EC@?N;_XM?"_2O%_
MP]^'^H_$'P=8^-_BUI?BG7/A?X3N?$6EQ>(/B%HO@BRT?4O&&K>#=*:Y^V>(
M]/\ #.G^(=#OM<O-*BNH--M-7TVXNI(XKVW=Q-MV2;>CTBWI*'M(O2^DJ=ZD
M7]JFG-7@G-+FC:_-&S<DG=6?+)0GK>WNSE&$M?=E*,7:347Z'17D7Q0^/OP2
M^"5[\/--^,/Q:^'GPPU#XM^.=(^&?PNL_'?BS1?"]S\0?B'KTT=OHG@GP?!K
M%Y:OX@\4ZK/)'%I^BZ8+F_NI'188&+ 'F_$?[5O[,W@[QWX_^&'BOX^_"'P[
M\1?A3\)-7^/?Q-\"ZSX_\,Z?XK^'WP3T!;=];^*WC'0KG48]1\.> =)CO+.3
M4/%&JV]KI%K%=6TTMTD<\3//-'75;S3U6]."G46^\(2C.:WA!J4E&+4G5G>U
MG>T9;=)S]G%[7M*I^[B[6E/W(MS]T^@:*^&H?^"FO_!/"Y^'6H?%VW_;<_9<
MF^%FD^-M(^&NI?$2/XV> '\&V/Q"U[0M2\4:+X*NO$2ZX=+B\3:OX<T;5M<T
M[1FN1?WFEZ;>WL$#P6TKKB>(/^"K/_!-#PHND-XF_;V_9*T!=?\ #FF>+]#.
MK_'GX=6!UCPKK4,]QI'B'3!<Z_&;[2=2@M;F>ROK;S+>XBMYGCD98W9;U3LT
MT[I6::=Y)RCHU?WHIRC_ #13E&\4VA)O51;7O.Z3>D)*$WHGI&<HPD[^[.2A
M)QDU%_H!^'_UO\]J*^<-/_;!_95U7Q7X5\#:;^T7\%KWQCXZ^(7Q!^$G@SPQ
M;?$CPI+KGBKXH_":UM+[XG?#SP_IJZG]JU;QGX"M-0L;CQ7X<LHYM5T2.\M3
M?VL'VB+?8\4?M<?LL^"/A_XL^*WC7]HSX(^#?ACX%^('B/X3^,OB#XL^)_@W
MPUX.\,_%'PCKM]X7\3?#G6?$>LZQ9:38^.=$\2Z9J&@7_A6:[77(=9L[C3?L
M)O(VAI.Z3<DTDTFVFK<SBE=M)*[J4TKO5S@DFYP4Y4DVDM7))Q2U<DU*5XI7
M<E:G-WBFK4YN]H3<?H?_ "*.HZ]>XKSGX4_%_P"%/QV\!Z)\4O@G\2_ GQ<^
M&WB4ZBF@>/OAMXLT/QMX/UF71]4O=#UF#3O$7AR^U'2;JYT?7-.U'1=7MH;E
MKC2]8T^_TN_BM[ZRN;>+RWX7?MH?LA?''Q'XS\'_  7_ &I/V>OBWXL^'6GW
M^K^//#7PT^,?P^\<Z]X/TC3+F*QU'6/$.D^&?$&IWVEZ1INH3)I>H:I=0)86
M6K;]+N;B*_BEMD&^6ZE[KC&4I)Z.,(I.4Y)V<8QBU*4G:,8M-NSN4KM)I-IR
M44TKWE)\L8*U[SE+W8Q5Y2E[J3EH?3%'?V]:^<?V?_VOOV6/VKH?%,_[,W[0
M_P &_CY#X(&A'QA-\(_B%X9\>Q>&/^$G35I/#?\ ;C^'-1U!=-_MR/0M9?2O
MM9C^W+I5^UOO%K*5X+5_^"BG[ ^@I\3Y=7_;0_9=L5^">L:9X>^,!D^.?PW=
MOAAKNLZ])X6TS1_':P^(I6\+ZC=^*89_#*6FL+:3+XBMY]$D1-4@EM$&TG9Z
M/EYK/1\EXI3L[/D;G%*5N6\HJ]Y132N[M)M*7*VDVE)WM%M77-[K]V_,[.T7
M9V^RQT']>OXT5\:>'_\ @HG^P5XJ^&7C#XT^'OVS?V8=6^$'P^UG1_#GCCXG
MVOQN^'9\ ^%?$/B*)9O#V@:WXL?Q FAZ?KFOH\7]B:3/>KJ&KO)'%IUM<RR(
MC>J:=^U'^S1J_P %)_VE-,_:%^"%]^SM:6=SJ%Y\>+;XJ^!I/@Y96-EJG]AW
MUU??$L:Y_P (;916.M;M&O6NM9B%GJZOIESY5\C0 >G,VFE%1<FTTHJ:O!R;
MLHJ:U@Y<JFM8.0];I6=Y-J*L[R<7:2BK7DXOXE%-Q^TD>[T5\V?#[]LC]DSX
MLZ?HVK_#']I;X%_$'2?$/ACXA^--%U7P=\4_!GB+3-0\)_"2_P##FF?%/Q##
M?Z7K%S:#2?AUJ'B_PK:>-;V29(?#4WB+1UUAK3^T+;S-WP1^T]^SK\2WL(_A
M_P#&WX8^,)=4^$ND?'O38O#_ (QT34IK[X(>(-4UK1- ^+EI%;W;R7'PWUW5
M?#FNV6C>,XE;P_JLVDWOV&_N$@=@I.RDWHH1E.=_=Y804N>4KVY8QY9<TI<J
MCRRYG%1DTKJZ75R44N\G:T5WD^:-HJ\GS1LG=7]VHKY6\>?MS?L7_"OP3\+_
M (E?$[]K']G+X<?#WXV:-:>(_A!XT\>_&;X?>#_#?Q-\.WUAI>J6_B#P-J_B
M'7].LO$^A#3-;T?4KC6-(FN].LM.U.POKRYM[6ZAE;V.Q^+_ ,*]4\9>&_AY
MIGQ&\%:EXY\8_#V]^+7A+PII_B72+W7O$WPOTW4_#NC7_P 0]!TVVNI;C5O!
MEIJOB[PMI\WB2Q2?24N_$.CP&ZWZA:B0OONK3=-W5O?4>9P_QJ*<G#2:BG)P
M44Y(NDD^CBII]XN2ASINR<>=J',FX\S45)R:B_1J0]#]#7R[X*_;=_8W^(_Q
M?US]GWP'^U3^SWXN^._AO7O%?A;7/@QH'Q?\!ZE\4M.\1^!+B_L_&^AS^ K?
M77\4OJG@ZZTK4H/%%G%I<DV@/97(U9+0Q-CG8/\ @H1^PM<^,_BA\.8/VO?V
M<[CQ[\$M*^)>N_&#P='\7/!+^(_ACHOP:DNHOBQJGCK2%U@WOABP^'$MC>)X
MUNM7AM8?#CVTZZH]L8G =]$[.TH\\79VE!:RG%[."5FY)N,4TVTFKMZ7O]EQ
M4EU3DTHIKHY-I13LY-I13;2/L7_/^?\ />BOE#PE^W?^Q-X]^%_CKXV^"_VN
M_P!FGQ1\(/A<UC'\3?B=HGQN^'&H>!?AS-J<D,6EP>//$]OXC?2?!\^JR7%L
MFE6_B&ZTZ;4S<VPL4G^TP;_:_AE\7/A7\:OA]H7Q9^$'Q'\#_%#X7^)[:_O/
M#OQ#\ ^*=%\6^"];M=)U"^TC5I=,\2Z'>WVD78TG5],U+2=56*[9]-U33=0T
MZ^6"\L[F&(;LI-W7*DY75N524I1<KVLI*,G%MI249--J,FE?;S;BO.4;<T5W
ME%RBI15W%RBFES*_HE%?+?PS_;@_8T^-%O\ $*[^#W[5_P"SE\5;?X3:)?>)
MOB;+\.?C1\._&R^ ?#.F17$U]XE\6#PWXBU)M#\.6T=G>^9KU^(-)\RQOHEO
M&DM+A(ND^ 7[5G[,_P"U3I/B#7OV:OCU\)?CQHGA/4++2O$VK?"7QYX=\>:=
MH.IZE9G4=/L=6N_#E_?P6-U?6'^F6L-PZ//;_O8PR88BUV3^%3>C^"3M&>WP
M2>D9_!)Z*3>@/3?2TN1WTM-*[@[VM-+7D?O6UY;:GT!1113&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?C;_ ,%4/A-^TQ^U!XT_8_\ V;_@A\(/ OQ(^&.F_%.X_:E_
M:0/QP\0^+O /P#\8>%_V?+OPV/AA\ ?&WC3PW\,/BTUW??$KXH>-](^(D'A:
M#P3XA>]TCX'ZH=9M['1[KSKG\L+3]B?]L+]HCP/_ ,$TOV<?C#\,O'/PQ^)/
M[#EY^WW\"-%_:*@TS5/%'@SX<>*_@EX2^']Y_P $]_VH/"?C:]TCPQJ/C7PY
M<-X3^%5UIWB;6= \.ZA\3->\+^/?#7BWP]ITNJ>(M"3^N'_/^?T_R:0GW[9(
M[X]CD8_STJ:?[I22M*3FZO.[J<:B514ZD'%64J,)J-.\9I<D7:TIPJ-3=]5&
M25*I22DKQ]G5BE6C)77-&J]9IN*:=M4E)?QG_#S]A;]L7]J35?V>-<^*7[/_
M (Z_9@^+=_\ M,?\%AOVC[#Q5K.BW&MZ%^RS^T;XY\8_ CXM?LM_$4ZW;8CU
MSPA_PN'P7++X;N(V%I\4_A_I?B'P_<K+I'B+4K:7V[]F[X<?M@^!+W]C;]M[
MXM?L9?&W1KSP%^W7_P %8_B5^T#\!/ ^DZ=XP^,/PXT/]M?5/$-WX,\5>%?"
MDVJ:/=_%'P+I'BBWATR[O_!LFH:_?>&]:TWQ9H^A:I817\</]80Q@=/_ -7X
MGI]3]:/UX]L'KQWZ?Y]K=2;C!>XN2$8JT%:_/3<Y)7]WGA3]ERJ3C&"I<MY4
M82E$XQFDI1O&/,E[SOR-UY1@Y63ER3K*HI-*3E!\WNUJL3^5.+]E7]MWXK?#
MOX(_ \?LI^'/^$1^-7[??[=W_!3GX^_"K]IWQKK/@'X=6GPLUSX]^+_%'[,O
M[.7QG\?_  E\$_'W0XOB5XQ\0?&+PE\<M1^'>A:3XN?3F^"5QHOB6[T@QZBM
M)\$;;]K[]G_6?^"36J_M'_LP_M(_$#6/^"?/AS_@HE^Q_P#%+Q+\$_A;XI^+
MD?BSPWI&E_ OP-^S1\5O"D]KINA:YXP\$?%7X7^&=$GL_'&I:%H>HZQXFT7Q
M?_;>C:3JMCJ-G:_U78Z=>/?^=(/PQVQ_G]?TI0FX)J*C_P N]6KO]U0IX6F[
MKE3E'#4XT7*2;LY27*VZ9,H1G&,)7Y8N;2BVK>TK2Q%1+XK1E6E&=E9KDA%N
M5G(_#3_@K/\ LL?$3]NQOV%O"/@3P7XML;#4]<_:AUK4/&.HZ!>VDGP"\7>*
M?V!OVA-/^ _Q$\;0EDF\+:OX)_: U/X:3Z:EVP,'C6RTS391)(QC;\Q8OV9?
MVQ/C4O[6G[67Q*_98^)7@WX\_MR?\$G_ /@KC8>,?AW<>';JYU3P+X]\5R?L
M>?!']D_]FB6ZMV)_X2G7_A'^SZ?&.@>'B\%]>ZUXF\;WJ1B\EOY*_L&I,<YS
MTZ>WK]<_IVK)THN%>$7*,:SQ#LI7Y%B:4J-51VYFZ2HP<Y+F:H4U[MYI]$*T
MX^RO:3I1I*[33E['$4L5"]F[)5J;FH1:2=6<E>2@X_RE_%GPQ^TIXX_8\_8:
MM=,E_P""HOBGQC^SO^WY^SAXX\=>*O%_[)'P"T#]H+X-^ _#O[,OQ:\->(=1
M^!/PXT#]FS0OAM\0/ O@_P 2ZI:Z9::[\1OAE\4-2CU;Q.UGJFK:]Y6DK:_I
M)XV\)?%;XJ?&7_@BI\3=/\/?M ^-=&^&7Q@_:"\1?%_QQ\:OAOH/@#XH>'+#
M6/V&?VE/AKI'BOXW>#_!/A/P-X/\!ZOXI\;>(-$T>&ST7PAX9T235-?TRUTS
M2;)+VWMJ_9#L/?'?\>N?3J>_7GI0#QGI]1C'YG_/Z#6I+VLY3E%1<L3'$OEN
MUSKVG.KR<GR3<V]U)<JYYUG[RQI^Y"G3C\-/#5<,FDDW3JI)-\L8+F@DTK+D
M:;2A25T_Y"=6_P""='[1WQM^/UCI-S\./'WPLN;3]OG_ (+4?'7X3?';5O"=
MW)I/P9^(OB;7O@/X_P#V+/C^LQ^6?0=4^)/@2TU;0K=B+/QYX=TOQ+X6N5ET
MG5M1MYKOP(^!7[9NFVG[-W[9/Q>_8S^+VG7?@C]L3_@K?\3?BK\ _#%AX/\
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MS[\4O@;I?CS4/B]^S_XQ^'?C#Q5X:UG0?"GQDO\ QSX1U6^\5W-RO@NT\6>
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M+O[9VD?M2^/_  GHG@?X3? WX)Z3^WUK_P =Q\7OAIXY\2ZU;:Y\0?%OQ/\
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M;XO_ /!*;]O7PA\&_P!O#]G'X?:C\*/CQ\,/VI/V?/V0;WP+)X TH_LJ:1X
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MAO0+CXA>)]"O-<&E6U]XB6 ?!'[1W_!)C]L7Q9HO[0'CKX2:!X+M_B7\7?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOGO]K3]H+3/V4/V8OC_^TUK7AR_\8:3\ O@_\0OB]J?A32[ZVTS4_$5A\/\
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M#^DZMK$BO;V4K1TOAOX@_P""8WQ#_;Z_:/\ V(H/^";7[*_A_3?V<?AGJGQ
M\0?M"ZM\#/V=HOA[XCOO!MK\&+CQ_P"&M+T\^"$U*T'P]'QKT+3/$/B'4+J/
M2K36]$\2Z(BK=Z/?"V(3Y8U9KK_:-2=:6CI3C@H4L76YYNT94L'77/*;E"HI
M1E)S=*2>L8R2A#V3E"-*BN117+.A5Q;=*FXP5W&>,HT^6,$IQ<6HQC&<9+Y!
M_P"":/[./Q_^ OQVTSX+?MQ?L<27?AK]OWX)>+/BS\?O$_B5?#'[0WPL\;_M
M]?"SXK>*/CCXB^(?C#3=%TO7?"7PEU3XC_#_ .-^H>%]%A\;I:G5T_9M\ Z)
MX9N;S6M*OI+CYOM/V:F^&W_!/+_@@==7'P0T'X1:IHNK7/B+]H_7O%_[!'CC
M]IK2O#NOW/[#_P >/"FD^(/V@_V<_AWIOASQSXZUC4_$>L:5X5T35/$FHV&H
M>'_%&N:/XIFO;B/1I[2Z^Q_AG^TK_P $P/B+^R;XJ_:]A_X))? GPK\.OAC\
M9_A5X;^.N@Z_^SU^SN/&GPO_ &9?C3X6\ _$CX:_MEWOAS2O &HWOB/X47OP
MJ^*OP_\ BEK^D:=%#KGAKPDWC^XG>[O/AOK5G/\ H3^RQ\&O^"<_[5H^-'B_
MX=?\$\OV28?@]X ^,'BGX.?#KXPO^S[\#+O1OCY?_#AX/#_Q/\;> [:S^'P2
M7X>^&?B?;^*/AGHGB@:MJ5MXTUKP3XEUC1XX_#XT;4-7N6THQI^R4/J?-%*4
M53I8>56OAJ#B[.-J&.AAXJ7O-8/V?)[;"XNEA\XR]G-SDY2E+ZW3E=1<9UZU
M-8?$3C%.4;^TH.ORQ3@E6A4C-4*N&G4_#']L3]F'QO\ $OXM?'WXLZ9\&=%\
M<_LX>%/@-_P1$UCQOXC\!_L4?$CP1^T3<_"'PU\4_B/J/Q$\;_\ !/>2]N+^
M]_9P\8?"7PQ GBOXE?!J7P!\0O&NF_#>6W\$1>(/AMXN\.Z7JNL^C>-?A-^T
M)\3M,^-W[&V@_LE_$7XN^ ?VA_\ @MA^U_\ M+_'_P ):]&_PD\#?$?]E#]G
M[6?@YXOL/#&H?$3QMIEEX?BTCXU_&/6OA3#X>GM;V0>/O!W@_P")%AH<UU:V
M>J7VF_=_PBN/V-OVB_\ AKO2_@?_ ,$6/@M<?$7]E/XK_#7X>VGPT^-GP+_9
MR^ GC+XBZ7\2O!'A+XBV_P 0&T[Q5X!U&\^&5A)X*\4VWBO2/#7CJUL?'>I:
M+)I4/B/P]X-\3WVH>%]$]W_85^$G[!G[:_P*NOC3>?\ !,3]DCX4V$/Q3^+/
MPQTK3)O@Y^SK\1M%\5Q_!SQWK?PTUCQOX1\7^&_ -KI.O>#=7\6^&_$UEX;U
M6"V2+5;#2QJ]@]QI>I6-U<9P3C3E2DN:FU#%.,TX.5/%5?;TKQ;5Z;G*DN11
MC*$8RISC'F;I6YN"DK\L^:-!24DW3J8>BXR24&Y*I[.56:J.;3E*-2#;BG5_
M,'X2_%/XL?#S5?\ @C'XC_:T^%'Q^\-^)/V"/'W[?7[*'[0/B>+X'?&#XKWE
ML_@;X!6_PR^#'Q%DU#X8>!?%][XVT7XP^!;[X>:U!\2?#FG77A/Q3XIU;Q(F
MFWS)I5^MK]+^%M&M/ /_  5MT?XL_ 3X87_[2-I^U]\4_#_CKXTZO\9OV _C
MMX,^*_[(.@O^QQ<:'H'Q?^#W[>_C_P  >&? -O\ !W5O#/A[PU\-M1_9[UF]
MN_$FG>+_ !_XY\#^!+VP\1S?%#PGI7O_ ,5O!W[$7P-_:9^#7P5^(O\ P2)^
M .@_"?X^?%6V^ WPL_:/LO@[^R#K'A_6_BC<_"/Q3\9;6RO/ACH]M=_$_0O
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M5/\ @GW\'?C_ .%OC7X5^#,'PV_8+LOV@=8\)_#KXQ-\?/AA^SYXQ_: N_\
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M !+_ &=OVM/%'Q0\'VG[-%AKW[1LMI^PEL\;_P##-WQJ^%WQ+LO$6L>"+O\
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M\3.2M%7Q2K+$596^&$FI)S3LG*G&&CA3/,/CY^SM^T#\:OVAOB=\=;/]D_\
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MY%3LK6=G3C&%OY(QC\,8I?F!I?\ P2<_91F_::^)W[17Q ^'?@'XD0^)[/\
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M4I)+1.4FDN9W****904444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!\7>*_#?@7X2_".TL+7XE>._$$T_AOP-X$U?4-%U>ST[QSPW_P $R(/#NO\
M@K75^-,]T?!__!47XS?\%*S:GX>PP?VI=?%WX<_&/X??\*=DF7QE*;>+PY%\
M6VU*+X@^5<SZF/#T5@?!NGIJ1N=/\)\/_P#!#WX8Z7\&OVH/@_JOQI\4ZW8_
M&/XG_"7Q-\"KRX\%Z$^E_LP_"']FWXSZ[^T)^S5^SAI/A35M4US1_B1\*_AC
M\4O&_P 2#J]KK9T*X\9^!/&UQX05/#EUI&D>);<:25KRTC%MI7YFOJW,E&Z?
M,OK&*E3YGR?[%*#E!XNG*)=-)VL[NT6[\J;KJ[FHM6Y:-!U++FY<7#E4WAJD
M7])ZG_P4M^%FH_&S]E3P=X"U'PYJ'P>^./AS]LW5?BK\1?B _BGX2>)?@/JW
M[('A_P  :QXI\._$7X?_ !*\/>%?$OP\UK39/%NICQ[HGQ3TOP9K?@W3]+MM
M0OM.6UO5EKJ;#_@JU^P)??#3QY\7G_:!LM&\ ?#5_A!/XRUCQ7\/?BSX+O=+
M\._'_P =:3\-O@M\1+7PWXN\!Z+XIU[X/?$KQGK=EIOA/XU>'M%U7X2:I:+J
M.NQ>-!X>T;6=5L/EMO\ @B_\/?$NB>!O#GCSQIX!T;08/ '[=7P_^,?A[]G?
MX#6?P(T#XF6G[<GPH^'?P9\2Z[X?M;OXE?$W5/!7B3P7X+^'6F0V>N^)M:^*
M>K^([HV9O[^PL=)L[ ^(_M1_\$HOVBO%OP>\8^*6^/NM_M'_ +4=]8_\$_OV
M?_AOXJ\/_#[X7?!&T^&_[.?[.W[=_P $OV@_&_C*7PUXE\5:YX&\:_%^#2O#
M.N?$;Q9KNL7EAX8\37G@[2_"_P /?A)X>AU.?POKUQ5-U*<9.48RG",IQ2E;
MVE7#QD[RY$U!SFDI1A#V*G6J58RI<E3&;G&%6:O)Q7-"#OJH4ZLFN6,9.\G%
M-M2E)U/9TJ5)JLY4_P!$M"_;Y_8(MM \1_&OPGXFD_MOQO\ %F;X)>,=)\)_
MLZ_&BX_:2\5_&+X<^!E\1S>!?%/P&T/X3R_M)ZSXD\"?"M8O%\L&L?#JX'AC
MX6/;^,&GL? TT&JO[C\1?VR_V8?A7\ _"7[4GC?XQ>&--_9\\=R_"Y/"'Q8T
MZ+6/%'A+7HOC1K.@:!\,M2LKSPIINMS'1/%.I^)M"CM]>EMXM%TZVU!-3UC4
M-.TV&YO(/S5\<?\ !&F3XF:AK7Q@^(_[0'ACXA?M7>(/VC=>_:!UKXB>,_V>
M+'4O@'JEKJ_[/_@G]F:P^%-]^SA8?%32-5'@GPY\,OAOX)U#2-<T_P"-^G?$
M<_$/1&\47GC:ZT74;[PA+Z?^V'^Q'\0]2_80_9R_97_9GT_2-,\1?"?]H7]@
M[7EUSX=>%_AI\.M&\%>'/@M^TM\)/B%\2?BMX3^''BO4T\ 6%MX2TGPWXB^(
M.F_#*.;78]0DLXO"FEZ=XBGN8;2\SNK0;;4W6PL&DG)0ISJ4(XB:=TI*E&I5
ME%MTU"4)1DI4E[66LK)OE^%4\3)N6C<X4ZTZ,=$W><J5*GHIRG&<914*C5)>
MXR_\%3_V#X/"WA7Q==?'&:SL_&7Q+\=?!?1/#]_\*OC38?$2/XQ_#C3].U;Q
MC\)=?^%-W\.H?B?X0^)^FZ5K&D:E:> ?%OA#0_%FO6&LZ3=^'])U2#5+&2YY
M&R_X**?\$T/AWK_[06N:'\2_!'AG6O#.B?%7XK_&?QAX5^#?Q!@M_B?8_LX6
M2Z-\:O%/A/QQX<^&[Z7^T[K7P-T[33I/Q+3X3:U\4?$/PWM-,ET[Q+;:1%IT
ML$'"?"K_ ()>:QX/^/?PG_:;^(/[1<GQ*^,/A?\ :J^/G[6'Q3O[7X2:9X(\
M*>/O%7QE_9.L/V//#O@[P+X:M/&VN77PK\(?#/X8>&_"3Z?+J^N_%#Q/XHU'
M3-7EUWQ!YVOFXTW#^"'_  2+\/?"[Q3\"-&\9?'#5?BM^S/^R2W[0Q_9=_9^
MUCX;>']'N_"\'[2OA[QIX'\9Z7\9/B4FL:K>?&K1/"_P[^(WCKP%X TZ+PG\
M/C!HGB%K[Q_<_$3Q+I^GZ];I?!>UJO)-VYFJ?-[.+5-U5%U+.HE9JDXSBY*2
M@\/3E7M>SYFI.?LU.%K1BYRBI3;E&#:@FHOD:E-.-U5BY*K.C2^E?C/^WM\)
M? OQ"\ _"KP/X_\ A9KWC[6OB]^R;X+\:Z5XJOOBM::;I?@S]KC5?B-I_P ,
M+OPAXG^''PC^)WAC7_B3XRA^&'BG4/!O@_Q%J_@_PR-,M;+6_B%XZ^'_ (=\
M1^$M7\0>"7?_  5Z_9PU[]J+X,?!?X7>-O!GBWX6^)_#'[8/B?XS?&[7#XQ\
M%>"OA_H_[*&B>'KW6O%7@GQEXK\,:-\/OBM\-X]9F\9Z!XO^)G@?Q3KW@3PQ
MJ/@W4M/F\0OJ5O>VL'FWP4_X(RZ9\'_A%\*?AS<_M(>(_B!XJ^&_[;W[._[6
M=Y\4O%GP[TH^)_%G@;]E3P-X5^$/P)^ %Y%9>*H/LNF>#/@QX"\&>#F\=2WV
MIW6I^(;3Q/X^N_"IUCQAJEJG%Z!_P0WLTT'X<_![QW^U=XO\9?LP?!CX$_MK
M?LO_  E^%ME\*?"GA7Q_X<^!_P"V?X8A\+:QI^N?&"VU[5%\4?$#X<Z;;V>G
M>&/&DOP^TW2-3TC2=(CUOP5/KPUSQ+K]/D7,XN;7[V4%.*CS*5&<J4)N$G:<
M)RHTYQC>G4K4J[56G0E2E+.S:492Y=:4)3IJ]TJ]*->K3C-:QG3A6J051QG3
MHU:$)0J5XU8K[Y/_  4V_8H3X=:K\3;KXNZMIFCZ7X\\"?#)O">M_![XXZ#\
M9]8\=?%.P;5_A=X?\(_L]ZS\-;'X\^-Y_BAH<5YXC^&EWX/^&^NZ=X_\+:3K
MGBCP?>:UX?T'6=1L&_L:_MQ^'/VI?V?OB]^T?J%KHV@?#GX<?'3]J?P#I6N^
M'9M=\0VFO_"_]GOXH^,O!VC?$0V1TB+71J'BGPIX7B\37OARTTJXO;&\O)-*
MM8+FYB6)OCGPS_P1YU#PCX3\*ZCX5^-WPD\!?M"?"_X[_"#XY_#'XT?##]D7
MP]X+T74]2^#_ ("^+?PMT_1?CY\.W^+&MWGQAMO%'@+X[_%C3]=G\-_$'X26
M>AZUXI.N_#72/ !@NK#4/ICX3?L ^*OA?^QS^T=^R]'^U-\3$\=?M#>//VJO
MB3=_M,> M T?X7?%'P1XQ_:C\>^,OB%J?B3PK:>';^YTG2/$/A'7/&%S+IVK
M>'7\-EI+:.\T&V\)W2V<E@3Y8JLX-SDH)4E)*-Y>UI/F3W<G2=7G4E%4Y1=*
M#JN<:L6KOV2=H7J0=5I\W)#EJJ<;**O&,O9\DHWE53YY0IN$J<^SE_X*8_L:
MP^#V\73?$/QQ%.OQ4B^"1^&DO[/7[1\?[0C?%2;P)_PM&#P;%^S"_P )!^T;
M/J5S\, WQ)MYHOA8]A<?#Q9/&T-V_AA&U0>T?&_]JWX%?LZ^'_ 7B'XJ>)]?
MT[_A:>MCPW\-O"WA/X:?%+XI?$WQWKG_  C6J^,[S3?"?PA^%?@OQI\5-?FT
M3PEH>M>)O$YTWP=<1^$] TK4=6\2OI5A9W$\?Y-:S_P1*O\ 6/A?\=_ LOQZ
M^$T/B#X__$;X8_$G4?&"?LIWCR?!3Q+\/_@9>_!!O&/[,!D_:(;QO\'OBQ;V
MMQ%XJ\"?%F^^(WC?Q3X2U6;Q!IWB4?$;0_$VH6"_:O[9_P"P-=_M8_LX?#[]
MGRT^+.G>'[SP-;:?96GQP^*'PR'QE^.N@WUAX,O?!L/Q;^$_Q$L?'GPLUKX3
M_M*6*7MQKFD?&G2;C588-5N]6@UKP/XAT+6+[1I4_AT3D_:TE):6=)P7M7%R
MLKQFG:4U:T[*G)4VYN-G)*3Y8N-9MM-N+C)>Q<E%.ZG&33A33E^[NY0=6*AZ
MOKO[?G[(OAKXXZ7^SCK_ ,8].TOXM:GXA\%>"SI-WX7\=+X6T3XB?$G1;;Q%
M\-_A5XP^)X\,-\+O OQ@^(NA7NGZKX!^$/C/QGH/Q+\:6.J:5<>&?"NJQZKI
MYNN2M/\ @IM^PS?>(?B)X8M/CYI$FH?#'PO\8O&6N7O_  B'Q&3PQXCT+]GN
M&YF^.C_"3QG)X.7P=\=M4^#WV2YA^)7AWX(Z[\0?$7@R^@DT_7]*L;X?9Z^=
M[O\ X)43_P#"<^([#2OVG?'4'[-'Q,_:7^ ?[8_QH^"VM>!_"_B3XB?$/]H;
M]GF#X*W7A_6(?V@;R]@U3PWX$^(/B_\ 9Z^%/CWXL^%$\!ZOXDUKQ)I6OP>!
M?B!\./#?B6]T&+RE/^"+(/@K2/@U>_M3>);WX"_!GP#^V'X3_9)^'K?"OP]!
MKWP?UG]L+X<?$[X6:_KWQ/\ '\/B9+_XYZ?\+?!OQ>\=:%\,= M=(^%ER=/U
M<3^/]?\ '7B#3]+\0V$RNHSY/>FH5G3CJHRG&%5TE*^L.:HJ481]_P!K"<IU
MJF&E#E=4_9N5-5)2A!RH^T:M*4(2E2]K:T4IRC&55R:LJ<H1]E'$*21^D7[.
M'[;W[+W[6NH^*-(^ 'Q03QSJ?@_PYX$\9ZO97/@[X@>"I[KP-\3K'4]0^'OC
M_P ,)X_\*^%CXV^'OC*#1-:C\/\ C[P9_;_@_4;[1]6TN#6FU+3;VTA^K3C(
M/<9QS^=?!7[/O[#T'P)^.&A?&>/XE2>)CHG["G[-7[$Z>&CX/CT2.6#]G;Q5
M\4_$T?Q&354\2:D;=_%I^)C6+^#UTUX="71$N8_$>K'4&@L_O3;_ /6QQ_>_
MEGBMJBC&I-4I.I34ZL83DN5RA&OB(4IV:3C[6A##5G%ZPE7G!N\&EA3E5<(N
MI!0FX492BFGR3G0HSJTVT[2]E6E6I*2TFJ<9QTDFW4444C8**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEX9^)&FZFOAK6[7P=;5O"_\ P5;_ &R]?\&Z+)H'[*'P6^,?Q6^/O[!NC?\
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M ,%3_B1XC\;?L2W-_H?PKA_9E_:7;3? -[^U9#X"_:,T_P '>,OVG]1^.?Q
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M=I1]K*HZ7O-)R4?@G*,(J,82ERQ;A=GL%%%%2= 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%GCQ=,TCXH?#/7?"/A3X)_$KXJ?$OXI:;XWTV#X7^!/&.L:3XLTKP[]-3?\
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MJ\9_$WQ'XR^(7B/XCWV@GQKX9TJ>_P#$YTNST_XL?$VZN[#4-3UW3[S1OO/
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M=TFG:QIMVT-Y#^E%% 'QK^T5^R?X]^//C'2/%?A;]N;]LK]F&PTOPU;>'I_
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M[<M_^$E;Q*/$S2CPYX?&CG1Q%J8U3ZEHH _+9?\ @F_\8E55'_!7;_@J20H
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M*D?^#_\ 81_^@,KZI_:4_9T\8?M P^#HO"?[6W[4'[*[>%)==EOY_P!FN_\
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M;CP!I'Q(\!>,-*N/ NEZ?JMOXBTWPZW0/^"BGAKQA\'_ (Y?$3PY:^"KW7O
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M?_*ZC_A57PO_ .B;^ O_  C_  ]_\KJ ]WM+[U_D?C1_Q$M?\$1O^CX])_\
M#%?M/_\ SDZ/^(EK_@B-_P!'QZ3_ .&*_:?_ /G)U^R__"JOA?\ ]$W\!?\
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M_P#YR=?LO_PJKX7_ /1-_ 7_ (1_A[_Y74?\*J^%_P#T3?P%_P"$?X>_^5U
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MC\:/^(EK_@B-_P!'QZ3_ .&*_:?_ /G)T?\ $2U_P1&_Z/CTG_PQ7[3_ /\
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M*4)QC^U0'^/K@^W^?RH['/Z#U_ _R/\ 2OYD_C5^UO\ \%.+#X&_\$H/C_\
M#O\ :H^ 'A'2_P#@HSXH_85^!NN> ]>_8ZN/&-U\,_B%^T9^SYJ?Q%\=_%BU
M\6Q_M$>&5\6Z'%XI\+ZG)I/PT3PUX5:TT[7+:R_X3ECHK3:MU?Q,_P""HW[4
MO[(GB?\ X*.>!?BK+\/?VF?&?[)GP[_X)K^"?@=9^&_ K_ VS^+7[1W[:FH^
M-? ]Y?>(;5_%OQ /A?P;<>+;;P]XAFT1/$&I3:'X;T/7+"PUR\U#4+-X[E"<
M9.#2=3VU;#PIQM*=2M0K0P\H4TM)2E5JT(4TY1=25>DE;]XZ6$:M.I"$XS3A
M4A1J*3O%1A7C*4)5'**Y8QC3K2J.S4(T:C?,N15/Z0<CU'UR,_Y_SB@Y[ 9/
M&>,_7IS_ )XK\7_CS\2O^"K?[&G[''[37[3'CCQ7^S9^V/\ %?PE\)=.\3>
M/V?_ (%_LJ_%WX<Z5X&^(-QKOA33/$E['X@?]HSXI>-_C-\*/A]H&I>*O&6J
MZ0GA/P!\0?$^E>%L6.M>&Y=2>QTWZ-_X)J_M"WG[3'P*O_B7+^VM^SG^W%87
MOBB>#3OB%^SS\&-9^ MOX*!TVQN[GX=?$/X=^)?C+\8/$FC>,M)DNEOU@\3#
MP+XACT'5-*_M3PFLI35]1F^LTFG[.,)3Y;R2YW)15TKO6*]]I4FY0@JCJ24'
M;=E"36E2<H1Z-N$5*3UM;1IJ#?M&E*2IN$927Z)_R_S_ )_//:CCV/.>><9Z
M8],]OTK^4KXL?\%9_P#@H+HGA2ZU?X.^%OAK\3O&^A?\%F?VZ/V3X_AD/"$U
MEJGQ&_9A_9 \#?$/XLCX<^&;R#5;B2W^,WBKP9\-=8\/>'/%*VETNJ^+M1T:
MWDT5(I75OI+Q[_P6DO?A]9_\%*_V@-!T[1/C5^SI^SY^S)_P3A^-'[*/A[0+
M!O"^M_$+Q%^W5'XUT'PI9^)_%=W)=RV^A^)/&=U\-HKBXET5+[P=H[Z](;'4
M;V(VM."E4C&5-.?,K1A!<U24GAL'B81C3OS2=58ZA1I)?%B%4HMQ<%*;LK1?
M-&/,HN\I**CSXO$8/WY/2#4\+5JRYFK8=1JKF4N1?T1CIW_'K2U\.?LK^#O^
M"AND:RWBG]LCX^_LN^/=(\1^"8Y;OX0? /\ 9N^('PX7X8?$>2XT&<6OA_XP
M^,OVA_B+>?$?P38V"^)M-NSK_P +_"&NZQJ4VAZW9W.@6=K?>'K[[CIO1VNF
M[7;BU))WE%KF6C:Y;WBY1:<7&33T47=7UL[--IQNFDT[22DM]I1C);.*>@44
M44%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7\\'_!(+_E)?_P %_P#_ +.W^!__ *KWQM7]#]?SP?\ !(+_ )27
M_P#!?_\ [.W^!_\ ZKWQM07'X9_X5_Z4C^A^BBB@@**** /Y^OVZ_P#E/K_P
M0C_[$+_@I=_ZSC8U_0+7\_7[=?\ RGU_X(1_]B%_P4N_]9QL:_H%H*EM'_"O
MSD%%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2?A^''Y>E
M?,W[9W[0G_#)_P"R3^TM^TR-$A\2S_ ;X&_$[XL6'ARYN7LK7Q#JO@?P=J_B
M'1]"N[V-7DL;36-4L+33KN^17:RM[F6Z",8@I_"+X!_MN_M9^/OV9?V[-(T+
M]J#]H'XO_P#!0.Q_8?M_VB/V?_@AXN_82\)? ;3-#UGQ=X:\<0>!?B=^R7X9
MU;X=GQ?\<O@KK_Q%;1?!_AYOC8?&?B2UU#PM _C'3+%O$=YI$6;GI5=FU1@I
MRLKMW7-&,8J[<G",ZCTY80A*4FDT-0;]F[Q2J5%23D^6*=X1<I2?NQ@I3IQN
M]Y348ZII_P!.P&<$]<>_UZ'_ /71U[?4'_/^17\L6C_M>_MH^*?V)/VU]'^
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M^(=0L$TNUL/E7_@G3XU_;Z_;_P#AU\'?^"A'BW]L"T^"'P7^,'B[4_'7@?\
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M-OPZ\8_#?P]\,;O49O$GAJ30[C5]'\3V<T_CAH_$#V<NC,K>&;]M0,MIY?\
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MPO\ ',7B'7+.]L?"OQ7^*-_XW^%-@?!&@:1\._[ T'0KG2O%NG6]P\^/H/\
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M*7M8IIIQ2DH-2B]4U/FBGK&?)4<)-1O*_1112*"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_G@_X)!?\ *2__ (+_ /\ V=O\#_\ U7OC:OZ'
MZ_G@_P""07_*2_\ X+__ /9V_P #_P#U7OC:@N/PS_PK_P!*1_0_11100%%%
M% '\_7[=?_*?7_@A'_V(7_!2[_UG&QK^@6OY^OVZ_P#E/K_P0C_[$+_@I=_Z
MSC8U_0+05+:/^%?G(****"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#]H+1O"?Q(\7>--1^#^N:]\16N_AG/XATRZTC0?'EM;RZ-8V)UK2O$EUJ/\
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M /9V_P #_P#U7OC:OZ'Z_G@_X)!?\I+_ /@O_P#]G;_ _P#]5[XVH+C\,_\
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M?'7X;#4Y=1A_X1/XM?#J6^G\%>-M/_LZ]LC+JGA^74[Y[.&]-WISFX<75E<
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MY)7?-"R=N65[QM=M<K5FV]]1])KI--5%TFG:ZFMI)V5U)-.R5K*Q\7?M'?\
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MPEXAUG3WL;_Q7X-@O9KF\@\'>*)]8\,07-Y>W$6DI+>7;S?:=(,=AW/X^_\
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M;:E$ES<W6C>*O$5G<#6!J<,S:K=7<D;7OEW"87[3'[ _[&O[8][X;U7]IO\
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M_P"T=J7A"YT^/Q-X9@TCP_::9XK6XU6^TFY\,^)_GSQ/^V/\5/C_ /!'P_\
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M_@"V_8_^(>G6NJ^'[_P9I_Q NO%_@F[OM-^&%E;>(FLL?6O#_P"Q5!XRT_\
M:(^)6IZ9XR\'?$V'XDI:ZE_PS/!'\/M'A^(X?X:?$(?M*_$/PA\'S+X<;0],
MN_$/PKU^T_:.\4>#-)T"RN?&.F?%+2=6\7^&3K?A?ZD\7ZO^RUXP^*5_\'/B
M-\/]+U+QQX^M_"GA%IOB+\!/&%IX,^)4OPPM?$_Q?\"^"_#7Q8\7> +;X8_$
M77_AS#?>/?B1X4\(>%_&FN^(/!]Q:?$'Q3I&EZ==Z#XMO-/N#7(HS2G-J2?+
M>-I)4)M:7O+EA6J-)WY:T(1YX0C4DMIR;M[/V;Y;)J7M&ZD8S:=_W<&X0<7\
M<J3<G%N27PW\>OVJOV@O%?P&^/\ :V/AW1?@;X@^%_[.?@WQEXY37=8\;>$?
MB'J>K?%?XC?&+X;:1K/PUU$2>&==^&EEI^D_")_B'X"_X2G0]=\3_$:^\9:7
M\+=5L/A+XC\,ZYX@N?T@^/GC/XE>!OA[+X@^%_A1?%.L0ZYH4&MRKH&K>-;O
MPKX-N+Y1XH\;6/PW\/:QX=\4?%"[\-Z:KW:_#_PCK^G>+]>A,P\+P:_KMM8>
M%M=77_V:/V<_%EMH%GXH^ _P=\1V?A30XO#'AFUUSX;^#]5M= \-VURM[;:!
MI%O?:1/%8:-:WRK?VNFVR16=M?JM]!#'=*LU>@^-_A]X%^)6A2>&/B'X.\,^
M-_#DMS!>2:'XKT33M>TIKNV\P07)L=3M[FV\^))9HUE\O>(9IH<^5-*CIJ7*
MU%J_/"5VK<RC'E?-:[2G;F<(VC#50DKQ<$OB3?PJ,DTK)IRDY*VK3<5:*E*\
MI>ZY1:34OS7TS]K7XM3>/_&VJ^'/B#\+/B?\,/B.G[%/AW]GJ\L? FK^'?!V
MA7G[3%EJ-U<_%'7O&">,M3U3Q/X7O-+MIM<\,^"Y[;0K[QMXAN_ /PUTWQ=X
M'N_$-[XLD]*\,_M.?&/QO\8;O]F;1K;X4Z'\4O!FI?&,>-OB1J.F>)]=\ ^(
M-%^$ND_LS:]:7/@'X>6OBOP_XC-]XFTW]J;P78^+XKSXAZI:?!SQ7X<\0^&[
MNY^(B:EX=U:_]^^+7@3]F+X>?#KXC_%#XG_"OX:1>!? GP5GL_'^H2_#/1M=
M:'X(_!ZWU'Q]9>$WT?3M"O\ 4-9\+^"7L=0U[PIX.L;&\ATS53)-X<TR+4KD
M>;T][^SI^S]JGA;PUX)U#X(_"F]\'^#M3U;6O"/AFZ^'WA:;0_"^LZ[/J%QX
M@U;0--DTMK72-3\0W&K:Q+K^H6$<%WKKZQJS:K-=_P!IWWGVK)Q?+[J]UWL^
M9)R<6_@7-&#4II-JJ[4Y2C"$)%3][6-XZ16RM>,(*5GUYN6VUX-RJ14IS<5^
M5S?M$_%37_V</VX]!T#7-1T_Q+\#OB5^U7!IEYXD\;^*M#^*7BB]UG]LWXMV
MWPMU3P9KEK+?7?A3]G[P]X;\.ZC\']#\9VD7B"2]\5^%/'/@/0_#?A72O@E)
M;>/OK6+]I7XOW/Q*O/V=X8/AG;_% ?''7OAM:_%&\\/^*A\.X_"FC?LX> _V
MC#J@^&Q\9Q:YJ_CN5/'UI\/K+P-;_%?2[;5M%\.>,/C3#X@LK;0+GX4'ZSO?
M@C\&M2C6+4/A1\.+Z)1X_14N_!?ARX01_%?Q99>/?BC$%DTY@8?B-XYTO2_&
MGCJ$_NO%GBW2],\1ZZM_K&G6=Y _Q/\ !3X.^-H-;MO&'PL^'OBB'Q)XDTWQ
MEX@37_!WA_5O[9\7:-X?M/"6D>*=3:]T^9KSQ'I7A6PLO#.G:W.SZG9:!:6^
MCV]U'I\26X223DY)OFY/=3:3<(.G>^KBI-J;45IRJ&L6Y)))2FWLX<L&K-QE
M*MSR<HOW9J,&X0O9\TN>3]R,'^8GA+]K_P")GBGXTZ[_ &)9Z;I7BCXC>&OV
M9O@5I&C^(/$/B3Q+\$O /Q)T/]H?_@I1X$^*WQ3T>PM)_#=SXD\/^*--_9]F
MD\#26@\#Z[\6!#\(O"^OZ_X4AN+;4?#_ #_P^_;'^.GABR^(?@O1?"5[\8?B
M/X0\??M>_$36=(T?1/BS\5E\?6'A/]K?XT?"CP-\$_ACXB\/6M[I?PKO-2C^
M'6NV<FN_$S49O"/P6N&\#^!)-$\6:7?:[XL\'?HK8>%OV9/&MG\7/ EG\+?
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MYMM2IVO)-N2H7CR>W<:EH4E4Y$XJ<HPHJK+65XJI.G4]U)6C5OI)+E^1]?\
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M_M9Y/$&K:SJFI:JUW>7]U-+YE;^$_P!G/XB:C\0?A3)\./A_XB;P'=>*=/\
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MI[7OC/S]7T7X06&C/*_PT\97'B6SM].^R=/^'7[+?Q2UOQ-HJ?"/X6^)M7^
MOQ)U?0=2BUGX7Z&X\'_$+Q[I_@;]H3Q'/HESJ^@I;S7/BFZ^('@[XC:_K&AR
MW%IJGC2>+5-1NYO%NAW#V';^)O@#\"_&5LUGXM^#7PM\46K>(]:\7M;:_P"
M?"VLP-XJ\26XM/$GB&2+4-+G1]9\168^Q:]J#!KK6;+-IJ<EU;%HCG.+G0JP
M5E.IAY4U-)\JG.BHJLDG%V55JM&FG%<L8TXS4:DVG2FER\R4^7$0J/E4=:=.
MK-NE9MI-Q_=NHVW=N4HN4(H_-W]D+]L'XK^+_#'P9\'6OA+Q!XZT7P;X._9_
M^&?Q.\2ZCX7^*?B+Q1<:SXJ_8T^%7[0.I?'+Q%\9M0MU^&_V2#5_B/X4\(:W
M\/=9O[WQOK\5_JOQ-A\:M</IG@/6_9/@[^U'\;_$NF?LO^+_ (RZ'\//ASX$
M_:#^&?PO\:1>)O#_ (6\9>+?#)^(GQCL;N^T?X S>,$\7VD?PXUWPPDOA2T\
M/_%/Q[X9D\'_ !Z\4>-+;X>^%="^'_C:PT+1_'/OW@GPI^RW?IJ'Q5\!_"CP
M(-1^$W_"5?"5?$'ASX/QKXOT.U^#:Z]\.-4\%>%[+2O#!\4:II_ARRL]?\(^
M%M(\,6=_!>:/>76C^$K>ZT_66M[ST.P^"?P2-]\/?%-G\(_AY;:O\-_#VCZ#
M\,M4D\ Z'8:Q\/O#FE:;>:=H6B^%/M.DP:AX0L]%TK5M4TO3-,L$TY]%L=7U
MC3+>"T@U+4;>?:HU*I.2BE&57G<7;W83J8BIRQM:+<HSI<K^&/(X)2IJ"EA"
M$H0C!R3Y:$:?VK^UIQP].4^9MM1YZ=7F3YI/VB=U/FE'S7]IWXXZK\)=(T;2
M? ]_I=Q\4?$&F>,_%?AWPE??#CQS\2Y?$'A7X=:59WGC"[DLO!.M^&H_!VB:
M=J.O^#M)U3XA^+=>L_#'A^^\3Z)IPLO$'B3Q!X=\/:I\S^ OVW?B=X],GQ'@
M\%^ ]*^#EK\<OV6_@P_A^2\U_4OB5J,?[4WP/_9E^(>E^)K?Q!%/:>%M.'P^
M\8_M'Z5I&H:1+H.H_P#"9^&M)U._M=2\):EIUE:^)/I'XL^+OV7O&7C[0OA1
M\3O!5G\8/&>@:KI*0Z-:? ;QO\<[#X::GXWMEL=.E\<Z_P"$_A_XU\,_""+Q
M+HMV9YKOX@:OX2L;_P )M/JU],_AJ.XO4W?"T/[.>J_#?Q;XM\'?#OPU>>!O
M#7Q \2WVOZ7X:^$=S=WUS\2_V4_$0^$+ZGI/@70_"UQXB\4>+_ASJWP&T7PE
M\.[GP[H6JZW<6/@#P5:_#\WMC9>%U,Q>DI--WG!Q;^%05U..Z=Y+2+3<8R3:
M;;:6SLYPC9I\LU**:4Y.5E"4;Z)QE*#O*S<;)I)J3^2_@'\>/BS\9_V@/V0?
M'/BFZ\.:!\/_ -H']AK]I'X^>$OAYX6U[Q+!<:)IVI_$3]A:]\'Z9\0M&U.^
MFT?QWXS\&^%_'\MM_P +#TS3?#MOH>I>+/&/A33/#EE8WAUSQ3W?[1W[57Q2
M^$OC7]HJU\(:'\,+_P '_LO_ +)O@?\ :S\76?BF^UZ/QCX]TC4M?_:-MO$_
M@#PVVFWEMIGA%Y/#WP+-SH_Q!U:S\36.D:_?P:3J/@[6+/5VU7PW]5^&?@E\
M#O /BO5?B3X/^$OPQ\&>-]6M?$<6L^.= \#^&= \47VG^*];L?%?BZUU#Q#8
M:9::G)9>)/$NF6/BCQ%;379M]7\16J:]JD<^K;[P^&:5\-OV:_C?K:_MJ:]X
M;L/&VC^+/A!\+$\'W'Q2^&]NH\+>$?A)XK^*_P 2?#'Q \.Z#XP\,P^-?#NI
M>)+CXE+XD=;^"UNGM_"W@+5K72--UG35F*4X1BG4E&,:4.:JVURJSG)RDY.*
MMRPJ.\VN90FVXQ3<%%)RER^\ZDVZ,$VW9RI*,%JVKIJ/-&,N5SBXQ<Y<LO.]
M#_::^.7B[Q+IGA73],^$_ABX^)?[0W[07P3^&FM:QI?BSQ#8^'=!_9LUWXMV
M_BGQEXKL;?Q3X6/C+QAXXA\%Z'HOA;X2Z%JO@YM$TS3O'?Q5O/B!X@L-/'PW
MTKD_"?[<7Q+\;_$7X3?"C3O"'PXTGQ+\7G^*6@6^O2ZQKVN^&/ OC']G3X@?
M&SX??%.#70G_  C]]KFD?&6]^%/]N_LG+:G0M9^('@?PS^T#XUUFPLK;X%7F
MD^+?I7X:W?[,/[4/PU9_#7PJ&N_#*^\0_P#"Q;73OBA^S=\0?A=HNM>)O&SW
MWC67XB>'=#^,WPW\%2:_J?B"[\2ZIKU]XV\/V-])<:KK>I37VK#4[Z\$GK$?
MP2^$-KI\.GZ7\+_ASI5M90_#R+3(;/P/X:AMM*'P?N4OOA$MA:1:=';VMM\*
M]0B2_P#A]9VZQ6OA&[#SZ!'I\DLK.-2BG"HGS13C-+]W/G47!Z2^":DIW3BK
MU(KFC"TX12?-[\9*TM8Z1E"SE&47=.\XN%E:]E&4N64KPD_%OV6?VDM;_:2M
M?$OB >%].\,:#X4\._"OPYXCTUK^2]\0^&OV@M3\(/XU^.'PNU9UV6DD/PFA
M\4_#SP;=W$4$%[!X^M_B)X?U6&"\\.-:P_/OQ\_:1_:!T'P_\<?#6CZWX-^"
M/Q7T#7?#VH_"+P_XC^%FO>.SXF^$=O\ &OP1\.]2^)>B>-6\=:1X)^)5MXDT
MOQCX<D\4^$]#TCPUXN^ NK^,]"\,>,K+5O[=\"^.O%'W)\%?A#H7P3\##P;H
MMW/JMQJ'BSX@?$'Q5XAO+'2=-O\ Q3X_^*GCKQ%\2O'_ (FO++0[+3]+M'UK
MQAXIUF]MK&TM1#IU@]GIL<DT=FDK\=K7PZ_9AM-6^*FFW_PO^%^K^)O'V@Z#
M#\9M TCX:Z3XN\7^+_!_Q.\3Z]H6CS?$'PWH.@:OXAUKP5XH\3:?XOFN;[7=
M/N/#;SZ1XUU_59XH-'\3:E:MZ34GRVO&4HI.*<N:E4:@KMQA*:G3BFY.-&48
MR4Y.<Y)Q;A.*;C?F4)/WI4X6JPBY/13G&,H3D_=YJL6UR)Q@OF[QQ^UAX[L?
MBC8?#CP1JOA7Q#IOBW6/B?\ !G3/'G_"G_B%I_ACP5\<_AC\#_'7Q5UR^D\2
M:QXXM/#GQ:TG3]9^&WBGPIKO@'P'):/X6U83Z+J_Q4F\5>$/%WANU\W^%G[9
M'QYO+3X(>!K_ ,-I\6?']O\  ']CWXK?%K4O#?PB^(=I-\0H_P!ISQ%XIT#6
M=3T'4?#<NK?#KX-+\+/#?@?Q!XZU/4?&NJZIH/Q4UF#4/!>@Z?\ ">SL)==M
M_P!"](^ _P #]!\70_$#1?@_\,=*\=V\R7-OXTL/ OABU\5V]XOAH>##>V_B
M"+3%U:&^E\'+'X4GO8KQ;NY\,PP:%/-+I<$-JF;IW[-W[/6D/X#?2O@;\)-,
M;X76MMI_PU:P^'GA.T_X0#3K+5QX@L-,\&_9]*C'AO3-.U]8];TW3='^R6.G
M:Q#;:G8V\%[;03Q*,;2O)\R<H2DFDM(RJ.RMI%-346EJXJ,6VZ5.<FU=.SY?
M=DHM:V<HPC=WU?*XMJZ^+F=HJI.*_/V^_;:_:.L_!LGCK_A$?@FVF77P#_:S
M_:0L-,#>.GNK/PW^Q_X]\+^$-3^']YJ']I1Q:AKGQOT[QSX?UG3/&]OI^GV'
MP1O-/UO2;WP1\;XY-.U5^P\3?MQ_$N'Q!\9;_P &?"JZU[P'\+-6^-'@_4/M
MO@?XD6,GAJZ^$/P,\1_%$?%/Q?\ $^2SA^&,_ACQ/X_T.P^%&D_"OP[/=>,'
MTOQ?X-^*8\9F'4=;\">&O;?"GQ"_8N\?^(M/^%/AW0?!-_\ VMHOQ7^$_A W
M_P &];T7X7^/]#\07$FO?&SX7?"GXC>(/ ^F_"CXJPZZ_@6^\0?$KP%\-O%7
MBB35+?P!KNN^(](GM?!6M7FDXT?BW]C+Q9K]AXSA^$6F>)O%/Q?\#_%G4;37
MK3]G'Q'KWBCXA_"GX4^%]"\(>//$A2S\"7FO^*?!5_X9\2>#_ 7A&06U_<?$
MS2/%7ACPQX L?$^DZK;05G*,YTI1IS:F\-44*EHRM5E24*=9M+WHQG[_ "I+
M63FKM1C+3FC'$<TH)4O;7=&3LW!5W4]BFW%J2H6IN2<FW#E:2<W'PCXJ_M*_
MM2VV@W_A'2-;^$WP^^)-CXH_X)H>.?\ A*=)\$Z]X[\.0> ?VR?VL+_X'^+?
MA)=Z!K_BS0[C6]1\,)X'UN&]^*EEJ'A:X\9>%O%$D'A[P'\)_%MCIWBRP^XO
MVA/BKK_PC^'%GK_AW3=&U;Q5XD^)'P:^$WA^7Q#+>6?A;2=>^-7Q9\&?"73_
M !+KRV1-]=Z7X;N_&*:ZOAJVU#2[SQ?>6%GX*L_$?AZ]U^WU_3^UU[X0?"7Q
M79Z]8^)OAGX"\067BSPUX4\'>);76?".A:A#KWA/P+JNMZ]X'\-ZQ'>V$HOM
M%\&:YXD\0ZUX4TNZ$EKX<UC6]5U+2(;.^OKF>3H_$7@SPCXP\,:CX*\6^%_#
MWBCP=J]BNF:IX5\0Z-IVM>'=2TU3&R6-_HVHVUSIUW:1M#$T=O/;R1(T43*H
M:-&7:HU-OV:4(^TE))ZM4W-R]FY)\UU34873=Y7G?F^+.'-[*C&;4IQA)5*D
M8I*I*4:2YE!I+24:DTI-)*:BHJ-T?D9J'[7OQ.^#6D_M?7FJ>(_#GC3XI>!O
MB_\ &KQMI7@NP\-_%#XB>$]<^&?[/?[-?[->J^,;/P[>V/B2UTO]G[P_J&M>
M+](O/$L_BG7?%&D?#3QYX_U;1[#1?BSK,=]J.K=HW[7'QP\+>,_C19:CK.A>
M+=+\9?MA?#_X"_ 73;#X(^-_$-Y\)/#VO?L,_#[]JWQ#?^*]'^&OB35O%WQ8
MAMM,C\6PZ?I5C9>'-3O/'>L*]]XT\-> +W3M*\"?<LO[*/[+T^F0Z+/^SI\#
M[C1X-0U[5(]+G^%?@>?3SJ?BK3=%T?Q3?RVDNB/!/=^)M,\.>';+Q%//')+K
MD/A_1%U1KLZ3IYM^FUSX"_ _Q.WB-_$?P@^&>N-XPL_"5AXJ;5?!'AN_/B*U
M\ WD.H>!(]9-SILAU%O!5_:VE]X2FNO,F\-W=E97.CR64UE:O"X\J@HM*4E&
MG%OX5:,*<))6<FN?D;3;<HMR:D^>2C44E&4;:MS<97O9RJU*D+I[\JFHM)I3
MC&,&N6"O^8?[0O[5W[0OB?\ 9Z_:;L--\,Z+\#?$_P */V-7^*OCJ;Q!J_C?
MPCX[O;_XF>*/VCOACX9U;X7ZG')X9U[X4RZ99? '4?BKX(NO%NCZUXH\63>-
M/"?P_P!3TOX8>(-&USQ(G[**<_E_];^8)Z_A7R]\8?A1^R5HWA/PE=_&#X+?
M"/5O"FC:I\/?@MX/M=:^$WA_Q79:*WQ?^(WA#X9^#/!NDZ4OA[5#I?AW6?'W
MB;PI;74$5M!H.ES&#Q#JK65MI4FHVGU'Q_GIQ4JUFDE?F7O6>JC3C"^ZLY2:
MFX17)3YG&+::L6^&U]%*]W>[<D[)V3:C:R;;;5D]FV5_/!_P2"_Y27_\%_\
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MOB7:?#:[UA/#&JGQKP?^S?\ M-71\4:UXR^ 4UA\/_%"_L@>*_BY^SCX7D^
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MCGQ#\3+T?&^]TS1?#-SX<^(WPY^'VGZ/\&?&'Q.M/$NKOX@TS0O!_CKP2?\
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M_@_XDR>-_%_Q0\)>+M.\(_"?6O%'A7Q[XN_9W\9_LX6\ESXJ\5^ ]<\1^*_
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M3W3;O4:2<DK>^XSY;=%1.$_93^)NMHK.ZIJG[9IZ*R4Z?-JN93M!-<\4R?\
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M/A9J'C?QI8:5J.K_ +8NLR:I8QZ VI1S_MFCXSCQE%&+K29K3RO!P^-6M_\
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MVRB>"]:T+6[*9!<VLUD);NXT&WBNC]EVK%/,8!"_EO'RGQ$_9E\,_$7Q]?\
MQ U+Q+XCT[4-0_X9D$MAIZZ4;%/^&8/CQKGQ[\+A#<V$USCQ-K^NSZ#XDW3-
MMT.&%M*^P:AYMX_Q?^W!\9?B[X>TO]HCX9Z])X7\->'?%'PWO[S]FN]L-*OK
ML>-=<\+Z%X#\0^*K3QMXZTKQZ->\%^)O#>MW/B6YU#PFWPJM_#^J_#-_"NN^
M%OB9K?B^\\4>#?#/5^+/VK?C!X4U#XK?"B35?!VN?&'P;\7M8T'PG?\ A7X3
M69T37OAIX?\ V=/A9\<O%>NZ_H7Q,_:D^%?A7PL? ^H_%/2=,UC5]3^-<4FL
M^'8K2/1O#HU*]U77_#2DU)5:\U\$U7G-[N5.%64ZEE;WJ<?:.44OA;=FTHK)
M4HW5!0BXQHT8)*5U&$ZM.%&%M7:52-.,9-N]1*'F]OXP?\$UOA7\9HO'=IXF
M\;^+8K/XC6/Q_P!'UI9/#OPT\27/AW3OVA9M)NO%.I_#:;QMX+\30> /'&F2
MZ+8Z9I_CC2K*?4[SPS/>:9J\%]JMAX,\0^#_ $_QK^P]\+_B)X(L/ASXTUCQ
M3K7@U/C%^TI\6]<TI;NUTV3Q&O[4'@3]I#X>>._!=YJ.FV]IJ.G:#8:!^TOX
ML_L/4-'NK'Q#;W>B:#/+JLA%Z+KXN\)_M\?M&_$+P=IWQ#\/>&?AS!H7CWXL
M_LV?!;P5X:T?PNFOZ[X7UCXW_L:_ /\ :PU#Q5XE\6^./CM\(O NO)<ZS\0_
M$'P3^'OA5[[P2^H^*_%7PZUDZ]XFU.+_ (5YXL^G/AO^T#^T4OQ.^$7AK]H+
MP?X6^%/A[XFCQ%X"\,0:9H^@>*;_ ,;?%[PQ%\;O$T^E:EJW@_X[>.H?A)>>
M+/A!\++'XS>&?"S:3\4_"GA_1X_%/P^\2_&Z_P#B+<>&]+&\H5*<YTFU&=*=
M2C-<S]V</:*<5)._-^[?)RN]W"47'1TW&K&I&GB(MM3@JT)J*^"K",.>2::2
ME&KRR4HM)>TYEI>?5^.OV-Y?BQHEGI?Q7^-_C[QKJ.F?#_Q_\,[/Q*_AOX;Z
M'J>L>%/'GB#X'^);V+QQHVC^$[?P1XMFU'4/@=86WCC1CX1TCP!X^T#QMXY\
M(ZKX%M/"&J6>@6%_X)?L7>!O@?\ $B?XGZ#XDU6YUK46^*5UJ.@V7AOP+X0\
M$6U[\5_#W[,GAO68?#/A7P7X9T.U\/:'HMC^RYX2/A[3_.U+4I)?$/B:]\4:
M[XFU>YBU1?)[3]I[XS:YXK\.3:=J7PNTO0OB!^U;\=_V3-'^&4_@[7M4^*/@
MG4/A3I'QDCT/XFZGK8^(^FZ?XM&LQ?">R^-NJ>!I/!?@=8/@1X^TNZTOQ7>W
M_AZT\0_$+Q'X8:KK_AO_ ()^?\$W+7Q1XXN?"7@?XS?\*%;]IGXP^![W5OA9
MK=KH?Q1^"_B_XA6&OZMX^TS7[[Q'X<\5?&7]HB3X2?#+XC_%*W\26GBSQ=KO
MQ2\2ZU8:WX3\3>+;/5]#SBFN:4+*52<(RU2<JDN5)275\O(_<34Y3A&#=24H
MH;BG&FT_<A*2NG94XQDKQE)QWE3E!1;NE%RGRQY7+[M\<_LVZEK/C;QUXX^&
MWQP^)WP/U#XJZ%HFA_$RU\"6/P\U:SUB[\/Z==:+H_Q!\.0^//!?BN/PG\5[
M3P\VF>$W\701ZCI.I^%?#_A[3M<\*:M?^&O"^JZ%S]Y^Q5\+8M+O?#OA>^U[
MP;X1'PW_ &2OA3X>\,:1-;WECX4\&_L=_$KQ3\1OAOIVDW>MPZEJMV=2;Q.W
MAO7;C5[_ %&YDT?2[*6TG@U1[J]GQ_%&I:A\(_''P>_9Z^ ^I^&/ EO\4W^+
M?BJ\\;_%&?QQ\7M%TW5/AWH?@F\'PP\,:)JGQ+\.:@OC;QI8>*;GX@V&FQ^,
M+?3['P-\,OBEKD'A>\OKZY\0:1\FZ7^V[^TKXS\.Z3XU\,#X#Z/H;P?L(:&]
MIJ/@WQSXF@\4ZU^V!^T+JO[/>I_$3PQX@L?B=X>A_P"%86%M+X8^,_PGT]M+
MO-5^(7A._B\-ZOXB\,-K5KXOTUT[\\73?O0DY0NTG'DY+VNVE&,VHPCJT^9\
MD8-LOF::>B<IJ"M:\IU*=6<%\*YI3I4JC<G=)14)34N6,OLVR_9*M_#'C^[^
M*/P]^*GC+P;XSU;7_B=>>(IO[(\):]H/B/PU\4?%VC>,M0\,ZMHNJ:,7,W@[
M6-*NKKX=Z_::C:7NA3Z_XA378/%&FZK=:6WF_@__ ()S?!KP)'K>G^$CI>@:
M7>>-O"OB_1;W1?A=\)=#\?:7:>&?C[X._:$B\':U\3=&\&6'C#QGX4B\1^"-
M$\+Z7#X@OIM8'A."*;Q7K'C+QK96'C&U\&\>?MH?M,>&_"?C?4-&E^!EUJOP
M;^#/_!0GXI^,KC5O WC9+7X@7_[%_P 9?#'@GP?H&A6EG\30WP_LOB#X6U:^
M_P"$SUR]N/'<WAWQ#';7^@:)J&GR/I47KS_M$?M 0?%Z+]G6_P#$7P;M?&.I
M?&.W\'V?Q:D^''BNU\(PZ#<_LXQ_&V/PA9_#V?XM3W^K?$S5-4LO$P\.W$GC
M^PTJ3X?>&_$&L7>BWFL^%Y4\11%I*DHJRG%*@M$W"$G./+T45.C*HE*SYH2=
MG*?+.9*$(R4FE&4GS:MQ<Y^TIOF2O><E.=/FL[1DE=1C>G]M?%CX9Z9\6?"M
MCX3U;4]2TFTL?B#\(_B''=:6MJUT^H_"#XL^"OBYH]@XO+>Y@^PZMJ_@BRTK
M52(A<C2[V\:SFM[P07$7SEKG[%7AG7)+_1)/B1X\M?A>_P 1?BS\9='^%\-I
MX0DTG1/BI\:+7XA2>,]:77Y?#<GB?6/#L/C+XG^-/BKX;\,:QJ=Y)HGQ)UI[
MM-;N?!>B^#O WA?Y4T7]N']H;Q%9>.?&-DOP1M_!7P;^'?P5\7^(8;?PGXPU
M6;XTMXG_ &J_VG/@#XR\5_#SQ)'\2;?3? _PX^(7@3X!Z'\4_@A>W6F_$RY@
MA^(6G-KFK^*M%TA9_$OOG[2JWWP]^-'@OX^>+M3O/''PAT9/@QX!O_ACIOQ.
M\6>!_$GPK\<^*/C#J'AGPO\ %_P1X)T+5+'PQ\;+_P"(>O\ C?PIX,\8>"?%
M\VE>([?P7\/=1L?A'_PL#Q'XKU_X1^.24%4C&$TI0JJ$>5WM*.*IM4]++6K"
M:4'+E<7*-W1GJGSJ#<T[2A!U5H_^7,VW?1VY)0FY)QDG&,O=FM'];S?"GP_>
M_!J?X(ZE=:I=>%[[X93?"O4+Y)K>UUFXT"Y\+/X3N[M;B.W:UM]4FTYY)EF2
MT:"&Z(=;?RU$5>&P_LC:7<:)KMAX@^(WBK6]:\2Z1^S5I6L^((]+\,Z3)/)^
MS'XZG\<^%]0M]+L],;3;.Z\374D=AXGBBC^Q?9HC+HEKI4C;4^5/@G\=OVC+
MU]#^&&L?%[X6P>(?%OQ0_P""FOB@?%WXC?#?7=4T72?"O[,'[7]]\+/"WPOT
M[PC9_&/PHUR;32/%#^(I-;NO'-I+X;^%_@!/"5GH&JWT^H?$CPQYQXS_ &IO
MBG^T_P#L1_MH^.FN?!/PBT3P=^Q=KNHZU\-+?3=;USXCZIJ/Q8_8+TGX]6GC
M[0/B+/XO\&P>&?"-MXB^)4W@KP@LWPUU*YU"?X/^-]2O?$MIK&N3^&_A??,Y
MS=9MN<I.<Y--R<E)U9R:2=VJDI)\L7S35HQE3E"HX<(*FJ7(O91I^SC"Z4>2
M471C"[:M&5-?:DN6#O)QFI1C]Z?L\_L9?"O]FSQ3XA\0?#_3?#$,.I6_B;3]
M$DA^%OPMT+QII&A^+/%D?C"_\-:Q\3_#/A'1_&_C/0]'O;73-+\-P^(=1FU!
M]&TG39_'.H^//%EG!XKC[&\^ 6H:9\2_%WQ'^&GQ7\8_#0?$W6O#GB'XK>$;
M#1O!/BCPOXN\0^'/#F@>"D\7Z</%GAS5=<\)^,]2\"^$/!?@G4;K2]8E\(S>
M'_"VGW8\$CQ7+>^*+GQ6?]JKQE9_LI?%KX_SZ=X/M_%_A/7-:TNX^'^HP:G9
M0?L^W5KJVA>&;_1_V@[_ /MAYK^;X4QZA<_%#XN^(/#G]@^&IO ,=S=^ -0\
M0>#XO#WQ-\6_/_Q;\:_&+Q]\:_AA^SIXQ\8?"OQ+HOA']J'X/OXT\0:'\+M:
M_P"$*\=:;XH_9]^/?Q9TSX2>,_!&I_%C6[6P\9^ ==^%?AGXG2I<Z]K%M_9/
MCOX'>,4\/6=WHS2>)YBK.G",5:FZ=&*BXN,86I62MS1E"%%4YI-N$^2$83J-
M*3IRO"I4D[\T:M5MM\TY1523W2:E*HY1NTI1<Y2DHQ<K?1_BK]A7PIXLT_7/
M"-Y\3?B#;_#*\\6?'OXD>'/A];V_@XVGA3XD_M':!\5-&^(.OP^()O#<GB37
M=$T_4OC/\1/&G@GPMKFH7EKX;\7^*+J66^U7PUH/P_\ "_@?#^('['GB+XG?
M%OXS1:SX^\2>'?@;\5_V3?V?_P!F[QAHVAMX3O+_ .(V@^#?&/[4E[\2-!OA
MK7AS4M1\%W6I>%/BOX<\.Q^+_#%Y9W5UH'B_QM:V=I9^*]'\$>,O!?DW[;GQ
M<\?O\2H-)^$^F_''7=5_9:\':1^T-)H/P7\(?$'Q-9_%'XN7&O)=>%_@#XIU
M;P';7FD6EOXO^"GACXM^$/$WA7X@PW6DZ;)\?O@Y\5[;1Y=5\)^&M3M.3\'?
MM.Z_HWQ+_:;^)OPQ\>?#3XG?"_Q%^VY^RAX/TWX:Z;8ZMKWQ&\:^$_VB/V2O
MV)+?2O%WP^\3KXXTO3-"CTK1_%]S\7=.\/#X>^)--\0>"O WQ NKG6],N-=N
M->^'RBU&*G#W8PLURQYFE3DO92:C"<I)N,XP]R3C[&,?>3IJ).SE[UI.<97=
MTFKJ\X[63UA)VE'6<FW&7/S?37B_]@[PEXUTSQ#X2U/XH_$1/AU>^)_VB_B%
MX5\%00^$/*\&?$G]J'PO\7O"_P 2?$D'B!_#;^(?$&DZ8GQT^)^M> _"FO7]
MUIGAS6_%VHMJ$VOZ/H?P]T;P+>^(W["GP\^)GQ5T+XJ:]XI\0IJ6A:E^SEK5
MM$=!^'VKZM97_P"S)\4=,^*O@C3?"WC'Q)X0UKQ5X'\'^+=>L63XH>%/"NI:
M9%XE*VU]HNH>%+V\\73>+OF7X3?ME_M6^/?!OP2\0>*? _P[\!Z!^T]<?L_)
M\./B_JVF^%=3\!>!IOBSX)^+GQ#U[3-3\.^"?VDO'&M>-;&[A\!> _A7\)?%
M>O:Q\'!XN^*/Q=T-)O"]S=:6? NJT]>_;1_:7CT'X]ZCH%_\!9T_9H^#?[2W
MQ&\1:V_@/QKJ.B?%S7/V??B9XV\+6UAX/6V^*]N?!6A:U8>#M4\(^.+B_O/&
M6H>"/BCH7B73=,'B?2]-4R59QDHMQC*#<;-J\7"FU/F:YD^2"<6[R;@HJFIT
MU&3&DTW:\4H032M'][4;A&"M&WM*L6_AC:?-[9TY7BOIO4_V#? ^O$1ZO\0?
M'CP:/KWQ[\4> KK3X/"-GK?@+Q)\<OVDO@[^UO9^)-*O;SPUJ>D:SK?PA^.W
MP<T;Q+\-#XE\/ZMHMQH\UOX>^(NA>/(+*ZN]6[OPI^RII^C_ !1TKXU^)OB'
MXJ\9?$RW\6:IXJUG5KO3O#>CZ1J$5S\,6^%NB^$M-T72M,C;1/"'A72;G5-=
MTBQ.H:EK,_BCQ!XAU/5M=U"'4(;*R\DTS]KOQ1JW[4_@?X:Z+:66L_!_XA?$
M+XN_"#3==O/"N@>&K^R\>?!+P%K?B#Q\FB:U<_''5_'WC-?#'C+PAXC\&:_+
M<?L[>$/!DG]IZ/>:/\0)8]+TB?XJ_)7[37P[\.^$=7_X*<:IX/BU6QUKP7^P
MS\.?&G@JWOO'WCYM#T+QO\1U_;)T_P 5ZW;Z?+KVH66CR>)T\/\ AZTUJ]TW
M2O/%KHFFRVL)N=+LC&J22G",59.+2:]Z45&6&PC48[:PQ%-7C)*I&,4VU*,E
MM!NIRQ4])J"C?9PKRE)NSUC:<6Y1<5)34MFF?I9!^R_X-3]FKP9^S/-XA\5_
MV#X \-?#+2/"WC:RFT6W\;Z+XD^#NJ^&?$_PW^(.G_:]&U+PM)XJ\*>-/!WA
MKQC86FK^&=8\)WNK:3!9:]X:UG0)[[1[O#\+_LJZ;I7Q/TOXS^)_B'XJ\9_$
MVW\:7/C#5]8N]-\-:-I.H6Z_"K4OA-H'@[3=$TK2XFT;PAX8TK6M<\2Z=:OJ
M.IZY/XN\1>(=1U'7;NPO[72=.^8_'/[4W[3'A7XIR?L^:1I?@;QIX^O?BQ>Z
M!I'CGPU\.M.L=(D\,Q_ '2?B_:^%?^$ ^(O[3WPYL=2\>W&J7'B74+9[+XP?
M:+WX8^"?%&HVOA.?4-$U?Q!8M\-_M:_M$7FD?$O6?B)I?P_^'6NZ%XN_9\^!
MWA/X.^%_!3?%?QV_Q^^,GP)_9Q^+^O>&[GQPWQS\!_"W7-+\.ZI\3/'?A/1=
M4&M^&_"]Y;6NE^*[[Q=<66BC2/&=07N\\&K1;2=WIRI4'RIZKXE0::7/)6?-
M%*H\G%2]I&232Y'43MIS5/;Q<FK72G'VU[N,'=WC*\#Z3_:+_8X^&G[1GC#P
M#X_\4P:"WB?P!X9\<^"K >*OAG\,/BIX>N_"WQ%OO!FI>((Y_#GQ-\*>)K&S
M\1:=?>!=$OO".OV#6RZ5=2:I;ZWIGB?0]4OM$G:W['_AFU\4V_BO0O&GB/1;
MU?'GQ:\5W=E#IWAVXTJX\/?&7PEH'A/Q5X'@M)=+4Z=I]B/"7AG4_#VK6,T6
MJZ;<:7)9S27VEW]U9/\ GKHO_!1;]H#Q'X%^/OC6WN/@/X?O?V</V;_'GQKU
M'P+KOAK4-2\3_%_Q#\)?VG_VS?@%XG\-:!<^$?CAXA\/>#]/\46_[-/@W3X=
M1\.ZW\9H/ OQ ^)>F00ZA\2=*DTK3M=]0\2?MM?M/6OAS]H[XIZ%\*_#%M\+
M/@_J/[7WA5=1\1V7@^.T\$ZA^S-XA\5^'?#WC'Q/JFF_M%S?$'Q=I/CI_ MU
MXBU?PT?@=\,O^$?\,?$CP9K$7BR7P_X-U'Q3\2%[+FC[-*+A4E*B[R2IOZPX
M0ES-.,5"JZSO4;:2E)N<.97KE;<7)).FZ;C=QNIJ/-!15W)R@H0:LK1M%W<H
M-1]^\9?\$]OA5XY\->%?#OB#7M7U9? WPP_9]^'7AA]?\.> O%NEPW'[.VM>
M)M7\,>(M<\*^+/#&M^&/$;^*K/Q;K_A?QKH^HZ6;*;PYJUY+X6E\*>*H='\5
M:1[-\&/V9O"'P5\1WOB3PS=6EI+J7PQ\$_#6X\.^&O!W@SP#X(LK?P=X^^,'
MQ&.KZ!X1\%Z+H^F:+/J^O?&?Q%'>VT0N!+;6&G7EY<ZCKMSK>M:K\P_$;X]_
M%3Q-^TKX4^&7@?XA>$/"7AOX??MI^ OA5XNAL?#UWK^H>(O#OB;]B+QS\<[W
MP7XQF'C72[6RO;G6Y](OM+,-G!);B\\&W[Z=J!LI(-?P/V=/VA?CK\6_"MQI
M7P^E^ G@C4/AW^S]\,_B#;> O%VE>.?+^(.O?$[3/B#<>'M2M_%/_">ZIJGP
M\^#">(?"S>!X_%\OA[XG^(;OQ?X7^)<2Z=Y?A6RTW7=%.I.%6LW*SYYRT7--
M/VDIS2BKOGESV4?>;<;147%QB,(QC&E%QC3BL/A4G*T%%1IJC3N[^["%*D^:
M3Y8PBW*;O*,_IWXE?LE^'OB+X@^),Y\>>,/#7@/XZ6_A"U^//PUT>V\+W&A?
M$NW\'VEMH4JC5M6T*^\0^%CX_P# UAHWPP^)KZ+J.[6?A]H.CV_A$^!/%\=_
MXSO_ &7X3_"[2OA)X>U_P]I&J:GJUMK_ ,3/BW\3[B?51:">VU3XN_$SQ7\3
M]7TVV%E;6T1TW2=4\67>FZ494DNSIUM;&]N;JZ,L\GPAX^^-_B[QO^S+INH:
MIXCU30OBEX*_;B_8?^%?Q2TK3O#9^%VM>$=;U7]L[]EJ37_ &K6OAKXJ?%WP
M]J=MKG@#QUIT6J7'A3XI>,?"GB7PMXL;1+R\N'DUS35\N'[=/[0?A/P1\-O&
M?C9/@EJ=K\:O@7\0_B9HUSIOA7QAX7\._!J7PE^T1^S+\$X_'/Q&UC4OB+KK
M>)OAEX5\*_M'O\6OBP;9/ LOAW1?AGX@MK+Q,NG:H-<T25=+V<9)IQB[)VA*
M/-%4DI.W-=S2I[1BG=24)).[/DCT4WB*C@[IQ>&A&=>HXJ^L834IVO4E9+EJ
M244?:/A3]D'P]X6U9=1'CKQ5JEMI_AW]K/PCX?L+JQT"'^R_#O[7'Q4^'_Q?
M\5V<]S::=$VJ7'@KQ+X%_LWP9?3QPSOX<U:2T\3CQ#K%FNNW'E7A3_@F[\'/
M!FOZUKVEW=A=WOB+PCIF@ZOKFN?"[X1ZO\0+;6])^ N@?L\P>(/"WQ.N/!:^
M-?"]M?>#_#6F:WK&@V6J3V\_BV&:YTV]T?P[JOB+PSK?V_X.'B?3]&@TOQUX
MM\+>+?%RF]N;G4/"_AJY\%6-Q9?:08!#X;O_ !AXVO8/L<=Q;VMS=G79XIY6
MCD\FV:41U^2'P;\0?M->-/B[\)HY/C+X(U#QU_:7_!8G0(/%'B[X<>)M:T'3
M?"7PS_;G^#7P_P#!NA-X"TGXL^'I]:?0%T>PLM#O9_&FE-H?P_D_X1>WCN]5
M \57&4E"-.I>RIQHN%2U[.BJ=2FXQMRSM&G&:DE;9)-U%!-0E*G%U(-1<<13
MJ*[2_?3J1E&HDE.*]^$6DDUJO=4)3M]SWG['W@^\@EMY/%_BP)+X/_8Y\'-M
M71-PL_V-/B[K_P 7_!MVA;2V'VOQCK'B"YTCQ;N5H$TJ"W.AQ:;>>9</TOB_
MP!\7/%W[,GQB^'OBS5_#'BCXI>._!7QYT72)=+BDT7PS:P^/+CQTOPU\(FZE
MM;2:>U\'^%M9\+^#-2\375E:7NOS:)=^)KVRMKK4I;>/XC\$?\% ?B#\5-1_
M9@UCP5I&A:=X1^-L_P &? 7Q CU3PEI-WIGPX^,'QN_9'7]J/2O">E>+]2^.
M_A#QKX\U7PYX9\3_  Y\4S6WA/X%:KX8U/PAJ.NZ1<^-=&\06>O:IX FT+XB
M_M$7W_!,W]BKXBI\:K&/XP>/-2_X)OOXS^)5]X,N[N?Q!I_QA^-O[/\ X9\4
MZ7K&DQ>.;*2;4=;LO&,^F>-]0_MB)?$UE)XDL[32O#DVO6T^A:5J3J_6*=5W
ME5K5</7=]74J5:\*\DTE;^-5J.44N>G4C[-.7+ 4+4)4JD5&,Z'LIQ@WK%4X
MQJTX23DTXQGAE3<>9\E2#5248^^?1/@[]C..&Z\%^+?B#\5O'OC7QQX4M/@%
M8Z?J&K0^#8DL-"^ M_XGU_1M"F.B>&M*@U34O$^O>,-6O/'WBH16DOB$:=X=
M72M,\.V^E>3=69/V+[*+[+8Z-\9OB7X?\.>#_%_QH^(_P=T;2;/P(ES\(?B7
M\=-'^)?A_P 2^,=!UJ?PI+J.O'P1I'Q>^(T/PC\-^*3JOACPK<>++V?Q9I7Q
M!BT'P!;>"?BO3/VG?C#^S!\#_B#\4WM?"/Q.\$S_ +0__!61/#OPW33-?T[Q
M\=9^"OQ#_;;^/.@A_B1>>+=1T>YL=6E^"VL^ SX8A^']HFE:7XC\-7MAKT)\
M(ZC8>*OIV3]H?]I;P=^S%^UE\7/B/X+\):=KWP9^#_BWXI_";Q;=:;X0TOPG
MXWCT;X2ZGXSVZWX'^'O[1OQVN;+1-*\1Z2;D:A+\4=(N=?\ "&O:5;6<-O>Z
M1J'B75ZJ-SG6FVI*52I4J\JM%U*DXU)IQO\ $GB%-7NW><XS<U5Y7R*ERTXW
M?*Z5&+^U)4H*%-I)72C&/(W9)+EA).$H1<>N_P#!-#X&ZYX=LO 4NL^++3X6
M^%O#OC[PU\,OAW]F\)>(=$^&6F>-OB?^S/\ '&RM=&3QWX;\7P^*M.\%_&/]
MFC2/&_AKPY\2K3QMX5>U\9>(O >N:%K'PZT[PUX4TCMA^Q!X.&B?"?P[::SH
M/A#2/AI\6-!^-+6WPJ^#_P */AA)=>.?#'BO0O$UC-X8N_#7AI+SP+8>(=,T
M"+X:_$EM-N=0USQ_\)]8\2^"-3UZUAURXOTX+XB?M1_%F?\ :9T_]GWX6:U\
M(;.TO?C-\,OAGJ_B3Q!X;U[QGJGA6Q\6?LF_M._M&:VDVDZ)\0/"UK=^*;B?
MX0_#Q?#\%]=Z39Z;X5\6:AK5]9>(#<:1$?DOXZ?M9?&/XF_LY?M1Z/J/BKX)
M?#N#X:?LSW2>.KR?2/%MGJ7Q%\9^*/CA^TE^S7J>H_#?4%^)%O)\,M.OM4^!
MD4_PXT754^)FL7/CKQYIGA#5]:EM_#\.K^,84I/EM?FDJ;BFVFHQQ'U>$FG%
MVY:DMN5RE[EHR4?W>3J12G:S2>);6GO25+VM:S5U^\@X^\VHOFD^9.3]I^J'
MQ-^!-QXV\=>'_B=X.^)GBWX3?$#1O!/BSX:7/B+PII/@G71JG@OQCJ?A[6;N
M.YTGQSX9\3:/_P )+X6U;PW;ZSX UNXL[O3=#U6^U5/$'ASQ?H&K:CX?NG_
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M+-XBU;PQIM]J%CHLOCUM \+:9K\MGI5Y:6>B6OUK^S9\#-7\(_&7]H+QY=?
M3P1\!OAQ\3_A;^SKX)\/_#WP_J?A74?MNI_#)_C;:>,[KQ%X=\&6Z^#=&MWL
M?&OAC0] ATB[U./6O".EZ/?:NVCZS+J?A3P\-22E*+BY*-9J+;2E.,::I-S3
M;<7K"\8RFXQNHJG32>C4$HO72,'96;NZDN?E3^&27O<K:C>\G.\V?5>M:)X
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MH/A_5;\^(O$8L[!KF^\1Z3X+L9]5\;_$'PCX5\4?.O[:'[+7B7]H*Z\>^"O
MNG?$+PF_[07P0C^ WQC^*&B?$3PGX;^'FH_"Y[WQ_:V^B^,O#ES:>(/B??\
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M;RA>=2RNO91C\-1N$;;24I)R;C=**3O*WOIQ;:BD](N[3]IM>/OK],+;X _
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MX)T7X(^&/#NBZ-\%?&WASQ*WA[2-6^)-II?QK^(GB[1H/$.J>+/%7@;6.5^
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MM]I>JZ;'J.CZDB)<6.H:>EY93QW-J'CPK?PM\.HO%>J_$BT\.^"HO&_]E_\
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M-I]G3O\ @I-\"M2\+:'XYL_#WQ&N_!5S\/OC[\4O&?B[3(OAUX@\+_"[P/\
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MCQ-3TWX$7?QD\*R:;XQ\/_&C4_@KIND7VF>1=MX@O?BG%I<]]:WO@N:XMO&
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MOC;6$B\$>)M;\4:=X7TW5O#\VJ^S^+/^"DG[.W@R_P#BQ;ZG_P )7?:?\*=
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M-\9M1LM4U;QSXRO-#\,2ZCX5G\1>%/ 4WB/2/$OQ4\2>!/ BZIXMTSF/%?\
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MZH? O@R 2:CKWB>RTQ[:]G^O++XH?#34_'NK_"O3?B%X'U#XG^'M$LO$VO\
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MWWMU]1V_^O\ _KI " !GOS[]:\?\)_'?X5^*M5\.>$D\=^"=*^)OB+X?:/\
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M%] \-^(;O2O$<_CC0VN5T[Q5X#ETJ'QCX2UN*ZT+Q+H>E:S97=C#V>M_M"_
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M_!8[2/&'@S3O$WP]_9A^,MCI_P =_@O\=OB[^PMXV^(FJ_"71_!/[4]I\!M
M'B?Q+ MCHWQ-U;QI\)WU7P:+KXJ>"[/XL:!X,D\8?#+1]5FDN_#?CA(O!382
MG"BJV(Y74]AAZDZD>55(^RC*GBY1<)6A)U'EGNPDU[2%/$12</;2A-.#G.C&
M#2D\115-N27[Y\U&G=IMJ,?KWO-*T>>E)VM#F\,^/'_!(?XQ>(?C%\:/B?\
M Z?X&>#?"$G[7W[.O[3OP3^#&D^+]=^$'AK6K3X<_L0^(_V3?'NE>+=8\/\
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M_P"']3AT6/X,ZI!KEY+JUI)'K5Y<Z3#9/%I/]HZA\P?$#_@LQ\%OAO\ $?\
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M:+:^-]!\4?LH?M'^$OC18>)OV0_#/PB^!FLW_P #)_%_QMG_ &YK_P =Z/\
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M\=7GQG^%GQ1^-WPZ\:V?Q(T/XO:Q\&]'\$0_"[X+_%/7OB'J=]X]EOO!>I^
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M^+2^']>^.O\ P51\/>#?VI&T'X1P_#C7/#O[#OQF_:3\82>"K#P3\/O$-O\
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MX=\6W'BU_C7XXL/V=-#TOX[^.-!TW5-/T?5++X?>&/%]WIWA+P9?^*]*\/\
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MT_8U_:,\>?'']J/_ (*.^%=7\9/XF^%'P?\ BW^S-IGP&TM_#^B:*WA?P/\
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M_ [51XP\3ZI)KG_"0:G-J)T/VX?^"J7[0'@G]F[]H'PQ\-?V<?BI^S9^V/\
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MD>+O&OP4\97-]\0?#'B[PK\./C%X;\)^,/%'@34_M]EIL/BC0_&?A#PI]:^
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M-TW4E\&>);(7#Z_H&I3S^8NK??L%_ *[^(/@3XIV5_\ 'SPYX_\ !'A#X9>
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M^J0ZC::DL=RUO93I_+'^UK\1_P!I[]I?]BS]M_X::'^T/^U5^TU^SAHG[/\
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MQ7X;\6"^N]1U#XH^#[&^T;7K#7(M>^'FHZ.UCX4U'0Y;0I%O7G_!+;]DC4_
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MN,X+]E/VB/V'/#'Q T7XH^*_A3I'@&V^.OC_ /9/C_8I@U;XV)\0?'7PCE^
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MTOQ(MGIZ^*+?6X+'2Q9_1+?LD_ +7_CYJO[2OAO5?B;X?^)%[XCT.\^(UO\
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M^^UWP9\./V0;_P#8;\+Z#K/CCQK<0VG[.^HZU\.O$;:"U]#KUMJL?B_3M?\
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MD8N4J,Y+2T:D%&$DK2522GI33B?I?X2_;^_89\?6WCFZ\#_M@_LT>,HOA?\
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M$_XS_%*ZU=-$^'7BG2_B'XD\1>.A?>-/%7CCQ'XFTK0O"VG^*-5\.VG-?\%
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M%N3DW'E32O*-*;M%)<\8RE"$N>:M!5/9O]YI']QM9_;Q_8E\._"WP!\<-?\
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M^)FC7<FJ^,+S1->C2]KP[2_^"*?Q@\%?#3]O/X<^!_C?\.Y[#_@H5\$_VO\
MX=_%MO%FB>*M1N?!GCKXE_'?]H3XH?LW^,/A[K+2WVH:7X,\-^"/VA/$/@WX
MP?">"+3?"E]XRT\?%GP0++Q1XE\?1^,XES6ERWC)T9M6Y9*%>-3#RC"+=E.$
MJ;Q$'6LJ<E!*-&%1JHFE!.FW+F7M*;GO&].2K1J<RU<90:HS5.+<VY/]YR1<
M'^Q^C_MO?L=ZY\.?B)\6M-_:I_9SOOAI\'=5M/#WQ=\?V'QJ^'&H^"?A?XCO
M9=/M[70/'?BJT\0R:'X8U>\N]3T^ST_3]7OK*YU&ZOK2WL8IYKFWC?RK6?\
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MO[0VG>#OA7\()/V@_@1J/PH_9S_9Y_X*-_LZ?!2\MO@[XLT#XIZSX?\ VY?
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M#Q==^"M.\,:+;Q:YX[^*OA/Q-\+O"JW/B2P&_P"/O!?_  2E^.?PE\1_!/\
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MKN@>"5\'_$[P%\=_#7C[X5Z_J:^%/&%CH"W?@]=-UO[L_:N_8MU_]HO]H/\
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M6O#GCSPIX4_9U_X)]_!+X_>!]6\?_MD_#_PWJ/B']@RPTJUT+Q_\/=!_9_\
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M,I_#^M:Q)X8TC4=4T[QEKOAG26^)WA*6#0&MM0M_SJ\-?\$B/CJ_PLU?P/\
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MZ3XQ^"_VK/VA/B%\7_VHOAG_ ,$\;_\ :_U?P]\"=3^ W@'PI\&?A!I_P/\
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M7PQ\0_#O2KI?">NZ1X:TCQ1HNO7O@N+1])O;>YNNQ_;=_P""H5Q^R5\;]/\
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M69\/6/QF^.?AW5/V:_BK/^SY\#/$/[5W@SQ)\<O"VE?$?Q%J^F^)?V-/ WQ
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M=S6;?X#:-^T%\:_V-=3^&?A+XE?L"ZI^W5\$=)\(?'KP_P#$_P 1>-++P_\
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M-CXEU_1O'7PRL];\5Z'XC;Q#?:Q^7/QH_P""K7[;X^&WPW\4?\+Z^+WA:_\
M!O['W_!2CQ'XS\5_L@_ +]G3QSX$^)WQH_8F_;.\/_LL_#O]HCXE6'QX^'?Q
M7N/ 7[+'BC2(M4\7_&"X\"^*?"0\+3ZXC:/XBTS1=*6^K^I+]H?]C/\ 9G_:
MKF\)WWQV^%NG^,-<\")K=OX-\7:=KWBWP)X[\.:7XI@M+;Q9X>TGQ_\ #SQ!
MX4\:VOA/QA;:?I]OXP\()KP\+^+(-.T^+Q%I&IQV-JL5%?V'OV3;<:+'8_ G
MP-I6F^&OV;O'G[(>@^'-%L[O1/!NE_LW?$R_\*ZIXZ^$UIX(T>]L?"*>'/$5
M]X*\-37<IT0ZQ"FG/;66I6MKJ&IPWN=13E!\MXM<SY5-KGF_K+53VSA*=.\:
ME"@J<:<Z=-P^LJG4E2A3JW2G"$DZD>=6C:].#48I4$XN#E%54YPJUFY3A*7-
M]7YX0JSG2\4^&7@+_@H1J_Q=^#?Q2^(/[2GPG;X+S^"_A5J7Q9^"/P^\%Z'?
M:'K'BN/]G_XC:'\3O^$#\>:AX.N/%[>$]>^/7B3X<?$/PG=7'C%;R/PGX'?2
M6FBM-:U+2=5_-?\ ;2_:L_;ZT;_@H%\9_@=^R=XX^//B/Q/\/_AQ^P!XN^"_
M[/O@W]G+X<?$']FKQ=?_ !C^-'QKT+]H>Y_:R^-^I_!Z^\7_  5\)_\ "L?A
M[IE_X-UM/VB/A'>/>:7XJG\':9XZU#3-0T2T_H&^&/PW\'?!_P"''@+X3?#O
M2IM"\ ?#+P;X:\ >"=#GU?6]>DT7PCX0T>ST#P[HYUGQ'J6K^(-4&FZ186EF
ME_K6J:CJ5RD(EO+VYG9Y6Q="^"WPR\-?%WXB?'71/"T=E\5OBMX1^''@3Q_X
MM74]:GE\1>%/A)>>/-0^'FD2Z3<ZE-H&GKX<N_B=XXFCO-)TK3]0U'^W7CUB
M[U".PTI++>;7UFG5II>QAB*]54Y0Y54A4J3JTJ4X1E-*";5.4.>:I4;TJ4[*
MG-8TTUAY0GK5EAZ%%2YK\LJ<(4ZE52Y8RE.4%*;E:$JE7EG4LW-2_*C0_P#@
MJ[\5/&NMV/@WP)^QYI]]XT^*/[8'[0W[&_[,</BO]HJR\,>$/BSXH_95\5_M
M*1?'7XG>._$>G?"'Q5K'PB^%OA3X=? 32=?TY[7P?\1_B'XH^(/C+7/A[H7P
M]N_#7@>U^*GC/E8O^"PGQ6\::UHO@CX,?L30^,/B;9? S]L7XI_%KP;X\_:5
M\._#>S^&WC']A7]H[2?V:_CE\,]/\6:7\+_B)HOCV+5_&%S?GX3^.-*.G:3X
MJFN?"<7C+3OAOHFK>*_$O@']&?$/[!W[)WBKX6R?!O6_A#I]QX#'QG\;?M$Z
M9;VOB;QQI?B?PI\<_B+XS\8_$#QE\5/ 7Q"TKQ/9?$/X=^-=7\3_ !"\<7":
MWX%\5>';G2]*\5ZYX9T=M/\ #&H7&CO\H>.?^".'[)7C[XN_"77M5\%>%]-_
M9V^$'[*?Q6_9G\/?LU>%]%\2>"M/,WQ8^*W@+XE>(O'1^)'@KQ[X<\0D>(+3
MPSXR\+?$SPOJ&F:G_P +@MOBAXNO/B#XBU>#5-?TGQ%SKVBI*+DO:NE"/M&K
MP598-)U903@Y0>+4IRHQE!U(2A:I0C&43HBZ/M'*:?LTZLE"\DW'ZS%TZ<9*
M_+-X6\%4G>-.HIN2JWIM>,7/_!;#1=8\*Z[\>?A[^SAKNO\ [)'PH\._L;Z[
M^T1\6_%7Q/T7P9\4/ !_;6^'WPE^*W@*+X>? ZS\+>+H/BI:?#SX>_'+X9:[
M\5[S4?BA\-[F"YUC4]$^&.F?%+5]"O;5O1]*_P""J.MW1_:_L/%?PC^$OP5\
M8_LX^-=)\'^!/A5^T!^T#X^^%'Q9^(=AXA^-NI?!3P9\1?&O@Z__ &6]4B\,
M_#/XM:C96>N_ KQ3^S[K/[6[?%N/6=)\(:%IUM\1+ZS\(W/UWXB_X)W_ +%/
MBCXC>$/BKJW[.O@!?%_@>Q^&NG:&FCV^J>&_!]Q:?!=P_P &%\4?#;PYJ6E_
M#CQS/\&V2%OA'=^-O"OB&\^&36]H? T^@?9+4PYFJ_\ !-_]C#7I?BC>^(/@
MXWB#7/B]JWA;6O%WC#7_ (B_%;7/'^G7W@;QW>_%#P.OPW^(>J^.;KQQ\&-/
M\%?$?4;[QUX.TCX.^(/ FD^%_%EW/KVA66GZE,UP>B4J;E+DA*,6ZJ@I24I1
M4IQ=.TK*+E&FFHJ2<::3A-XB4U4CA&ZC!2UDE2<G9\LG&+]HN7FNE*7Q2C).
MHW'V<</&$HU/RTO_ /@J;\7?'?Q*_9H^*7@GX3?%.\7PQ\&?^"P-I\8OV._A
M3<:EXVUCXQ_&S]BKQ5^SOX4\)Z#\.KSQ-\._A]X]\4-J5[J_B*[^'7]L_#/P
M%XZ:S\:2Z?K_ ,,+3Q9;OX7C_4;]GG]H?4_VQ?V1M9^)VD^/?AG\%_%VL6GQ
M%\)ZGXL^#'CN[^-.F_!#Q5X<O-4T>^FU*Y^/7P(^"&H:;\1? 301WOBSP#\7
MO@5H2>$?$=K<:/XBT/Q!HUN+S5KFC_\ !.?]C3P[!86_ASX,1>&_[+M?V@[7
M2[KP[X[^)VA:EI?_  U1=^$-1^/MYIFK:3XUL]4TW5_B+JG@3PMJU]KEG=P:
MSI&KZ9)JWAN_T74=2U6YONMMOV'OV6K/]G#QW^R5!\)[!?@'\4;;QE!\3?!S
M>)/&TNK?$6X^(E_<ZGX^UOQU\0I?$LGQ+\6^*_&E_>7-SXH\8Z_XOU#Q7KKS
M.-2UFX3"C.:7LY1A'FDX+DYG*"C4=2$ZK<HR=10D^?DO)SA%PI0M#GFJTYH-
M-I*I>>D9-TDJG(N5KV;G%2@G[JA4:E.=VH0?S-_P2S^,OQH^.7P]^/OC7QM\
M6_%_[07P'B_:*\1^'_V._P!H/XE^"?AAX"^(GQM^!>A>"? EGJWCV_TOX,>!
MOAG\-=;\"7'QD'Q/T?X3^/=#\!>%)_B%\/\ 2-(\7R:2VF:MHNJZGY+_ ,%9
M/CE^TM^S-)\(?BY\%OBM\<? 7A2Y\<?!GPAXLO#\-_V9_%W[$'@FRUOX^^ _
M"GC#Q%^U[K?B3P;KO[8NB:;XV\$^.KSPSX-U/]G#5;31_#FO^'K'5O&EUX9T
MRZOM<E^H?!7_  34_9H^&.J?!B;X;-\7_"7AGX*?%73OC%HO@"]^./Q3^)'@
M_P 0>*_#OPC\??!KP/I^N6WQA\4_$75]+\'> ?#WQ#U77/#'@WP)K'@[P^GB
M[1_"6MZM9:JGAK3[1?4OB_\ L/?LN?'[XG^$_B_\9?A7;?$3QGX*'A8Z#!XC
M\5>.KGP+]I\#>(-0\5>#-2USX41>)X/A7XLUGPGXBU6_UCPWKGBOP9K6L:)?
MSB?3;VW:&W\G1-1JT)J\H4ZE'VBG&FG4IT71YW.$?W<YXA1J^TC:,$W%2O#G
MYH2?)6C*UYTZW)RN7+"I5554XIRM.,*7-2DI7<KJ=K2<%'SC]N_]LW5?V/\
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MB_6];LOA==ZEXYT3X</K'A/3O$OFO_!33_@K*WP-_;.^!/[-_P ./VL?@?\
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M*_\ 2D?T/T444$!1110!_/U^W7_RGU_X(1_]B%_P4N_]9QL:_H%K^?K]NO\
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M^E6NI:EXH\4:7>7WQ C^%>G^$-5^$OQ@TOXFZC\0KCP+K?Q,L?"VG_"2_P#
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M<K+[.KLFN9MI.ST:3DT]U%-7;71*ZN_\G;WWVYZ=?\]Z/\_TKYU^/G[0.E?
M34?@6NOZ:UYHGQ=^,-]\+-2O;2#7-5UG1O+^"?QE^*6DW'AWPKX9T3Q!K_C?
MQ#KFO_"_2?!>E>$]&L3JFI7'B@3Z<+N]L[?2]0KS_M<?L]P67A#43\1K::R\
M9P75Q:3V7AWQAJ">&;?3O$\W@?5[GXH?8?#UR?@S:Z#XZM=0\">)+GXO)X)A
M\-^.='UWP9KKZ=XFT+6=+L7?:R;N[*VNK:27JVU9;NZZM)CTWT]UR_[=B[2D
M^R33NW9)*^JO;Z1.>W'^'M2U\4>"?VU/!>O7WQ@O/%&D>*?"?AOP+\:#\#?
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MH?*OC+]M;XC^"_%^L_!S4/ ^C7OQ/TWXK^*_!EMXC\)^"OCG\3/"-UX3\+_
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M?^&FLQ>/(WM_AU^UC\5?VG([#_A%9@^IV?Q*^#OQN^$UO\/_ +;+XJGEM)M
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M_@GAIWP7\1>![Z;QGX,^(7A[0K#X)ZOXFL/%_P ,O%C^(+OXG?!+X!_"_P"
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M=JNE7.K1>&H?A=X>\&?#CQ-X%\6^%;>]$VIKJ7C/5/CA\/?#,=EK9CTJ75_
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M'X>UOXX:PWPV\?:%H_QR^(>GZGK7C75_C-X4\1:P_AK6I_ ECI^B7GAK6OO
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MN_\ 6<;&OZ!:"I;1_P *_.04444$A1110 4444 %%%% !1110 4444 %%%%
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M?&3QO^T?XM^+OQO_ &E_VB_'/@71?A5>?&GX_:K\-6\0^&_A/H6IG7K/X9>
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MY91=TFU*:?-\.?LG?\%"OVP_B+8?\$GO$'QOL/V:;W2/^"F<7COQG+IWPI\
M_%+PKJ7PJ\!Z#^Q_XF_:"T+0$U+Q?\7_ !O;>(O%Z^--'M=(U?Q =+L-$N/#
M37%O8^'K75)(=6A^:_CE_P %J?CM\./&4/AR_P#$_P"Q?\ ?"B?MF_\ !2;]
MGW4OBQ^T+X>^+&H^!=,\$?L4Z-X#UKX;I?IX1^*&AZO'XZ^)DWB>_P! UC4-
M-M]:@.H2Z7-X6\ W][%_8&L?JE=?\$Q_@]:_ #]C/X&^"OBI\>/AEKG[ ]IX
M:M/V:/V@/!.N?#1OCAX2_L#X::K\(-1?6'\7_"OQ7\(?%UMXW^'VMZIX?\<:
M#XC^$6H>%];@NO-BT&QGM[22WY_P1_P24_9E\&ZE\&=8OO$'Q:^(.I_"K6_V
MP?%GBZZ^(OB#P=X@/[1OC']N;1XM$^/_ (I^/\4'@+38-;OM9LH530],^'T7
MPV\+Z-"(]-&@W>BVUII=OM4LY5^6RBW45!--+E;IRI.6K<>7DE3GS<TOWJER
MSA&:)I6BZ;K<TDX/VJ23Y96JQ?*G:,K\U*<-8QBZ<E)IN-_D'X8_\%;?VAM1
M_:L_9&^%7QQ_9O\ #_P8^%'[17[$/[-/Q6^(<^J76NS_ !$^ _[5G[5'CSX\
M>#_@]X%\77%U?V5B/A;X[UGX(P_##1X;_P 'Z/XTTGXO_$_X<>'/$%_9SZU-
MI%EZ9X[_ ."D?QG\/_\ !&#X(?\ !16#3?@?X9^,'Q3^&_[%OBKQ /&UCXJB
M^ _@B]_:7^*?P5\ >-_$&J6"^/='\46O@WP+I'Q-UOQ%"M_\0H9;2#1K>75M
M;GMHKJ2;TSPW_P $=/V<=(^&.M_"WQ!\3/VA?B'I&L_L/_"K]@FWU_QIXL^'
MA\8>'/A5\"OB)\2OB;\$_'GAG7?"OPM\+?V7\:_A/XB^(\1\%>.S:3VFGCX?
M_#W5KCP_>^*]*UKQ'XA]NOO^"=?P6O\ ]AOX3_L S>*_BB/@[\'=,_9NTKPU
MXE&J^"V^)&HVO[+GQ#^&WQ*\!#Q!J4G@1O!UXVM:W\+= L/&BV'@?2X-2T2\
MUFUT6+P]>7%GJ&GW7]E*I^YYHTW5PS]Y2THK'U*N)C)1?,Y1P;A1O!_O$Y1I
M.$H0G+"U90CLYQI8B,TG&TJJP;A0J1<TURSQ/O\ +-)P<8U*O.IU::_$#QO_
M ,%W_CEHFD^ ICXU_8$^'_AJ;Q;_ ,% /"TW[3/C*'XS^,?V:/VFT_9!TO\
M9FU?P!K7[-&H>$_&FC^)-.M?BO?_ !T\4_#R^ALIOCW#9>/?AGKUKX!U+XC)
M%#97_P"COA[]MO\ ;B_:+\?>%O@G^SW\#_@E\#_B_P"#?V,_V<OVI?VG]._:
MKU#XD:[;?#CXB_M*6OC9O!G[,&B>'OA[%X3\0KKFF77PP\=KXX^+.KSW,'@R
M"/18D^%GB77+C4M"T_[@^.W[%'P:_:-^(_@CXB?%!O$VIP^#/@1^TU^SA-X
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M9]G]S/T=HK\XO^'P?_!*G_I(K^QE_P")$_"__P":2C_A\'_P2I_Z2*_L9?\
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M^YGZ.T5^<7_#X/\ X)4_])%?V,O_ !(GX7__ #24?\/@_P#@E3_TD5_8R_\
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M/T=HK\XO^'P?_!*G_I(K^QE_XD3\+_\ YI*/^'P?_!*G_I(K^QE_XD3\+_\
MYI* L^S^YGZ.T5^<7_#X/_@E3_TD5_8R_P#$B?A?_P#-)1_P^#_X)4_])%?V
M,O\ Q(GX7_\ S24!9]G]S/T=HK\XO^'P?_!*G_I(K^QE_P")$_"__P":2C_A
M\'_P2I_Z2*_L9?\ B1/PO_\ FDH"S[/[F?H[17YQ?\/@_P#@E3_TD5_8R_\
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MTC@_8,_\1!_9\_\ G>4?\.J_^"8'_2.#]@S_ ,1!_9\_^=Y7WK10%WW?WO\
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MSX*_X=5_\$P/^D<'[!G_ (B#^SY_\[RC_AU7_P $P/\ I'!^P9_XB#^SY_\
M.\K[UHH"[[O[W_F?!7_#JO\ X)@?](X/V#/_ !$']GS_ .=Y1_PZK_X)@?\
M2.#]@S_Q$']GS_YWE?>M% 7?=_>_\SX*_P"'5?\ P3 _Z1P?L&?^(@_L^?\
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M_P 1!_9\_P#G>5]ZT4!=]W][_P SX*_X=5_\$P/^D<'[!G_B(/[/G_SO*/\
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M+ON_O?\ F?!7_#JO_@F!_P!(X/V#/_$0?V?/_G>4?\.J_P#@F!_TC@_8,_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
